- Conditions: Somatisation Disorder; Somatoform Disorders
Intervention: Behavioral: Acceptance and Commitment Therapy
Sponsor: University of Aarhus
Not yet recruiting - verified January 2012 - Conditions: Cannabis Dependence; Psychostimulant Dependence
Intervention: Drug: Risperidone
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified January 2012 - Conditions: Substance Use; Sexual Risk Behaviors
Interventions: Behavioral: Risk Reduction Therapy for Adolescents; Behavioral: Usual services
Sponsor: Medical University of South Carolina
Recruiting - verified January 2012 - Condition: Cerebrovascular Accident
Interventions: Behavioral: Combined dCIT with FET; Behavioral: Combined BAT with FET; Behavioral: Control intervention group
Sponsors: Chang Gung Memorial Hospital; National Science Council, Taiwan; National Health Research Institutes, Taiwan
Recruiting - verified December 2011 - Portable Mantram Meditation for Veterans With Military Related Post Traumatic Stress Syndrome (PTSD)Condition: PTSD
Interventions: Behavioral: Portable Mantram Repetition Meditation; Behavioral: Present-Centered Group Therapy
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified January 2012 - Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCondition: Hepatitis C, Chronic
Interventions: Drug: tenofovir; Drug: ribavirin; Drug: ribavirin; Drug: ribavirin; Drug: caffeine; Drug: caffeine; Drug: midazolam; Drug: midazolam; Drug: tolbutamide; Drug: tolbutamide; Drug: pegylated inteferon; Drug: pegylated interferon; Drug: BI 201335; Drug: BI 201335; Drug: BI 201335; Drug: BI 207127; Drug: BI 207127; Drug: BI 207127
Sponsor: Boehringer Ingelheim Pharmaceuticals
Not yet recruiting - verified February 2012 - Conditions: Purpura; Idiopathic Thrombocytopenic Purpura
Interventions: Drug: rituximab; recombinant human thrombopoietin (rhTPO); Drug: Rituximab
Sponsors: Shandong University; The Affiliated Hospital of the Chinese Academy of Military Medical Sciences; the First Affiliated Hospital of AnHui Medical University; The First Affiliated Hospital of Dalian Medical University; Shandong Provincial Hospital; Shenzhen Second People's Hospital; The First Affiliated Hospital of China Medical University; Chinese Traditional Medicine Hospital of Zhejiang Province
Recruiting - verified September 2011 - Conditions: Hazardous Drinking; Binge Drinking; HIV-infected
Interventions: Behavioral: cognitive behavioral group therapy; Behavioral: health education group
Sponsors: Brown University; Moi University; Syracuse University; Indiana University; Yale University
Not yet recruiting - verified January 2012 - Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Gefitinib and Nimotuzumab; Drug: Gefitinib
Sponsor: Yonsei University
Recruiting - verified December 2011 - Condition: Neck Pain
Interventions: Procedure: Craniosacral Therapy; Procedure: Sham Craniosacral Therapy
Sponsor: Universität Duisburg-Essen
Not yet recruiting - verified February 2012 - Condition: Chronic Hepatitis B
Intervention: Drug: Pegylated interferon alfa-2a plus nucleos(t)ide(s)
Sponsors: Marcus Schuchmann; Johannes Gutenberg University Mainz; Roche Pharma AG
Not yet recruiting - verified January 2012 - Condition: Cerebrovascular Accident
Interventions: Behavioral: Task-related unilateral arm training; Behavioral: Task-related bilateral arm training; Behavioral: Combined uni- and bi-lateral arm training; Device: Robot-assisted bilateral arm training; Device: Robot-assisted unilateral arm training
Sponsors: Chang Gung Memorial Hospital; National Science Council, Taiwan; National Health Research Institutes, Taiwan
Recruiting - verified January 2012 - Condition: Chronic Headaches
Intervention: Behavioral: Behavioral Treatment for Chronic Headache- Exercise Version
Sponsor: University of Mississippi Medical Center
Recruiting - verified November 2011 - Conditions: Pain; Hip Fracture
Interventions: Drug: Placebo; Drug: Acetaminophen IV
Sponsor: Lancaster General Hospital
Recruiting - verified January 2012 - Condition: Autoimmune Autonomic Ganglionopathy (AAG)
Interventions: Drug: Intravenous Immunoglobulin; Drug: Intravenous Immunoglobulin
Sponsors: Beth Israel Deaconess Medical Center; Mayo Clinic; Vanderbilt University; New York University Medical Center; The University of Texas Southwestern Medical Center; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting - verified January 2012 - Condition: Behavior Problems, Child
Interventions: Behavioral: Chicago Parent Program; Behavioral: Parent-Child Interaction Therapy
Sponsors: Johns Hopkins University; The Family Center at Kennedy Krieger Institute; University of Iowa School of Nursing
Recruiting - verified January 2012 - Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy; Other: Near target push-ups; Other: Placebo home-based computer vergence/accommodative therapy; Other: Placebo yoked prism flippers
Sponsors: Jaeb Center for Health Research; National Eye Institute (NEI)
Not yet recruiting - verified January 2012 - Conditions: Meibomian Gland Dysfunction; Dry Eye
Interventions: Device: LipiFlow System; Device: Warm Compress Therapy + Lid Scrub
Sponsor: TearScience, Inc.
Recruiting - verified January 2012 - Condition: Multiple Myeloma
Intervention: Drug: NOX-A12
Sponsor: Noxxon Pharma AG
Not yet recruiting - verified January 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30; Drug: biphasic insulin aspart 30; Drug: sitagliptin; Drug: metformin
Sponsor: Novo Nordisk
Not yet recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI)
Not yet recruiting - verified January 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Acute Exacerbation of Chronic Obstructive Airways Disease; Chronic Hypercapnic Respiratory Failure
Intervention: Device: Nightly NIV for at least 6 hours
Sponsors: University Hospital, Gentofte, Copenhagen; Philips Respironics
Not yet recruiting - verified January 2012 - Condition: Hypertriglyceridemia
Interventions: Dietary Supplement: CaPre™; Dietary Supplement: CaPre™; Dietary Supplement: CaPre™; Other: Standard of care
Sponsors: Acasti Pharma Inc.; JSS Medical Research Inc.
Recruiting - verified January 2012 - Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Everolimus
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified January 2012 - Condition: Hallux Valgus
Interventions: Drug: Tapentadol IR 50 mg; Drug: Tapentadol IR 75 mg; Drug: Placebo
Sponsor: Janssen Research & Development, LLC
Recruiting - verified January 2012 - Condition: Osteoarthritis, Knee
Interventions: Other: knee OA project; Other: conventional PT
Sponsor: Meir Medical Center
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Usual care; Procedure: self-monitoring for patients with severe COPD; Procedure: nurse-monitoring for patients with severe COPD
Sponsors: Regione Veneto; European Commission; Unità Locale Socio Sanitaria di Treviso; Unità Locale Socio Sanitaria Veneziana; Unità Locale Socio Sanitaria di Verona; Unità Locale Socio Sanitaria di Padova; Azienda Ospedaliera di Padova; Azienda Ospedaliera Universitaria Integrata Verona
Recruiting - verified January 2012 - Condition: Congestive Heart Failure
Interventions: Other: Usual care; Procedure: Telemonitoring for patients with Congestive Heart Failure
Sponsors: Regione Veneto; European Commission; Unità Locale Socio Sanitaria di Treviso; Unità Locale socio Sanitaria di Pieve di Soligo; Unità Locale Socio Sanitaria di Padova; Unità Locale Socio Sanitaria di Verona; Unità Locale Socio Sanitaria Veneziana; Unità Locale Socio Sanitaria di Mirano; Azienda Ospedaliera di Padova; Azienda Ospedaliera Universitaria Integrata Verona
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Behavioral: Aerobic Exercise; Behavioral: Control Group
Sponsors: Federal University of Rio de Janeiro; Rio de Janeiro State Research Supporting Foundation (FAPERJ); Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified January 2012 - Conditions: Chronic Pain; Opioid Abuse, Unspecified Use
Interventions: Behavioral: Mindfulness-Oriented Recovery Enhancement; Behavioral: Conventional Support Group (SG)
Sponsors: Florida State University; National Institute on Drug Abuse (NIDA); Fahs Beck Fund for Research and Experimentation
Recruiting - verified January 2012 - Conditions: Aphasia; Stroke
Intervention: Device: Magstim SuperRapid
Sponsors: University of Cincinnati; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Januvia (Sitagliptin phosphate); Other: Placebo
Sponsors: Blandine Laferrere, MD; Merck
Not yet recruiting - verified January 2012 - Conditions: Multiple Sclerosis; Apraxia
Interventions: Other: Occupational Therapy; Other: Physical therapy
Sponsor: University Hospital Inselspital, Berne
Not yet recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Inspiratory muscle training; Other: Respiratory exercise
Sponsor: Universidade Federal de Sao Carlos
Recruiting - verified January 2012 - Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib; Procedure: laser ablation (LA)
Sponsor: Cardarelli Hospital
Recruiting - verified January 2012 - Conditions: Prostatic Neoplasm; Prostate Cancer; Prostatic Adenocarcinoma; Hormone Refractory Prostate Cancer; Stage IV Prostate Carcinoma
Interventions: Drug: Abiraterone acetate plus prednisone; Drug: Abiraterone acetate plus prednisone; Drug: Abiraterone acetate plus prednisone
Sponsors: University of Washington; Janssen, LP
Not yet recruiting - verified January 2012 - Condition: Osteoarthritis of the Knee
Interventions: Drug: Placebo; Drug: Hyruan Plus; Drug: LBSA0103
Sponsor: LG Life Sciences
Recruiting - verified January 2012 - Condition: Hypertension
Intervention: Procedure: Renal denervation
Sponsor: Katholieke Universiteit Leuven
Not yet recruiting - verified January 2012 - Condition: Shoulder Impingement Syndrome
Intervention: Other: Shoulder resistive exercise
Sponsor: Texas Woman's University
Not yet recruiting - verified January 2012 - Conditions: Sexually Transmitted Infection; HIV
Interventions: Behavioral: Tailored Socio-Contextual Intervention; Behavioral: Standard of Care
Sponsors: University of Wisconsin, Milwaukee; National Institute of Mental Health (NIMH)
Not yet recruiting - verified January 2012 - Conditions: Brain Cancer; Brain Stem Glioma
Intervention: Radiation: Radioactive iodine-labeled monoclonal antibody 8H9
Sponsors: Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; Johns Hopkins University
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Device: Everolimus Eluting Stent or Zotalolimus Eluting Stent; Drug: ARB, CCB, ACE-inhibitor, statin, Nitrate, Antiplate etc.
Sponsor: Yonsei University
Recruiting - verified January 2012 - Condition: Lung Cancer
Intervention:
Sponsor: Third Military Medical University
Not yet recruiting - verified December 2011 - Condition: Carcinoma, Renal Cell
Intervention: Drug: Sorafenib (Nexavar, BAY 43-9006)
Sponsor: Bayer
Not yet recruiting - verified February 2012 - Condition: Bipolar Disorder
Interventions: Drug: Ketamine hydrochloride injection; Drug: Flat tonic water (e.g., Canada Dry Tonic Water)
Sponsor: Juvenile Bipolar Research Foundation
Not yet recruiting - verified January 2012 - Condition: Dysphagia
Intervention: Other: speech therapy
Sponsor: Federal University of São Paulo
Recruiting - verified December 2011 - Condition: H. Pylori Infection
Interventions: Drug: TAK-438; Drug: Lansoprazole; Drug: Amoxicillin; Drug: Clarithromycin
Sponsor: Takeda Pharmaceutical Company Limited
Not yet recruiting - verified January 2012 - Condition: Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
Interventions: Device: Sirolimus-eluting stent; Device: Biolimus-eluting stents; Drug: pravastatin 20mg/day after DES implantation; Drug: pitavastatin 2mg/day after DES implantation; Drug: Non-ARB /day after DES implantation; Drug: Eposartan 600mg/day after DES implantation
Sponsor: Yonsei University
Recruiting - verified January 2012 - Condition: Radiation Induced Sarcoma
Interventions: Genetic: tumor genetic predisposition to develop sarcoma assessment; Genetic: tumor genetic predisposition to develop sarcoma assessment
Sponsor: Centre Georges Francois Leclerc
Recruiting - verified January 2012 - Condition: Preterm Premature Rupture of Membrane
Interventions: Drug: Cefazolin; Drug: Clarithromycin; Drug: Cefazolin; Drug: Clarithromycin
Sponsor: Samsung Medical Center
Recruiting - verified January 2012 - Conditions: Non-Hodgkin's Lymphoma; Epstein-Barr Virus
Interventions: Biological: EBV-specific T-cells; Biological: EBV-specific T-cells
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified December 2011 - Condition: Birth-weight
Interventions: Behavioral: Behavioral therapy; Other: Exercise; Other: Behavioral therapy and exercise
Sponsor: University of Turin, Italy
Recruiting - verified January 2012 - Conditions: Obesity; Eating Disorder
Intervention: Behavioral: Telephone based Cognitive Behavioral therapy
Sponsor: University Health Network, Toronto
Not yet recruiting - verified January 2012 - Condition: Smoking Cessation
Interventions: Behavioral: Telephone counseling; Drug: Nicotine-replacement therapy (patches); Behavioral: Monetary incentives
Sponsors: University of California, San Diego; University of California, San Francisco; Centers for Medicare and Medicaid Services; California Department of Health Services
Not yet recruiting - verified December 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Aspirin or thienopyridine; Drug: Aspirin and thienopyridine
Sponsor: Associations for Establishment of Evidence in Interventions
Recruiting - verified January 2012 - Condition: White Spot Lesions
Interventions: Device: Vanish varnish; Device: Oral B Minute-Gel
Sponsors: 3M; University of Tennessee Health Science Center
Not yet recruiting - verified December 2011 - Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Fingolimod (FTY720)
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified December 2011 - Condition: Bleeding
Interventions: Drug: TachoSil®; Drug: Surgicel® Original
Sponsors: Nycomed; Baxter US
Not yet recruiting - verified December 2011 - Conditions: Smoking; Type 2 Diabetes
Interventions: Behavioral: Acceptance and Commitment Therapy; Behavioral: Standard smoking cessation intervention
Sponsor: Rhode Island Hospital
Recruiting - verified December 2011 - Conditions: Obesity; Diabetes
Interventions: Procedure: Gastric By-Pass; Drug: optimized medical management
Sponsor: University Hospital, Lille
Recruiting - verified December 2011 - Condition: Pulmonary Disease
Interventions: Drug: Nitric Oxide; Other: Routine treatment protocol
Sponsors: Fudan University; Children's Hospital of Fudan University; Hebei Provincial Children's Hospital; Shen-Zhen City Maternity and Child Healthcare Hospital; Hunan Children's Hospital; QuanZhou Women and Children's Hospital; The First Affiliated Hospital of Xiamen University; Xiamen Women's and Children's Hospital
Recruiting - verified December 2011 - Condition: Atrial Fibrillation
Interventions: Other: sphygmomanometer cuff inflations; Other: standard of care
Sponsor: Baystate Medical Center
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: GW685698/GW642444; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: GW685698/GW642444; Drug: CCI18781
Sponsor: GlaxoSmithKline
Not yet recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified January 2012 - Condition: Diabetic Foot Ulcer
Interventions: Device: standard hoem treatment; Device: LLLT-808 B-cure laser machine
Sponsor: Hadassah Medical Organization
Not yet recruiting - verified December 2011 - Condition: Epilepsy
Interventions: Drug: VX-765; Drug: Placebo
Sponsor: Vertex Pharmaceuticals Incorporated
Recruiting - verified January 2012 - Condition: Melanoma
Interventions: Drug: Sylatron; Drug: Yervoy
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Merck
Not yet recruiting - verified January 2012 - Conditions: Depression; Anxiety; Myocardial Infarction
Intervention: Behavioral: Internet‐based CBT
Sponsor: Uppsala University
Not yet recruiting - verified January 2012 - Condition: Asthma
Interventions: Device: NIPPV (PALMtop PTV); Device: Volumetric CO2 (NM3); Device: USCOM
Sponsor: Vanderbilt University
Not yet recruiting - verified December 2011 - Conditions: Actinic Keratosis; Skin Lesions; Porokeratosis; Porokeratosis, Disseminated Superficial Actinic 1; Actinic Porokeratosis
Interventions: Drug: SR-T100 gel; Drug: Vehicle gel
Sponsors: G&E Herbal Biotechnology Co., LTD; Statplus Inc. (Taipei, Taiwan Republic of China)
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Intensive treatment with sodium bicarbonate; Drug: Standard treatment with saline infusion
Sponsor: University of Roma La Sapienza
Not yet recruiting - verified December 2011 - Conditions: Chronic Subclinic Inflammation; Redox Status
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: resveratrol
Sponsor: University of Turin, Italy
Recruiting - verified December 2011 - Condition: Cutaneous T Cell Lymphoma
Interventions: Other: Resiquimod gel (0.06%); Drug: Resiquimod gel (0.2%)
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified December 2011 - Condition: Mental Disorders
Interventions: Behavioral: Computer-assisted live supervision; Behavioral: Delayed video-based supervision
Sponsors: Goethe University; Central Institute of Mental Health, Mannheim; German Association for Behavior Therapy
Recruiting - verified February 2012 - Condition: Fatigue in Multiple Sclerosis
Intervention: Other: Physical exercise
Sponsor: Novartis Pharmaceuticals
Recruiting - verified December 2011 - Condition: Quality of Life
Intervention: Behavioral: Cognitive Behavioral Therapy
Sponsors: Gerencia de Atención Primaria, Madrid; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria
Recruiting - verified December 2011 - Condition: Depression
Interventions: Other: OxIGen + iCBT; Other: iCBT; Other: Waitlist Control
Sponsors: Alishia Williams; The University of New South Wales
Recruiting - verified December 2011 - Conditions: Blood Coagulation Disorders; Hemorrhage
Intervention: Drug: Human fibrinogen concentrate
Sponsor: University Children's Hospital, Zurich
Recruiting - verified January 2012 - Conditions: Dyspnoea; Chest Pain; Cough
Intervention: Other: Focused Sonography of the heart, lungs and deep veins
Sponsors: Odense University Hospital; University of Southern Denmark
Recruiting - verified December 2011 - Condition: Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate (GTR); Drug: Glatiramer Acetate (Copaxone®); Drug: Placebo
Sponsor: Synthon BV
Recruiting - verified January 2012 - Condition: Schizophrenia
Interventions: Drug: TC-5619 5mg; Drug: TC-5619 50mg; Drug: Placebo
Sponsors: Targacept Inc.; AstraZeneca
Recruiting - verified January 2012 - Conditions: Healthy Subjects; Renal Impairments
Interventions: Drug: Levetiracetam 250 mg; Drug: Levetiracetam 500 mg
Sponsors: UCB, Inc.; Parexel
Recruiting - verified January 2012 - Condition: Ulcerative Colitis
Interventions: Other: Standard MBSR; Other: Tailored MBSR
Sponsor: Rush University Medical Center
Recruiting - verified December 2011 - Condition: Schizophrenia
Interventions: Drug: GWP42003 : GWP42004 (40:1); Drug: Placebo
Sponsor: GW Pharmaceuticals Ltd.
Recruiting - verified January 2012 - Conditions: Anxiety Disorders; Generalized Anxiety Disorder
Intervention: Behavioral: Motivational Interviewing and Cognitive Behavioural Therapy
Sponsors: York University; Ryerson University; University of Massachusetts, Amherst
Not yet recruiting - verified December 2011 - Conditions: Postoperative Cardiac Complication; Heart Failure,; Left Ventricular Cardiac Dysfunction; Inappropriate Phrenic Nerve Stimulation; Perioperative/Postoperative Complications
Interventions: Procedure: Standard Left Ventricular (LV) lead; Device: Quartet Left Ventricular (LV) lead
Sponsor: St. Jude Medical
Recruiting - verified January 2012 - Condition: Sepsis
Interventions: Other: Fluid Resuscitation; Other: Standard of Care
Sponsor: Cheetah Medical Inc.
Recruiting - verified February 2012 - Condition: Acute Kidney Injury
Interventions: Drug: nafamostat; Drug: heparinized saline priming group
Sponsors: Seoul National University Hospital; SK Chemicals Co.,Ltd.
Not yet recruiting - verified December 2011 - Conditions: Memory Impairment; Anxiety
Interventions: Procedure: Acupuncture; Procedure: Control group
Sponsor: National University of Health Sciences
Recruiting - verified December 2011 - Conditions: HIV; Sexual Risk; Sexually Transmitted Diseases; Substance Abuse; Violence; Victimization
Interventions: Behavioral: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC); Biological: Test, Treat, Retain(TTR) only
Sponsors: RTI International; University of North Carolina, Chapel Hill
Not yet recruiting - verified December 2011 - Conditions: HIV Infections; Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN); Drug: Ribavirin (RBV); Drug: Boceprevir (BOC)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified January 2012 - Condition: Liver Carcinoma
Interventions: Drug: sorafenib; Drug: SIR-Sphere
Sponsors: Assistance Publique - Hôpitaux de Paris; Ministry of Health, France
Recruiting - verified November 2011 - Condition: Heart Failure
Intervention: Device: Barostim Neo System
Sponsor: CVRx, Inc.
Recruiting - verified November 2011 - Condition: Tinnitus
Interventions: Other: Sound Based and Educational Therapies; Other: Integrated Medicine Therapies and Sound Based Education Therapies; Other: Integrated Medicine Therapies and SBE
Sponsors: Duke University; National Institutes of Health (NIH); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified November 2011 - Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: NOX-A12
Sponsor: Noxxon Pharma AG
Not yet recruiting - verified December 2011 - Condition: Fear of Childbirth
Interventions: Other: Art Therapy and therapeutic conversations; Other: Therapeutic conversations
Sponsor: Helsingborgs Hospital
Recruiting - verified October 2011 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Metformin; Behavioral: Dietary Restriction; Behavioral: Exercise Training
Sponsors: Pennington Biomedical Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified December 2011 - Conditions: Intracranial Aneurysm; Subarachnoid Hemorrhage
Interventions: Device: Hydrogel coil; Device: Bare platinum coil
Sponsors: Kobe City General Hospital; Translational Research Informatics Center, Kobe, Hyogo, Japan
Not yet recruiting - verified January 2012 - Condition: Acute, Displaced Midshaft Clavicle Fractures
Interventions: Procedure: Conservative Treatment; Procedure: Surgical treatment
Sponsor: Hvidovre University Hospital
Recruiting - verified December 2011 - Condition: Macular Degeneration
Interventions: Biological: VEGF Trap-Eye (BAY86-5321); Drug: Visudyne
Sponsors: Bayer; Regeneron Pharmaceuticals
Recruiting - verified January 2012 - Condition: Postpartum Depression
Intervention: Behavioral: Interpersonal therapy-based treatment
Sponsors: Women and Infants Hospital of Rhode Island; National Institute of Mental Health (NIMH); Pacific Institute for Research and Evaluation; Brown University
Recruiting - verified January 2012 - Conditions: Depression; Generalized Anxiety Disorder; Panic Disorder
Interventions: Behavioral: CCBT+ISG/Collaborative Care; Behavioral: CCBT/Collaborative Care
Sponsor: University of Pittsburgh
Not yet recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China; Other: usual care
Sponsor: Henan University of Traditional Chinese Medicine
Not yet recruiting - verified October 2011 - Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione; Drug: none-control group
Sponsor: James A. Haley Veterans Administration Hospital
Recruiting - verified December 2011 - Condition: Spinal Cord Injury
Intervention: Drug: SPINALON (buspirone + levodopa + cardidopa)
Sponsors: Nordic Life Science Pipeline Inc.; Department of Defense
Not yet recruiting - verified December 2011 - Condition: Mental Disorders
Intervention: Behavioral: Mindfulness-based group treatment
Sponsor: Lund University
Not yet recruiting - verified November 2011 - Condition: Colorectal Cancer Metastatic
Intervention: Device: TheraSphere
Sponsor: Nordion (Canada) Inc.
Recruiting - verified January 2012 - Condition: Actinic Keratosis
Interventions: Drug: Broad Area ALA 1-hour incubation; Drug: Broad Area ALA 2-hr incubation; Drug: broad area ALA 3-hour incubation; Drug: Spot application ALA 2 hour incubation; Drug: Vehicle PDT
Sponsor: DUSA Pharmaceuticals, Inc.
Recruiting - verified January 2012 - Condition: Dementia
Interventions: Behavioral: The Talking Sense manual; Behavioral: Treatment as usual - communication information and advice
Sponsors: University of Portsmouth; Solent NHS Primary Care Trust; The Sir Halley Stewart Trust
Not yet recruiting - verified November 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: RV568; Drug: RV568; Drug: Placebo
Sponsor: Respivert Ltd
Recruiting - verified December 2011 - Conditions: Stress Disorder, Post-Traumatic; Substance-Related Disorders
Interventions: Behavioral: Integrated Cognitive Behavioral Therapy; Behavioral: Treatment-as-usual
Sponsors: Dartmouth-Hitchcock Medical Center; Brown University; Providence VA Medical Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Conditions: Urinary Incontinence; Urinary Incontinence, Urge
Interventions: Behavioral: Mindfulness-Based Stress Reduction (MBSR); Behavioral: Sham Yoga Group
Sponsor: University of Utah
Recruiting - verified November 2011 - Conditions: Major Depressive Disorder; Dysthymic Disorder; Depressive Disorder NOS; Neuropathic Pain
Intervention: Behavioral: Mindfulness Based Cognitive Therapy
Sponsor: Massachusetts General Hospital
Recruiting - verified December 2011 - Condition: Painful Diabetic Neuropathies
Interventions: Genetic: Low Dose: 16 mg VM202; Genetic: High Dose: 32 mg VM202; Genetic: Placebo (Normal Saline)
Sponsors: ViroMed Co., Ltd.; VM Biopharma
Not yet recruiting - verified November 2011 - Condition: Diabetes Mellitus
Interventions: Drug: Abciximab; Drug: control
Sponsor: Seoul National University Bundang Hospital
Recruiting - verified November 2011 - Conditions: Rectal Cancer; Quality of Life; Surgery
Intervention:
Sponsors: Sahlgrenska University Hospital, Sweden; Swedish Cancer Foundation; The Swedish Society of Medicine; Assar Gabrielsson Foundation; The Gothenburg Medical Society
Not yet recruiting - verified November 2011 - Conditions: Dental Caries; Compliance Behavior
Interventions: Procedure: caries infiltrant; Procedure: Diammine silver fluoride; Procedure: Dental Flossing
Sponsors: University of Sao Paulo; University of Copenhagen
Not yet recruiting - verified November 2011 - Condition: Heart Failure
Intervention: Behavioral: Educational intervention
Sponsor: University of Oslo
Not yet recruiting - verified November 2011 - Conditions: Stress Disorders, Post-Traumatic; Substance-Related Disorders
Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD; Behavioral: Individual Addiction Counseling; Behavioral: Treatment as usual
Sponsors: Dartmouth-Hitchcock Medical Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Acute Achilles Tendon Rupture
Intervention: Procedure: Early weight-bearing
Sponsors: Hvidovre University Hospital; DJO Incorporated
Recruiting - verified November 2011 - Condition: Non ST Segment Elevation MI and Unstable Angina
Interventions: Procedure: One-Stage group; Procedure: Multi-Staged group
Sponsor: Gennaro Sardella
Recruiting - verified November 2011 - Condition: Irritable Bowel Syndrome
Interventions: Drug: Milnacipran; Drug: Milnacipran; Drug: Milnacipran; Drug: Placebo
Sponsors: Spencer Dorn, MD, MPH; Forest Laboratories
Recruiting - verified January 2012 - Condition: Non-small Cell Lung Cancer
Interventions: Other: MRI Screening Form, MRI, Demographic / Medical Data form; Other: MRI Screening Form, MRI. Demographic / Medical Data
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified November 2011 - Condition: Pulmonary Arterial Hypertension
Interventions: Other: Iloprost (Ventavis inhaled, BAYQ6256); Other: Iloprost (Ventavis inhaled, BAYQ6256)
Sponsors: Bayer; Dra. Pilar Escribano Subías - Coordinator - HU 12 de Octubre - Madrid (Spain)
Recruiting - verified February 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: LY3009104; Drug: Placebo; Drug: LY3009104; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified January 2012 - Condition: Traumatic Brain Injury
Interventions: Behavioral: Group Interactive Structured Treatment; Behavioral: Alternative Intervention
Sponsors: Craig Hospital; Rehabilitation Hospital of Indiana; Hunter Holmes McGuire VA Medical Center; VA Palo Alto Health Care System; Wayne State University; University of Washington
Not yet recruiting - verified November 2011 - Conditions: Hepatectomy; RFA; Giant Cavernous Hemangiomas
Interventions: Procedure: RFA; Procedure: hepatectomy
Sponsor: Southwest Hospital, China
Not yet recruiting - verified November 2011 - Condition: Resistant Hypertension
Intervention: Device: Barostim Neo System
Sponsor: CVRx, Inc.
Not yet recruiting - verified November 2011 - Condition: Heart Failure
Intervention: Device: Barostim Neo System
Sponsor: CVRx, Inc.
Not yet recruiting - verified November 2011 - Conditions: PONV; Nausea
Interventions: Drug: Aprepitant; Drug: Ondansetron
Sponsor: Sergio Bergese
Recruiting - verified November 2011 - Condition: Perennial Allergic Rhinitis
Interventions: Drug: mometasone furoate plus azelastine HCl; Drug: mometasone furoate; Drug: azelastine HCl
Sponsor: Hanlim Pharm. Co., Ltd.
Recruiting - verified November 2011 - Condition: Low Back Pain
Interventions: Behavioral: Cognitive Behavioral Therapy; Behavioral: Mindfulness Based Stress Reduction
Sponsors: Group Health Cooperative; National Center for Complementary and Alternative Medicine (NCCAM)
Not yet recruiting - verified November 2011 - Condition: Acute Alcoholic Hepatitis
Interventions: Biological: ELAD (Extracorporeal Liver Assist System); Biological: Standard of care only
Sponsor: Vital Therapies, Inc.
Not yet recruiting - verified November 2011 - Condition: Gait or Balance Disorder Problems
Interventions: Drug: betahistine dihydrochloride; Other: placebo
Sponsor: Abbott Products
Not yet recruiting - verified October 2011 - Condition: Hemodialysis Fluid Allergy
Intervention: Device: Dry weight adjustment
Sponsor: Zonguldak Karaelmas University
Recruiting - verified November 2011 - Conditions: Relapsing-remitting Multiple Sclerosis; Secondary-progressive Multiple Sclerosis
Interventions: Drug: estriol; Other: Placebo; Drug: Norethindrone; Other: Progestin Placebo
Sponsors: University of California, Los Angeles; Adeona Pharmaceuticals
Recruiting - verified November 2011 - Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab; Drug: Ranibizumab
Sponsors: Vitreo-Retinal Associates, PC; Genentech
Recruiting - verified January 2012 - Condition: Hereditary Cerebellar Ataxia.
Intervention: Other: stem cell transplantation
Sponsor: General Hospital of Chinese Armed Police Forces
Not yet recruiting - verified December 2011 - Conditions: Stroke; Infarction, Middle Cerebral Artery
Interventions: Genetic: Autologous BMSCs transplantation; Genetic: Autologous EPCs transplantation; Genetic: IV infusion of placebo
Sponsors: Southern Medical University, China; The Second People's Hospital of Nanhai District of Foshan; The first people's hospital of Haizhu District of Guangzhou; Cellonis Biotechnology Co. Ltd.
Recruiting - verified November 2011 - Condition: Hepatitis C Infection
Intervention: Drug: Boceprevir
Sponsor: Arrowhead Regional Medical Center
Recruiting - verified November 2011 - Condition: Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsor: Nycomed
Not yet recruiting - verified November 2011 - Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib; Drug: Rapamycin; Drug: Irinotecan; Drug: Temozolomide; Drug: Irinotecan; Drug: Temozolomide
Sponsor: University of Regensburg
Not yet recruiting - verified November 2011 - Condition: Mild Cognitive Impairment
Interventions: Device: H-Coil Deep TMS; Device: SHAM Coil TMS
Sponsor: Brainsway
Not yet recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: SSRI antidepressants; Behavioral: attributional retraining
Sponsor: Nanjing Medical University
Not yet recruiting - verified October 2011 - Condition: Multiple Myeloma
Interventions: Drug: masitinib 6 mg/kg/day; Drug: placebo
Sponsor: AB Science
Recruiting - verified November 2011 - Condition: Opioid Induced Constipation
Interventions: Drug: TD-1211; Drug: TD-1211; Drug: TD-1211; Drug: Placebo
Sponsor: Theravance
Recruiting - verified November 2011 - Condition: Leukemia
Interventions: Drug: Azacitidine (AZA); Drug: Tyrosine kinase inhibitor (TKI); Drug: Azacitidine
Sponsors: M.D. Anderson Cancer Center; Celgene Corporation
Not yet recruiting - verified October 2011 - Condition: Immunization
Intervention: Behavioral: Music Therapy
Sponsor: Florida State University
Recruiting - verified October 2011 - Condition: Depression
Interventions: Behavioral: CBT - active; Behavioral: CBT - euthymic; Behavioral: CBASP
Sponsors: Philipps University Marburg Medical Center; Universität Duisburg-Essen
Recruiting - verified October 2011 - Condition: Ulcerative Colitis
Interventions: Drug: Placebo; Drug: CP690,550; Drug: CP690,550
Sponsor: Pfizer
Not yet recruiting - verified January 2012 - Condition: Depression Disorder, Major
Interventions: Drug: RO4995819; Drug: RO4995819; Drug: RO4995819; Drug: Placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified January 2012 - Conditions: Myocardial Infarction; Cardiovascular Disease
Interventions: Other: DAPT will be stopped after randomisation; Other: DAPT wil be continued 6 months after randomisation
Sponsors: Maasstad Hospital; Medtronic
Not yet recruiting - verified October 2011 - Condition: Addiction
Intervention: Behavioral: STICA Intervention
Sponsor: Johannes Gutenberg University Mainz
Recruiting - verified January 2012 - Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast; Other: placebo; Drug: 5 mg Montelukast
Sponsor: Children's Mercy Hospital Kansas City
Not yet recruiting - verified October 2011 - Condition: Spinal Cord Injury
Interventions: Procedure: Conventional Treatment; Drug: Lithium Carbonate; Biological: Cord Blood Cell; Other: Placebo
Sponsors: China Spinal Cord Injury Network; Chinese PLA Chengdu Army Kunming General Hospital; StemCyte, Inc.
Recruiting - verified October 2011 - Conditions: Alzheimer's Disease; Schizophrenia
Interventions: Drug: amisulpride; Drug: amisulpride; Drug: amisulpride
Sponsor: Institute of Psychiatry, London
Not yet recruiting - verified October 2011 - Condition: Hypertension
Intervention: Other: Telecare, selfmonitoring, lifestyl behaviour
Sponsor: VU University Medical Center
Recruiting - verified January 2012 - Condition: Spinal Stenosis of Lumbar Region
Interventions: Drug: predinose oral; Drug: placebo group
Sponsor: Federal University of São Paulo
Recruiting - verified October 2011 - Conditions: Inhalation Burns; Smoke Inhalation Injury
Interventions: Other: standard care; Drug: Heparin
Sponsor: Tehran University of Medical Sciences
Not yet recruiting - verified October 2011 - Conditions: Perioperative Hemodynamic Optimization; Cardiac Surgery
Interventions: Other: Goal-directed Resuscitation Therapy (GDT); Other: Standard protocol
Sponsors: University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Not yet recruiting - verified October 2011 - Condition: Stroke
Interventions: Other: Creative therapy (art and music therapy); Other: Physical therapy
Sponsor: Mahidol University
Not yet recruiting - verified October 2011 - Conditions: Cardiovascular Diseases; Acute Coronary Syndrome
Interventions: Drug: clopidogrel; Drug: prasugrel
Sponsors: University of Maryland; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified October 2011 - Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout FlaresCondition: Gout
Interventions: Drug: Rilonacept; Drug: Placebo; Drug: Allopurinol
Sponsor: Regeneron Pharmaceuticals
Recruiting - verified January 2012 - Condition: Bipolar Disorder
Intervention: Other: Cognitive Remediation
Sponsors: Rigshospitalet, Denmark; TrygFonden, Denmark; Copenhagen University Hospital, Hvidovre
Recruiting - verified November 2011 - Conditions: Hemiplegia; Brain Tumor
Intervention: Device: Focused rigidity bi-valve long arm cast
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified October 2011 - Conditions: Sleep Apnea, Obstructive; Patient Compliance
Interventions: Behavioral: Tailored; Other: Usual care
Sponsors: Milton S. Hershey Medical Center; National Institute of Nursing Research (NINR); Sigma Theta Tau International
Recruiting - verified December 2011 - Conditions: Gastroparesis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: 10mg TZP-102; Drug: 20mg TZP-102
Sponsor: Tranzyme, Inc.
Recruiting - verified December 2011 - Condition: Peripheral Arterial Disease
Intervention: Drug: Iloprost (Ilomedin, BAYQ6256)
Sponsor: Bayer
Recruiting - verified January 2012 - Condition: Fluid Volume Disorder
Intervention: Procedure: risk stratification group
Sponsor: Charite University, Berlin, Germany
Not yet recruiting - verified May 2011 - Condition: Stroke; Sequelae
Interventions: Procedure: Thai Traditional Massage (TTM); Procedure: Physical therapy program
Sponsor: Mahidol University
Not yet recruiting - verified October 2011 - Condition: Ankle Sprain
Interventions: Other: Physical Therapy; Other: Wii Balance Board
Sponsor: University Hospital, Geneva
Recruiting - verified October 2011 - Condition: Hospice Informal Caregivers
Intervention: Behavioral: Problem Solving Therapy
Sponsor: University of Washington
Recruiting - verified January 2012 - Conditions: Obesity; Morbid Obesity
Interventions: Device: abiliti system implant; Device: Laparoscopic adjustable gastric band (Allergan Lap Band)
Sponsor: IntraPace, Inc
Recruiting - verified October 2011 - Condition: Trichotillomania
Intervention: Behavioral: Habit Reversal Training
Sponsor: University of South Florida
Recruiting - verified September 2011 - Conditions: Suicidal Ideation; Major Depressive Disorder
Interventions: Behavioral: Dialectical Behavior Therapy Skills (DBT-S) Groups; Behavioral: Wait List-Treatment as Usual; Behavioral: No intervention-treatment as usual
Sponsor: Maurizio Fava, MD
Not yet recruiting - verified September 2011 - Condition: Smoking Cessation
Interventions: Drug: Meclizine; Drug: Nicotine patches
Sponsors: Duke University; Philip Morris Products S.A.
Recruiting - verified January 2012 - Condition: Burns
Interventions: Biological: human umbilical cord mesenchymal stem cells; Biological: human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells; Drug: Conventional therapy
Sponsors: Shenzhen Beike Bio-Technology Co., Ltd.; The Second Affiliated Hospital of Kunmming Medical College
Recruiting - verified October 2011 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets; Drug: Placebo
Sponsor: Lung Rx
Not yet recruiting - verified October 2011 - Conditions: End-Stage Renal Disease; Kidney Failure
Interventions: Biological: CD4+CD25+CD127lowFoxP3+ T regulatory cells injection; Drug: Alemtuzumab; Drug: Mycophenolate mofetil; Drug: Sirolimus; Drug: Tacrolimus; Drug: Cyclosporine; Drug: Everolimus; Procedure: Kidney transplantation
Sponsors: The Russian State Medical University; Russian Academy of Medical Sciences
Recruiting - verified November 2011 - Condition: Substance Abuse
Interventions: Behavioral: Treatment As Usual (TAU); Behavioral: Individual clinician-provided CBT; Behavioral: CBT4CBT
Sponsor: Yale University
Not yet recruiting - verified December 2011 - Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo; Biological: Epratuzumab 400 mg; Biological: Epratuzumab 1200 mg; Biological: Epratuzumab 100 mg; Biological: Epratuzumab 600 mg
Sponsor: UCB, Inc.
Recruiting - verified October 2011 - Condition: Ankle Fracture
Intervention: Other: Fracture union
Sponsor: University of Florida
Recruiting - verified September 2011 - Conditions: Coronary Occlusion/Thrombosis; Peptic Ulcer Hemorrhage
Intervention: Other: Screening for risk factors for ulcer bleeding
Sponsors: Odense University Hospital; Aarhus University Hospital; Danish Heart Foundation; Region of Southern Denmark; The Research board of Odense University Hospital
Recruiting - verified October 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere® Insulin with Gen2 Inhaler; Drug: Insulin aspart, basal insulin; Drug: Technosphere® Insulin with MedTone C Inhaler
Sponsor: Mannkind Corporation
Recruiting - verified September 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Amphetamine-dextroamphetamine (AMPH); Drug: Placebo; Behavioral: Well-being therapy
Sponsor: David P. Soskin,M.D.
Not yet recruiting - verified November 2011 - Conditions: Streptococcal Infection; Gram-positive Bacterial Infection; Bacterial Infection
Interventions: Biological: Group B streptococcus vaccine; Biological: Placebo
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified October 2011 - Condition: Postoperative Nausea and Vomiting
Intervention: Other: Ear seeds
Sponsor: Group G-6
Recruiting - verified November 2011 - Condition: Lumbar Radiculopathy
Interventions: Other: Lumbar Transforaminal Epidural Corticosteroid Injection; Other: Physical Therapy; Other: Observation
Sponsor: Stanford University
Recruiting - verified September 2011 - Conditions: HIV-1 Infection; Cardiovascular Disease
Interventions: Other: Control; Other: Intervention Group
Sponsor: Holdsworth House Medical Practice
Recruiting - verified November 2011 - Condition: Wegeners Granulomatosis
Interventions: Drug: Gusperimus + glucocorticoids; Drug: cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
Sponsor: Nordic Pharma SAS
Recruiting - verified January 2012 - Condition: Obesity
Interventions: Drug: Letrozole, Gonadorelin-GnRH, Luveris-lutropin, cetrorelix; Drug: Letrozole, Gonadorelin-GnRH, Luveris-lutropin, cetrorelix
Sponsor: University of Colorado, Denver
Recruiting - verified October 2011 - Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa2a; Drug: Ribavirin; Drug: Peginterferon alfa2a; Drug: Ribavirin
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Recruiting - verified September 2011 - Condition: Inflammatory Myelopathies
Interventions: Device: FES Cycling; Device: Cycling without FES; Procedure: Lumbar puncture; Behavioral: Mood assessment
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tDMARDs; Drug: biodmards
Sponsor: Pfizer
Not yet recruiting - verified September 2011 - Condition: Substance-Related Disorders
Interventions: Behavioral: Substance Abuse Education; Behavioral: Mind-body Bridging
Sponsor: University of Utah
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsor: AstraZeneca
Recruiting - verified December 2011 - Condition: Opioid Induced Constipation
Interventions: Drug: Placebo once daily; Drug: 0.1 mg of S-297995 once daily; Drug: 0.2 mg of S-297995 once daily; Drug: 0.4 mg of S-297995 once daily
Sponsor: Shionogi
Recruiting - verified October 2011 - Condition: Low Back Pain
Interventions: Procedure: Acupuncture and standard treatment in general practice; Other: Standard treatment in general practice
Sponsor: University of Oslo
Not yet recruiting - verified September 2011 - Condition: Depression Disorder, Major
Interventions: Drug: RO4917523; Drug: RO4917523; Drug: Placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified January 2012 - Conditions: Plantar Calcaneal Spur; Fasciitis, Plantar
Intervention: Device: algometer
Sponsors: Meir Medical Center; Clalit Health Services
Not yet recruiting - verified September 2011 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: TAK-438; Drug: Placebo; Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: TAK-438; Drug: Placebo; Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: TAK-438; Drug: Placebo; Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: TAK-438; Drug: Placebo; Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Atrial Fibrillation
Interventions: Drug: Warfarin; Drug: aspirin
Sponsor: Nanjing Medical University
Recruiting - verified September 2011 - Conditions: Chronic Thrombocytopenia; Immune Thrombocytopenia
Intervention: Drug: E5501
Sponsor: Eisai Inc.
Recruiting - verified January 2012 - Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone; Other: placebo
Sponsors: University Hospital, Toulouse; Ministry of Health, France
Recruiting - verified October 2011 - Condition: Influenza
Interventions: Biological: 2011-2012 Sanofi Pasteur Fluzone®; Biological: 2011-2012 Sanofi Pasteur Fluzone® High Dose
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Gastric Ulcer
Interventions: Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal UlcerCondition: Duodenal Ulcer
Interventions: Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 30 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 50 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 70 mg; Drug: Antidepressant + Placebo
Sponsor: Shire Pharmaceutical Development
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsor: Shire Pharmaceutical Development
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsor: Shire Pharmaceutical Development
Recruiting - verified January 2012 - Conditions: Premature Birth; Placenta Previa
Interventions: Procedure: Placement of a Cervical Cerclage; Procedure: Standard Expectant Management
Sponsor: Obstetrix Medical Group
Not yet recruiting - verified September 2011 - Condition: Pain
Interventions: Drug: SSR411298; Drug: placebo
Sponsor: Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Acne Vulgaris
Interventions: Drug: GSK2585823(CLDM 1%-BPO 3% gel); Drug: CLDM 3% gel twice daily
Sponsor: GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Nutrition Therapy
Interventions: Behavioral: Information provision intervention; Behavioral: information provision + flat incentive; Behavioral: Information provision + tiered incentive; Behavioral: Usual Care
Sponsors: University of Pennsylvania; National Institute on Aging (NIA)
Not yet recruiting - verified September 2011 - Condition: Prostatic Neoplasms
Intervention:
Sponsor: Copenhagen University Hospital at Herlev
Recruiting - verified September 2011 - Condition: Substance-Related Disorders
Intervention: Behavioral: Computer Based Treatment
Sponsor: VA Connecticut Healthcare System
Recruiting - verified July 2011 - Condition: Hepatocellular Carcinoma
Interventions: Other: Radiation therapy; Other: Transarterial chemoembolization
Sponsor: Asan Medical Center
Not yet recruiting - verified September 2011 - Condition: Advanced Solid Tumors
Interventions: Drug: E7050 plus E7080; Drug: E7080 plus E7050; Drug: E7050 plus E7080 or E7080 alone plus E7050 add-on therapy; Drug: E7050 plus E7080; Drug: E7050
Sponsor: Eisai Inc.
Recruiting - verified December 2011 - Condition: Diabetes Mellitus
Intervention: Drug: SYR-472
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Congenital Nasolacrimal Duct Obstruction
Interventions: Drug: Besifloxacin; Drug: polymyxin b/trimethoprim - ophthalmic
Sponsors: University of Medicine and Dentistry New Jersey; Bausch & Lomb, Inc.
Recruiting - verified September 2011 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Zhejiang University; Science and Technology Department of Zhejiang Province
Recruiting - verified September 2011 - Condition: Parkinson's Disease
Intervention: Behavioral: Ballroom Dancing Classes
Sponsor: University of Arkansas
Not yet recruiting - verified September 2011 - Conditions: Body Dysmorphic Disorder; Obsessive-Compulsive Spectrum Disorder; Anxiety Disorders; Somatoform Disorders
Interventions: Behavioral: Cognitive Behavioral Therapy; Behavioral: Supportive Psychotherapy
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified October 2011 - Condition: Endometriosis
Interventions: Drug: Placebo; Drug: TAK-385; Drug: TAK-385; Drug: TAK-385; Drug: Leuprorelin acetate
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Uterine Fibroids
Interventions: Drug: TAK-385; Drug: TAK-385; Drug: TAK-385; Drug: Placebo
Sponsor: Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Abdominal Surgery
Interventions: Other: Liberal fluid therapy; Other: Restrictive fluid therapy
Sponsors: Bayside Health; Australian and New Zealand College of Anaesthetists
Not yet recruiting - verified August 2011 - Conditions: Diabetic Nephropathy; Chronic Kidney Disease
Interventions: Drug: Atrasentan low dose group; Drug: Atrasentan high dose group; Drug: Atrasentan placebo group
Sponsor: Abbott
Recruiting - verified November 2011 - Condition: Alzheimer Disease
Interventions: Behavioral: Web-based psycho-educational program; Behavioral: Consultation in memory clinic
Sponsors: Assistance Publique - Hôpitaux de Paris; Direction de l’Hospitalisation et de l’Organisation des Soins (PREQHOS); Fondation Médéric Alzheimer
Not yet recruiting - verified August 2011 - Conditions: Parkinson's Disease; Insomnia
Interventions: Device: Light box (Litebook company); Behavioral: CBT and sleep hygiene; Drug: Doxepin and Zopiclone; Device: Light box ( Litebook company)
Sponsor: McGill University Health Center
Recruiting - verified December 2011 - Condition: Acute Coronary Syndromes
Interventions: Drug: PRASUGREL; Drug: Clopidogrel
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - verified December 2011 - Conditions: Patient Non-Compliance; Schizophrenia and Related Disorders
Interventions: Behavioral: Falloon et al. Psychoeducation Program; Behavioral: Generic Treatment
Sponsor: University of Cagliari
Not yet recruiting - verified September 2011 - Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342; Biological: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified November 2011 - Conditions: Stress; Quality of Life
Interventions: Other: Auriculotherapy (protocol group); Other: chinese auriculotherapy; Other: Control Group
Sponsors: University of Sao Paulo; Sociedade Hospital Samaritano
Not yet recruiting - verified August 2011 - Condition: Vitiligo
Interventions: Drug: Group 01; Drug: Group 02
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified August 2011 - Condition: Pheochromocytoma
Intervention:
Sponsor: Medical University of Vienna
Recruiting - verified August 2011 - Conditions: Stroke; Hemiparesis
Intervention: Other: Simultaneous Bimanual training
Sponsors: New York University School of Medicine; Mount Sinai School of Medicine
Recruiting - verified April 2011 - Condition: Community Acquired Pneumonia
Interventions: Drug: BT086; Drug: 1% Human Albumin infusion
Sponsor: Biotest
Recruiting - verified August 2011 - Conditions: HIV Infection; Hepatitis C
Intervention:
Sponsors: Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Gastrointestinal Cancer
Interventions: Dietary Supplement: Nutritional supplements containing arginine, n-3 and nucleotides; Dietary Supplement: Isocaloric control
Sponsor: Nestlé Nutrition Corporate
Not yet recruiting - verified August 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: high dose BI 10773 placebo; Drug: high dose BI 10773 placebo; Drug: high dose BI 10773 placebo; Drug: high dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: BI 10773; Drug: linagliptin; Drug: linagliptin; Drug: linagliptin; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: low dose FDC placebo; Drug: low dose FDC placebo; Drug: low dose FDC placebo; Drug: low dose FDC placebo; Drug: linagliptin placebo; Drug: linagliptin placebo; Drug: linagliptin placebo; Drug: linagliptin placebo; Drug: BI 10773; Drug: BI 10773 high dose; Drug: BI 10773 low dose
Sponsors: Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified January 2012 - Conditions: Pain; Constipation
Interventions: Drug: oxycodone/naloxone prolonged release (OXN PR) tablets; Drug: oxycodone prolonged release (OxyPR) tablets
Sponsor: Mundipharma Research GmbH & Co KG
Recruiting - verified September 2011 - Conditions: Trigger Points, Myofascial; Myofascial Trigger Points; Myofascial Pain Syndrome
Intervention: Other: cervical spinal manipulative therapy
Sponsors: Canadian Memorial Chiropractic College; University of Guelph
Not yet recruiting - verified August 2011 - Condition: Vitamin D Deficiency
Interventions: Drug: Cholecalciferol; Drug: Cholecalciferol; Drug: Cholecalciferol; Drug: Cholecalciferol
Sponsor: Umeå University
Recruiting - verified November 2011 - Condition: Advanced Hepatocarcinoma
Intervention: Drug: Pravastatin
Sponsors: Hospital Donostia; INSTITUTO BIODONOSTIA
Recruiting - verified January 2012 - Conditions: KSHV Inflammatory Cytokine Syndrome (KICS); KSHV; HHV-8
Interventions: Drug: Zidovudine/Valgancyclovir; Drug: Rituximab/Liposoma Doxorubicin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2011 - Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of PsychotherapyConditions: Psychiatric Disorder; Somatoform Disorders; PTSD
Intervention: Behavioral: psychotherapy
Sponsor: Hannover Medical School
Recruiting - verified June 2011 - Condition: Opiate Dependence
Intervention: Behavioral: employment based reinforcement
Sponsors: Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2010 - Condition: Relapsing Remitting Multiple Sclerosis (RRMS)
Interventions: Drug: Fingolimod; Drug: Placebo
Sponsor: Novartis
Recruiting - verified December 2011 - Condition: Heart Failure
Intervention: Other: CMR Guidance in terms of guiding LV lead implantation
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified August 2011 - Conditions: Generalized Anxiety Disorder; Social Phobia; Separation Anxiety Disorder
Interventions: Behavioral: Computerized Cognitive Behavioral Therapy; Behavioral: Treatment as usual
Sponsors: University of South Florida; Access Behavioral Health; Henderson Mental Health Clinic; Directions for Mental Health
Recruiting - verified August 2011 - Condition: Constipation
Interventions: Other: Opioid Dose Intervention; Other: Opioid Assessment Intervention; Other: Vinca Alkaloid Assessment Intervention
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Institutes of Health (NIH); University of South Florida
Recruiting - verified January 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal capsules of lactobacilli; Drug: Vaginal capsules of lactobacilli
Sponsors: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine; Ministry of Health, China
Recruiting - verified August 2011 - Condition: Depression in Parkinson's Disease
Interventions: Drug: Xiaoyao Pill; Drug: Bupleurum+Ginkgo; Drug: placebo
Sponsor: Xuanwu Hospital, Beijing
Recruiting - verified August 2011 - Condition: Bipolar Disorder
Interventions: Dietary Supplement: Omega-3 Supplementation; Behavioral: Psychoeducational Psychotherapy (PEP); Other: Placebo Intervention
Sponsors: L. Eugene Arnold; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Peripheral Arterial Disease
Interventions: Behavioral: Supervised Treadmill Exercise Therapy; Other: Health education sessions (Control); Drug: granulocyte monocyte colony stimulating factor (GM-CSF)
Sponsors: Northwestern University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Sorafenib is the Present Standard Treatment for Advanced HCC; More Active Treatments Were Used in Clinical Practice; Whether Active Treatments Could Give Survival Benefit?
Interventions: Procedure: hepatectomy; Procedure: transcatheter hepatic arterial chemoembolization; Drug: sorafenib
Sponsor: Sun Yat-sen University
Recruiting - verified January 2011 - Condition: Pain
Interventions: Procedure: 27-gauge; Procedure: 30-gauge
Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Recruiting - verified November 2011 - Condition: Lumbar Spine Degeneration
Interventions: Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft
Sponsor: Medtronic Spinal and Biologics
Recruiting - verified January 2012 - Condition: Prostate Cancer
Interventions: Other: ADT Therapy; Drug: Axitinib; Procedure: Prostatectomy
Sponsors: M.D. Anderson Cancer Center; Pfizer
Not yet recruiting - verified August 2011 - Condition: Hepatitis c
Interventions: Behavioral: Leap-c group intervention; Other: No Intervention: Standard of care referral to a specialist
Sponsors: University of Massachusetts, Worcester; National Institute of Nursing Research (NINR)
Recruiting - verified November 2011 - Condition: Psoriasis
Intervention:
Sponsor: National Taiwan University Hospital
Recruiting - verified July 2011 - Condition: Oppositional Defiant Disorder
Interventions: Behavioral: Treatment Program for Children with Aggressive Behavior; Behavioral: Play group
Sponsor: University of Cologne
Recruiting - verified July 2011 - Condition: Osteogenesis Imperfecta
Interventions: Drug: BPS804; Other: Untreated reference group
Sponsor: Novartis Pharmaceuticals
Recruiting - verified January 2012 - Conditions: Breast Cancer; Cognitive/Functional Effects; Depression; Fatigue; Pain; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
Interventions: Genetic: DNA analysis; Genetic: gene expression analysis; Other: enzyme-linked immunosorbent assay; Other: flow cytometry; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: adjuvant therapy; Procedure: assessment of therapy complications; Procedure: quality-of-life assessment; Radiation: 3-dimensional conformal radiation therapy; Radiation: breast irradiation; Radiation: external beam radiation therapy; Radiation: hypofractionated radiation therapy; Radiation: intensity-modulated radiation therapy; Radiation: whole breast irradiation
Sponsors: Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Uncomplicated Falciparum Malaria in Children
Intervention: Drug: artesunate (AS) - amodiaquine (AQ) - methylene blue (MB)
Sponsor: University of Heidelberg
Not yet recruiting - verified June 2011 - Condition: PKU
Interventions: Dietary Supplement: diet; Drug: sapropterin dihydrochloride
Sponsors: Children's Research Institute; Georgetown University
Recruiting - verified August 2011 - Conditions: Coronary Artery Bypass Graft Surgery (CABG); Patients' Expectations; Coronary Heart Disease
Interventions: Behavioral: Expectation Manipulation Intervention; Behavioral: Supportive Therapy
Sponsors: Philipps University Marburg Medical Center; Department of Cardiac and Thoracic Vessel Surgery, Heart Centre, Philipps University of Marburg, Baldingerstraße 1, 35032 Marburg, Germany
Recruiting - verified July 2011 - Condition: Marital Relationship
Intervention: Behavioral: Hold Me Tight
Sponsors: Capital District Health Authority, Canada; Dalhousie University
Not yet recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: inhaled corticosteroid/β2 agonist Monotherapy; Drug: Inhaled corticosteroid/β2 agonist Combination Therapy
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; Merck
Not yet recruiting - verified July 2011 - Conditions: Ascites; Cirrhosis
Interventions: Behavioral: Residency Program Teaching; Behavioral: Lecture; Other: Pocket Card Reference; Behavioral: Pager
Sponsor: Boston Medical Center
Recruiting - verified July 2011 - Condition: Depression
Interventions: Behavioral: Deprexis; Behavioral: Wait-list
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified July 2011 - Conditions: Chronic Hepatitis C; Genotype 1
Interventions: Procedure: Educational Intervention; Other: No Intervention
Sponsors: Chronic Liver Disease Foundation; Clinical Development Group
Recruiting - verified December 2011 - Conditions: Cancer; Liver Cancer; Hepatocellular Carcinoma
Interventions: Drug: PI-88; Other: Placebo
Sponsor: Medigen Biotechnology Corporation
Recruiting - verified February 2012 - Conditions: Knee Arthroplasty; Knee Arthritis Osteoarthritis; Osteoarthritis; Osteoarthritis, Knee; Musculoskeletal Diseases
Interventions: Device: AposTherapy Biomechanical System; Other: Physical Therapy Program
Sponsor: Tel-Aviv Sourasky Medical Center
Recruiting - verified August 2011 - Conditions: Low Back Pain; Osteoarthritis
Intervention: Behavioral: mindfulness group meetings with psychologist
Sponsor: Meir Medical Center
Not yet recruiting - verified August 2011 - Condition: Chemotherapy Induced Nausea and Vomiting
Interventions: Drug: Aprepitant; Drug: Placebo
Sponsors: All India Institute of Medical Sciences, New Delhi; Dr. Reddy's Laboratories Limited
Not yet recruiting - verified July 2011 - Condition: Chronic Pulmonary Hypertension
Interventions: Behavioral: Exercise and Respiratory Training; Behavioral: control group: continuation of set life style
Sponsor: University of Heidelberg
Recruiting - verified July 2011 - Condition: Sub-Acute Stroke
Intervention: Device: Robot therapy and transcranial direct current stimulation
Sponsors: University of Southampton; Sobell Department of Motor Neuroscience and Movement Disorders, UCL, London
Not yet recruiting - verified May 2011 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: E3810; Drug: E3810; Drug: Teprenone
Sponsor: Eisai Co., Ltd.
Recruiting - verified October 2011 - Conditions: Gastric Ulcers; Duodenal Ulcers
Interventions: Drug: E3810; Drug: E3810
Sponsor: Eisai Co., Ltd.
Not yet recruiting - verified October 2011 - Conditions: Adenocarcinoma of the Pancreas; Normal Pancreatic Exocrine Function
Interventions: Other: Timing of start treatment with pancreatic enzymes; Other: Timing of start treatment with pancreatic enzymes
Sponsor: Foundation for Liver Research
Not yet recruiting - verified July 2011 - Conditions: Pulmonary Arterial Hypertension; Eisenmenger Syndrome
Intervention: Other: respiratory and exercise therapy
Sponsor: University of Heidelberg
Not yet recruiting - verified July 2011 - Condition: Cocaine Abuse
Intervention: Behavioral: prize contingency management
Sponsors: University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Conditions: Myocardial Infarction; Multivessel Coronary Disease
Interventions: Procedure: FFR-guided revascularisation strategy; Procedure: staged revascularisation
Sponsors: Maasstad Hospital; Abbott Vascular; St. Jude Medical
Recruiting - verified September 2011 - Conditions: Thyroid; Cancer
Intervention: Drug: alpha-lipoic acids
Sponsor: Asan Medical Center
Recruiting - verified July 2011 - Condition: Acne Vulgaris
Interventions: Drug: GI148512; Drug: vehicle gel
Sponsor: GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Intervention:
Sponsor: AstraZeneca
Recruiting - verified December 2011 - Condition: Hepatitis C, Chronic
Interventions: Drug: BI201335; Drug: BI201335 24W; Drug: PegIFN/RBV; Drug: PegIFN/RBV
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified January 2012 - Condition: Custodial Grandparents
Interventions: Behavioral: Behavioral Parent Training; Behavioral: Cognitive Behavioral Therapy; Behavioral: Psychosocial-Informational support
Sponsors: Kent State University; National Institute of Nursing Research (NINR)
Not yet recruiting - verified July 2011 - Condition: Chronic Venous Insufficiency (CVI)
Intervention: Device: V0322 BC
Sponsor: Pierre Fabre Medicament
Recruiting - verified July 2011 - Conditions: Atrial Fibrillation; Coronary Artery Disease; Post Operative Arrythmia
Intervention:
Sponsors: Emory University; Medtronic
Not yet recruiting - verified April 2011 - Condition: Osteoporotic Distal Radius Fracture
Intervention: Behavioral: motor cognitive therapies
Sponsors: University of Stuttgart; German Federal Ministry of Education and Research
Recruiting - verified April 2011 - Condition: Stable Angina
Interventions: Device: Endothelial cell capture stent with 1 month clopidogrel; Device: Everolimus eluting stent with 12 month clopidogrel; Drug: Atorvastatin 20mg loading; Drug: Atorvastatin 80mg loading
Sponsor: Yonsei University
Not yet recruiting - verified September 2011 - Condition: Alcohol Abuse
Interventions: Other: Intervention group; Other: Control group
Sponsors: University of Southern Denmark; TRYG Foundation
Recruiting - verified December 2011 - Condition: Crohn's Disease
Interventions: Drug: Placebo; Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Not yet recruiting - verified January 2012 - Condition: Blood Stream Infection
Interventions: Other: Topical Emollient Application; Other: Routine Skin Care
Sponsor: Aga Khan University
Recruiting - verified July 2011 - Condition: Stenosis of the Bilio-biliary Anastomosis After Orthotopic Liver Transplantation
Interventions: Device: Non-expandable plastic stent (plastic endoprosthesis); Device: Covered self-expandable metal stent (cSEMS)
Sponsor: Johann Wolfgang Goethe University Hospitals
Recruiting - verified July 2011 - Condition: Disease Alzheimer
Interventions: Behavioral: Physical Therapy (standard); Behavioral: Balance and Gait training in Individualized sessions; Behavioral: Kinect; Behavioral: Group Xbox Kinect
Sponsor: Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified June 2011 - Condition: Crohn's Disease
Interventions: Drug: Placebo; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: high maintenance clopidogrel; Drug: routine dual antiplatelet; Drug: policosanol on the top of dual antiplatelet treatment
Sponsor: Shenyang Northern Hospital
Recruiting - verified April 2011 - Condition: Fibromyalgia Syndrome
Intervention:
Sponsors: Andreas Michalsen; Dr.Heinz Horst Deichmann Foundation,Essen,Germany
Recruiting - verified November 2011 - Condition: Epilepsy, Partial Seizures
Interventions: Drug: Pregabalin add-on therapy; Drug: Pregabalin add-on therapy; Drug: Pregabalin add-on therapy
Sponsor: Pfizer
Recruiting - verified January 2012 - Conditions: Thyroid Cancer; Papillary Microcarcinoma
Interventions: Behavioral: Focus groups; Behavioral: Focus groups
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified November 2011 - Condition: Post Traumatic Stress Disorder
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS); Behavioral: Cognitive Processing Therapy; Device: Repetitive Transcranial Magnet Stimulation (rTMS)
Sponsors: The University of Texas at Dallas; Department of Defense; University of Texas Southwestern Medical Center
Recruiting - verified July 2011 - Conditions: Obesity; Morbid Obesity
Interventions: Behavioral: Experiential-Cognitive Therapy for Obesity; Behavioral: Behavioral cognitive Treatment; Dietary Supplement: Nutritional groups (NT)
Sponsors: Universidad Nacional Autonoma de Mexico; Istituto Auxologico Italiano; Medica Sur Clinic & Foundation
Recruiting - verified July 2011 - Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (BOC); Drug: Placebo to boceprevir; Drug: Peginterferon alfa-2b (PEG); Drug: Ribavirin (RBV); Drug: Cross-Over Boceprevir Treatment
Sponsor: Schering-Plough
Recruiting - verified February 2012 - Condition: Muscle Spasticity
Intervention: Other: No treatment
Sponsor: Allergan
Recruiting - verified June 2011 - Conditions: Schizophrenia; Bipolar Disorder
Intervention: Behavioral: Illness Management and Recovery (IMR)
Sponsors: Mental Health Centre Ballerup; Mental Health Services in the Capital Region, Denmark; The Danish Health Fund
Recruiting - verified May 2011 - Condition: Pain, Postoperative
Interventions: Drug: control group; Drug: treatment group
Sponsor: Children's Hospital of Pittsburgh
Recruiting - verified June 2011 - Condition: Acne Vulgaris
Interventions: Drug: Azelaic acid; Drug: Adapalene; Drug: Azelaic acid
Sponsors: University of Magdeburg; Intendis GmbH
Recruiting - verified June 2011 - Conditions: Intermittent Claudication; Peripheral Arterial Disease
Interventions: Procedure: Percutaneous Transluminal Angioplasty; Other: Supervised Exercise Therapy
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified May 2011 - Condition: Pulmonary Hypertension
Intervention: Other: respiratory and exercise therapy
Sponsor: University of Heidelberg
Recruiting - verified June 2011 - Conditions: Epistaxis; Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Sodium tetradecyl sulfate (sotradecol)
Sponsors: University of Minnesota - Clinical and Translational Science Institute; American Rhinologic Society
Recruiting - verified August 2011 - Condition: Nephrotic Syndrome
Intervention:
Sponsors: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi; IL Sogno di Stefano; Nando Peretti Foundation
Not yet recruiting - verified June 2011 - Condition: NYHA Class III Heart Failure
Interventions: Device: CCM therapy; Other: No intervention: Optimal medical therapy
Sponsor: Impulse Dynamics
Recruiting - verified June 2011 - Conditions: Nonunion of Bone Graft; Fractures Non Union
Interventions: Other: RIA harvesting group; Other: AICBG harvesting group
Sponsor: St. Michael's Hospital, Toronto
Not yet recruiting - verified June 2011 - Condition: Depression
Intervention: Behavioral: Structured patient-centered follow up of depression
Sponsors: Göteborg University; Vastra Gotaland Region
Recruiting - verified June 2011 - Conditions: Carcinoma, Hepatocellular; Cirrhosis
Intervention: Procedure: Liver transplantation
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; AISF (Associazione Italiana per lo Studio del Fegato); CNT (Centro Nazionale Trapianti); NITp (Nord Italia Transplant project); OCST (Organizzazione Centro Sud Trapianti); AIRC (Associazione Italiana per la Ricerca sul Cancro); Ministero della Salute, Italia; Basilicata Region
Recruiting - verified June 2011 - Conditions: Nicotine Dependence; Opiate Dependence
Interventions: Behavioral: Intensive, tailored intervention; Behavioral: NJ Quitline Referral
Sponsors: University of Medicine and Dentistry New Jersey; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Proteinuria; Idiopathic Membranous Nephropathy
Interventions: Drug: Repository Corticotropin Injection; Drug: Placebo
Sponsor: Questcor Pharmaceuticals, Inc.
Recruiting - verified January 2012 - Condition: CTEPH
Intervention: Behavioral: respiratory and exercise therapy
Sponsor: University of Heidelberg
Recruiting - verified June 2011 - Conditions: Heart Failure; Congestive Heart Failure
Intervention: Device: Vagal Nerve Stimulation
Sponsor: Boston Scientific Corporation
Recruiting - verified January 2012 - Condition: Menstrual Problem
Intervention: Drug: Marvelon
Sponsors: Family Planning Association New South Wales; Merck
Not yet recruiting - verified June 2011 - Conditions: HIV; Drug Addiction
Interventions: Behavioral: Psycho-education; Behavioral: Experimental
Sponsors: RTI International; University of Cape Town
Recruiting - verified December 2011 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: Recombinant anti-tumor and anti-virus protein for injection; Drug: Recombinant anti-tumor and anti-virus protein for injection; Other: Saline Injection
Sponsors: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences; Beijing Genova Biotech Company, Ltd.
Recruiting - verified January 2012 - Condition: Low Back Pain
Interventions: Drug: Intra-articular corticosteroid injection; Drug: Intra-articular saline injection
Sponsor: University of Florida
Recruiting - verified September 2011 - Condition: Second-degree Hemorrhoids
Interventions: Procedure: Single hemorrhoidal ligation per session; Procedure: Triple hemorrhoidal ligation
Sponsor: Federal University of Amazonas
Recruiting - verified October 2011 - Conditions: Social Anxiety; Schizophrenia
Interventions: Behavioral: Cognitive-Behavioral Therapy based intervention immediately; Behavioral: Wait list
Sponsors: McGill University; Canadian Institute of Health Research Grant operating under Dr Martin Lepage
Recruiting - verified June 2011 - Condition: Myelodysplastic Syndromes
Interventions: Drug: Group 2: Placebo; Drug: Group 1: Epoetin alfa
Sponsor: Janssen-Cilag International NV
Recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide/formoterol (Symbicort® Turbuhaler®); Drug: Tiotropium (SpirivaTM)
Sponsor: AstraZeneca
Recruiting - verified January 2012 - Conditions: Depression; Anxiety; PTSD
Interventions: Behavioral: Treatment as usual; Behavioral: Voluntary Savings/Loans Assoc; Behavioral: Cognitive Processing Therapy
Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting - verified June 2011 - Condition: Treatment Resistant Depression
Interventions: Other: Moderate Intensity Aerobic Exercise; Behavioral: Usual Care
Sponsors: Milton S. Hershey Medical Center; Penn State University
Recruiting - verified June 2011 - Condition: Congestive Heart Failure (CHF)
Intervention: Behavioral: Existential Group Therapy
Sponsor: Meir Medical Center
Not yet recruiting - verified August 2011 - Conditions: Pneumonia; Respiratory Insufficiency
Interventions: Other: Oxygen therapy; Other: Helmet CPAP
Sponsor: University of Milan
Recruiting - verified May 2011 - Condition: Burns
Interventions: Procedure: DE graft and PRP concentrate; Procedure: DE graft
Sponsor: University Hospital Ostrava
Recruiting - verified June 2011 - Condition: Chronic Hepatitis
Intervention: Drug: Peginterferon alpha-2a + Ribavirin
Sponsors: Casa Sollievo della Sofferenza IRCCS; Casa di Cura Mater Dei; IRCCS L. Spallanzani; Ospedale Francesco Ferrari, Casarano; Ospedale SS. Annunziata, Sassari; IRCCS Policlinico S. Matteo; Arcispedale S. Anna, Ferrara; Azienda Ospedaliero-Universitaria, Catania; Ospedale di Venosa; Ospedale R. Dimiccoli, Barletta; IRCCS De Bellis, Castellana; USL Napoli 1; Ospedale San Giuseppe Moscati, Avellino; Cardarelli Hospital; Ospedale Civile Vittorio Emanuele II, Bisceglie; Azienda Ospedaliero-Universitaria Careggi; Azienda Ospedaliera V. Cervello; Ospedale Civile Spirito Santo; Ospedale di Canosa di Puglia; University of Palermo; San Camillo Hospital, Rome; Campus Bio-Medico University; Ospedale Sandro Pertini, Roma; Ospedali Riuniti, Foggia; Ospedale SS. Annunziata, Taranto; Ospedale di Mottola; Ospedale Santa Caterina Novella, Galatina; University of Florence; Ospedale Valduce, Como; University of Bari; Azienda Ospedaliera, Siracusa; Azienda Ospedaliera, Lucca
Recruiting - verified August 2011 - Condition: Sleep Apnea, Obstructive
Interventions: Behavioral: modified ME intervention; Behavioral: Education Only
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified June 2011 - Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: BMS-663068; Drug: Raltegravir; Drug: Raltegravir; Drug: Tenofovir; Drug: Tenofovir; Drug: Ritonavir; Drug: Atazanavir
Sponsor: Bristol-Myers Squibb
Recruiting - verified June 2011 - Condition: Mental Illness
Interventions: Behavioral: Decision Aid Tool; Other: Treatment as Usual
Sponsor: Institute of Psychiatry, London
Recruiting - verified November 2011 - Condition: Relapsed Multiple Myeloma
Interventions: Drug: Lenalidomide 15mg; Drug: Lenalidomide 25mg
Sponsors: Boston VA Research Institute, Inc.; Celgene Corporation; Kansas City Veteran Affairs Medical Center; VA Pittsburgh Healthcare System; VA Greater Los Angeles Healthcare System; Michael Debakey Veterans Affairs Medical Center; Edward Hines Jr. VA Hospital
Recruiting - verified September 2011 - Condition: Posttraumatic Stress Disorder
Interventions: Behavioral: Mindfulness & Compassion Meditation-based Exposure Therapy; Behavioral: Present Centered Therapy for PTSD
Sponsor: University of Michigan
Recruiting - verified April 2011 - Condition: Chronic Venous Insufficiency
Intervention: Other: neuromuscular electrical stimulation
Sponsor: Faculdade Evangelica do Parana
Recruiting - verified May 2011 - Condition: Social Phobia
Interventions: Behavioral: CBT-Manualized Intervention; Behavioral: CBT-Treatment as Usual
Sponsors: Dresden University of Technology; Goethe University; University of Göttingen
Recruiting - verified July 2011 - Conditions: Sustained Virologic Response; IL28B Polymorphism
Interventions: Drug: peginterferon alfa 2a (pegasys); Drug: peginterferon alfa-2a (pegasys)
Sponsors: The Catholic University of Korea; Ulsan University Hospital; NHIC Ilsan hospital; Inje University; Soonchunhyang University Hospital; Yonsei University; Chungnam National University; Keimyung University; Kyungpook National University; Konyang University Hospital; Inha University Hospital; Hallym University Medical Center
Recruiting - verified October 2008 - Condition: Pain
Interventions: Behavioral: Psychoeducation for substance abuse; Behavioral: CBT for pain in Substance abuse
Sponsors: University of Michigan; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified June 2011 - Conditions: Cigarette Smoking; Drug Use
Interventions: Behavioral: Standard Treatment; Behavioral: BAD-AS; Drug: Transdermal Nicotine Patch
Sponsors: University of Maryland; American Cancer Society
Recruiting - verified July 2011 - Condition: Prostate Cancer
Interventions: Other: Brachytherapy + Decapeptyl® SR 22.5mg Triptorelin; Radiation: Brachytherapy
Sponsor: Ipsen
Recruiting - verified January 2012 - Condition: OSA
Interventions: Procedure: CPAP group; Procedure: non CPAP group
Sponsor: Chinese University of Hong Kong
Recruiting - verified January 2011 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline; Drug: Bupropion; Drug: Nicotine patches
Sponsors: Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified January 2012 - Conditions: Amyotrophic Lateral Sclerosis; ALS
Interventions: Biological: HYNR-CS inj; Biological: Control group
Sponsors: Corestem, Inc.; Hanyang University
Recruiting - verified May 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Attention Deficit Disorder
Intervention: Behavioral: MIP Protocol
Sponsors: The National Center on Addiction and Substance Abuse at Columbia University; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified June 2011 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained release; Drug: fluoxetine; Drug: placebo
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Lumbar Spinal Fusions
Interventions: Drug: Pregabalin 150 mg; Drug: Placebo
Sponsors: Hospital for Special Surgery, New York; Pfizer
Recruiting - verified June 2011 - Conditions: Crohn's Disease; Colitis; IBD; Inflammatory Bowel Disease
Interventions: Drug: Placebo; Drug: Ustekinumab; Drug: Ustekinumab; Drug: Ustekinumab; Drug: Ustekinumab
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified January 2012 - Condition: Meniere's Disease
Interventions: Other: Diaoshi Jifa therapy plus the Western medical treatment.; Other: drug
Sponsors: Beijing Administration of Traditional Chinese Medicine Bureau; Beijing Hospital of Traditional Chinese Medicine
Recruiting - verified October 2011 - Condition: Substance Use Disorders
Interventions: Behavioral: Drum-Assisted Recovery Therapy for Native Americans (DARTNA); Behavioral: Treatment-As-Usual
Sponsor: University of California, Los Angeles
Recruiting - verified April 2011 - Conditions: Stress Disorders, Post-Traumatic; Substance-Related Disorders
Interventions: Behavioral: Concurrent Treatment of PTSD and Substance Dependence; Behavioral: Relapse Prevention Treatment
Sponsors: The City College of New York; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Condition: Human Immunodeficiency Virus Infection
Intervention:
Sponsors: Abbott; Triaca Magna, SA
Recruiting - verified December 2011 - Conditions: Hyperbaric Oxygen Therapy; Recovery Time; Contrast Media; Sonography
Intervention: Procedure: Hyperbaric Oxygen Therapy
Sponsor: RWTH Aachen University
Not yet recruiting - verified July 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Cilostazol; Drug: Placebo
Sponsor: Duk-Woo Park
Recruiting - verified September 2011 - Condition: Spinal Metastases
Interventions: Procedure: Preoperative embolization; Procedure: Control group
Sponsor: Rigshospitalet, Denmark
Recruiting - verified November 2011 - Conditions: Traumatic Brain Injury With Brief Loss of Consciousness; Traumatic Brain Injury With No Loss of Consciousness
Interventions: Behavioral: Cognitive Rehab; Behavioral: Brainworks; Behavioral: Informational Handout/Provider Visits
Sponsors: Brooke Army Medical Center; The Defense and Veterans Brain Injury Center; Henry M. Jackson Foundation for the Advancement of Military Medicine
Recruiting - verified June 2011 - Condition: Stroke
Interventions: Other: RGRM; Other: Therapeutic riding; Other: No intervention
Sponsors: Göteborg University; The Sten A Olsson foundation for Research and Culture
Recruiting - verified May 2011 - Conditions: Radiculopathy; Herniated Disk
Interventions: Procedure: Open microdiscectomy; Procedure: Percutaneous Diskectomy SpineJet
Sponsor: University of Sao Paulo
Recruiting - verified March 2011 - Condition: Hereditary Ataxia
Intervention: Biological: human umbilical cord mesenchymal stem cells
Sponsors: Shenzhen Beike Bio-Technology Co., Ltd.; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; The Affiliated Nanjing Brain Hospital of Nanjing University Medical School; Nanjing University Medical College Affiliated Wuxi Second Hospital; Affiliated Hospital of Xuzhou Medical College; The Second Hospital of Nanjing Medical University
Recruiting - verified October 2011 - Condition: Parkinson's Disease
Interventions: Behavioral: Physical therapy; Behavioral: Group Exercise Class; Behavioral: Home Program
Sponsors: Oregon Health and Science University; American Physical Therapy Association
Recruiting - verified January 2011 - Conditions: Pain; Advanced Cancer
Interventions: Drug: Sativex®; Drug: Placebo (GA-0034)
Sponsors: GW Pharmaceuticals Ltd.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified August 2011 - Conditions: Delirium; Respiratory Depression; Overmedication
Intervention: Device: Acupuncture Therapy
Sponsors: Oregon Health and Science University; Medical Research Foundation, Oregon
Not yet recruiting - verified May 2011 - Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Conventional-dose prednisone group; Drug: High-dose dexamethasone group
Sponsors: Shandong University; Chinese Academy of Medical Sciences; Peking Union Medical College Hospital; Ruijin Hospital; Wuhan Union Hospital, China; Tongji Hospital; Affiliated Hospital of Shandong University of Traditional Chinese Medicine; Anhui Provincial Hospital; Chinese Traditional Medicine Hospital of Zhejiang Province; Second Affiliated Hospital of Shanxi Medical University; Xinjiang Uygur Autonomous Region People's Hospital; Shenzhen Second People's Hospital
Recruiting - verified September 2010 - Condition: Scoliosis
Interventions: Device: Thoraco-lumbo-sacral Orthosis; Other: Watchful waiting
Sponsor: Chinese University of Hong Kong
Recruiting - verified May 2011 - Condition: Hypertension
Interventions: Drug: LFF269; Drug: Comparator; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified September 2011 - Condition: Mild Cognitive Impairment
Interventions: Other: group cognitive intervention; Other: Home-based cognitive intervention; Other: Waitlist control
Sponsors: Inha University Hospital; Eisai Inc.
Recruiting - verified May 2011 - Conditions: Acute Myeloid Leukemia; Acute Myelogenous Leukemia
Interventions: Drug: Azacitidine; Drug: Lenalidomide - single agent; Drug: Cytarabine - intravenous; Drug: Cytarabine - subcutaneous; Drug: Lenalidomide in combination; Drug: Daunorubicin; Drug: Idarubicin
Sponsor: Celgene Corporation
Recruiting - verified January 2012 - Condition: Myelodysplastic Syndrome
Interventions: Drug: BSC; Drug: HIDRA/VPA
Sponsor: Basque Health Service
Not yet recruiting - verified April 2011 - Conditions: PTSD; Substance Use Disorders
Intervention: Behavioral: Cognitive behavioral therapy for PTSD
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified October 2011 - Conditions: Cancer; Metastatic Malignant Neoplasm to Femur; Risk of Fracture
Interventions: Procedure: Surgery Alone; Other: Combined Surgery and Radiation therapy
Sponsor: University Health Network, Toronto
Recruiting - verified September 2011 - Condition: Hormone Deficiency
Interventions: Drug: Growth hormone treatment; Drug: Testosterone treatment
Sponsor: Max-Planck-Institute of Psychiatry
Not yet recruiting - verified July 2011 - Condition: Urinary Incontinence, Stress
Intervention: Behavioral: Questionnaire on Quality of Life.
Sponsors: pfm medical ag; Aix Scientifics
Recruiting - verified September 2011 - Conditions: Critical Limb Ischemia; Peripheral Artery Disease
Interventions: Biological: PTA + Infusion of MSC_Apceth; Procedure: PTA
Sponsor: Apceth GmbH & Co. KG
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsor: Novartis
Recruiting - verified August 2011 - Condition: Thrombocytopenia
Intervention: Drug: E5501 (previously known as AKR-501 monomaleate)
Sponsor: Eisai Inc.
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: Zoladex+AI; Drug: TAM
Sponsor: Fudan University
Recruiting - verified April 2008 - Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550; Drug: placebo
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin human/Insuman Comb 25 (HR1799); Drug: Insulin human/Novolin® 30R
Sponsor: Sanofi-Aventis
Recruiting - verified January 2012 - Condition: HIV
Intervention: Behavioral: Treatment Advocacy
Sponsors: Children's Hospital Boston; National Institutes of Health (NIH)
Not yet recruiting - verified May 2011 - Condition: Papillary Thyroid Carcinoma
Intervention:
Sponsor: Yonsei University
Recruiting - verified May 2011 - Condition: Lactic Acidosis
Intervention: Drug: entecavir, lamivudine
Sponsor: Asan Medical Center
Not yet recruiting - verified May 2011 - Conditions: Pre-Eclampsia; Pregnancy; Hypertension
Interventions: Drug: Nifedipine; Drug: Labetalol
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting - verified May 2011 - Condition: VARICOSE VEINS
Intervention: Drug: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G
Sponsor: EMS
Not yet recruiting - verified August 2011 - Condition: Hepatocellular Carcinoma
Interventions: Procedure: RFA; Procedure: hepatic resection
Sponsor: Sun Yat-sen University
Recruiting - verified March 2010 - Conditions: Panic Disorders; Anxiety Disorders
Intervention: Behavioral: Panic Control Treatment (PCT)
Sponsors: Michael Debakey Veterans Affairs Medical Center; South Central VA Mental Illness Research, Education & Clinical Center
Not yet recruiting - verified April 2011 - Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium; Drug: Placebo
Sponsor: Jordi Gol i Gurina Foundation
Recruiting - verified May 2011 - Condition: Stage IV Solid Tumor Diseases
Interventions: Behavioral: Individual Meaning-Centered Psychotherapy (IMCP); Behavioral: standard Individual Supportive Psychotherapy (ISP); Behavioral: enhanced usual care (EUC)
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Depression
Intervention:
Sponsors: University Hospital, Bonn; Dept of Anaesthesiology and Intensive Care Medicine; Department of Psychiatry and Psychotherapy, Brain Stimulation Group
Recruiting - verified March 2011 - Conditions: Homelessness; Substance Abuse Disorders; Mental Disorders
Interventions: Behavioral: LifeSkills Training/Intensive Case Management; Behavioral: Time and attention control
Sponsor: Department of Veterans Affairs
Recruiting - verified November 2011 - Conditions: Delirium; Intensive Care Unit Syndrome
Intervention:
Sponsor: Onze Lieve Vrouwe Gasthuis
Recruiting - verified April 2011 - Condition: Type 2 Diabetes
Interventions: Procedure: Telemonitoring group; Procedure: Telemonitoring & Telemedicine; Other: Usual Care
Sponsor: LG Electronics Inc.
Recruiting - verified April 2011 - Condition: Chronic Non-Specific Low Back Pain
Interventions: Other: Yoga Class; Other: Physical therapy; Other: Education
Sponsor: Boston Medical Center
Not yet recruiting - verified April 2011 - Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT)Condition: Stroke
Interventions: Behavioral: Modified Constraint-Induced Movement Therapy; Other: Therapy as usual
Sponsors: Universitätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research
Recruiting - verified January 2012 - Conditions: Obesity; Weight Loss
Interventions: Procedure: Laparoscopic gastric sleeve; Procedure: Gastric Banding; Procedure: Multidisciplinary lifstyle intervention; Procedure: Roux-en-Y Bypass
Sponsors: University of Hohenheim; German Federal Ministry of Education and Research
Recruiting - verified April 2011 - Condition: Rectal Cancer
Interventions: Drug: Rifaximin; Drug: Placebo
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified August 2011 - Condition: Apneas of Prematurity
Intervention:
Sponsor: Medical University of Vienna
Recruiting - verified April 2011 - Conditions: Pediatrics; Ceftazidime; Ciprofloxacin; Voriconazole
Interventions: Drug: Ceftazidime; Drug: Ciprofloxacin; Drug: Voriconazole
Sponsor: University Hospital, Bordeaux
Recruiting - verified November 2011 - Conditions: Substance Abuse; Substance Dependence; Alcohol Abuse; Drug Use; Relapse
Interventions: Behavioral: Dual Processing; Behavioral: Relapse Prevention
Sponsors: Inova Health Care Services; Virginia Commonwealth University; Georgetown University
Recruiting - verified August 2011 - Condition: Arteritis
Interventions: Other: Music; Other: no music
Sponsor: University Hospital, Limoges
Not yet recruiting - verified March 2011 - Conditions: Neurocognitive Disturbance; HIV Infection
Interventions: Drug: Lithium; Drug: Rivastigmine; Behavioral: not initiate treatment
Sponsor: Fundacio Lluita Contra la SIDA
Recruiting - verified September 2011 - Conditions: Carcinoma; Carcinoma Renal Cell; Kidney Neoplasms; Kidney Diseases; Chemokines
Interventions: Biological: Biological sample; Biological: Biological sample
Sponsor: University Hospital, Bordeaux
Recruiting - verified November 2011 - Conditions: Parkinson's Disease; Daytime Somnolence
Interventions: Device: Bright Light Treatment (Sun Ray Sunbox SB-558); Device: Dim red light (Sun Ray Sunbox SB-558)
Sponsors: Northwestern University; National Parkinson Foundation
Recruiting - verified April 2011 - Conditions: Myocardial Infarction; Segment Elevation Myocardial Infarction (STEMI)
Interventions: Drug: Ticagrelor; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified September 2011 - Conditions: Urinary Bladder, Overactive; Urinary Bladder Diseases; Urologic Diseases; Urological Manifestations; Signs and Symptoms
Interventions: Drug: Solifenacin succinate and Mirabegron; Drug: Mirabegron; Drug: Solifenacin succinate; Drug: Placebo
Sponsor: Astellas Pharma Inc
Recruiting - verified April 2011 - Conditions: Cancer; Distress
Interventions: Behavioral: personalized, motivational messages; Other: Control Group
Sponsors: University of Massachusetts, Worcester; National Institute of Mental Health (NIMH); Polaris Health Directions
Recruiting - verified September 2011 - Condition: Health Behavior
Intervention: Other: Yoga Research Tool
Sponsors: University of Connecticut; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified April 2011 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsor: Kirby Institute
Not yet recruiting - verified April 2011 - Condition: Musculoskeletal Pain
Interventions: Behavioral: Interdisciplinary intervention; Behavioral: Control Group, Brief Intervention
Sponsors: Sykehuset Innlandet HF; University of Bergen
Recruiting - verified March 2011 - Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab(Lucentis), verteporfin(Visudyne)
Sponsor: Seoul St. Mary's Hospital
Recruiting - verified April 2011 - Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Azacitidine
Sponsor: Asociación Andaluza de Hematología y Hemoterapia
Recruiting - verified April 2011 - Conditions: Blocked; Randomized
Intervention: Behavioral: Sound Production Treatment
Sponsor: Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Obstructive Sleep Apnea
Interventions: Behavioral: Web-based Access to CPAP Data; Behavioral: Web-based Access to CPAP Data with Financial Incentive
Sponsors: University of Pennsylvania; National Institute on Aging (NIA)
Recruiting - verified December 2011 - Condition: Mental Health Wellness 1
Interventions: Other: mindfulness-based stress reduction program; Other: Usual care
Sponsors: University of Alberta; CASA: Child, Adolescent and Family Mental Health
Recruiting - verified September 2011 - Conditions: Substance Abuse; Mental Disorders
Intervention: Behavioral: Double Trouble in Recovery
Sponsors: Western Michigan University; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2011 - Condition: Adverse Anesthesia Outcome
Interventions: Drug: conventional liberal fluid regimen; Drug: restricted fluid regimen
Sponsor: Mahidol University
Not yet recruiting - verified May 2011 - Condition: Breast Cancer
Intervention: Other: ART-THERAPIE
Sponsors: Centre Francois Baclesse; Ligue contre le cancer, France
Recruiting - verified April 2011 - Condition: Pancreas Cancer
Intervention:
Sponsors: IFAG AG; Hiscia Society for Cancer Research; IFAG Basel AG, both Switzerland
Recruiting - verified October 2011 - Condition: Colorectal Cancer
Intervention:
Sponsors: IFAG AG; Hiscia Society for Cancer Research (sponsor); IFAG Basel AG (CRO), both Switzerland
Recruiting - verified October 2011 - Conditions: ST-elevation Myocardial Infarction; (STEMI)
Intervention: Drug: Atorvastatin
Sponsor: General Hospital of Chinese Armed Police Forces
Recruiting - verified April 2011 - Condition: Hypertension
Interventions: Procedure: Telemonitoring; Procedure: Telemonitoring & Telemedicine; Other: Usual Care
Sponsor: LG Electronics Inc.
Recruiting - verified April 2011 - Conditions: Acute Coronary Syndrome; Obstructive Sleep Apnea
Interventions: Other: Standard care; Device: continuous positive airway pressure; Other: Reference
Sponsors: Sociedad Española de Neumología y Cirugía Torácica; ResMed; Fondo de Investigacion Sanitaria; Esteve-Teijin; Fundacion RESPIRA; Societat Catalana de Cardiologia; Sociedad Madrileña de Neumologia
Recruiting - verified April 2011 - Condition: Organ Preservation Rate
Interventions: Procedure: FOPS; Radiation: CRT
Sponsor: Asan Medical Center
Recruiting - verified September 2010 - Condition: Necrotizing Enterocolitis
Interventions: Procedure: cooling blanket/mattress; Procedure: Standard treatment of care at normothermia
Sponsor: Great Ormond Street Hospital for Children NHS Trust
Recruiting - verified June 2011 - Condition: Major Depressive Disorder (MDD)
Interventions: Behavioral: ART; Behavioral: CFT-C; Behavioral: i-CBT-D (individual cognitive therapy for depression)
Sponsors: Philipps University Marburg Medical Center; German Research Foundation
Recruiting - verified April 2011 - Condition: Nicotine Dependence
Interventions: Drug: Varenicline (Chantix); Drug: Bupropion (Zyban); Drug: Nicotine patches; Drug: Nicotine Inhaler
Sponsors: Duke University; National Institute on Drug Abuse (NIDA); Philip Morris Products S.A.
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: Laparoscopic duodenal exclusion; Other: Conventional Medical Treatment
Sponsor: McKenzie Health System
Recruiting - verified March 2011 - Conditions: Type 2 Diabetes; Vitamin D Deficiency
Interventions: Drug: Vitamin D2; Drug: Sugar pill
Sponsor: Ambika Ashraf, M.D.
Recruiting - verified October 2011 - Condition: Coronary Artery Disease
Intervention: Drug: Clopidogrel
Sponsors: Associations for Establishment of Evidence in Interventions; Medtronic
Recruiting - verified May 2011 - Conditions: Vaginosis, Bacterial; Infertility; Miscarriage
Interventions: Drug: Metronidazole; Drug: Placebo
Sponsor: Stanford University
Recruiting - verified March 2011 - Condition: Endometriosis
Intervention: Procedure: Specific Autoregulation Therapy (SART)
Sponsors: University of Jena; Technische Universität München
Recruiting - verified March 2010 - Condition: Parkinson's Disease
Intervention: Behavioral: Occupational Therapy
Sponsors: Radboud University; Prinses Beatrix Fonds
Recruiting - verified April 2011 - Condition: Cystic Fibrosis
Intervention: Other: Yoga
Sponsors: Seattle Children's Hospital; Firland Foundation
Recruiting - verified March 2011 - Condition: Heart Failure
Interventions: Other: Combined training; Other: Electrical stimulation; Other: Inspiratory muscle training; Other: Control group
Sponsors: Instituto de Cardiologia do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified March 2011 - Condition: Fanconi Anemia Complementation Group A
Interventions: Biological: filgrastim; Drug: plerixafor; Procedure: leukapheresis; Biological: genetically engineered hematopoietic progenitor cell therapy; Other: laboratory biomarker analysis; Genetic: polymerase chain reaction
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified December 2011 - Conditions: Acquired Immunodeficiency Syndrome; Tuberculosis
Interventions: Other: Comparison of different treatment strategies; Other: Comparison of different treatment strategies; Other: Comparison of different treatment strategies
Sponsors: Karolinska Institutet; Addis Ababa University
Recruiting - verified March 2011 - Conditions: Atrial Fibrillation; Stroke
Intervention: Other: early standardised rhythm control
Sponsor: German Atrial Fibrillation Network
Recruiting - verified December 2011 - Condition: Neck Pain
Intervention: Other: Manual Therapy
Sponsor: Masefield and Cavallaro Physical Therapy
Recruiting - verified March 2011 - Condition: Endocrine System Diseases
Interventions: Drug: Metformin; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified January 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: Standard of Care (SOC: Peg-IFN once weekly + Ribavirin BID) + DEB025; Drug: SOC + DEB025 400 mg; Drug: SOC + DEB025; Drug: Placebo + SOC for 48 weeks
Sponsor: Novartis Pharmaceuticals
Recruiting - verified September 2011 - Conditions: Q Fever; Fatigue Syndrome, Chronic; Coxiella Infection
Interventions: Behavioral: Cognitive behavioral therapy; Drug: Doxycycline; Drug: Placebo
Sponsors: Radboud University; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified April 2011 - Robotic Brace Incorporating Electromyography (EMG) for Moderate Affected Arm Impairment After StrokeCondition: Stroke
Interventions: Device: Myomo e100 Robot and repetitive task specific training; Behavioral: Repetitive task specific training (RTP) targeting the affected arm; Device: Myomo e100 neurorobotic brace
Sponsor: University of Cincinnati
Recruiting - verified March 2011 - Conditions: Hypertension, Pulmonary; Pulmonary Arterial Hypertension; Functional Disorder; Genetics
Interventions: Device: EndoPAT measurement; Biological: Blood Test
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Pfizer; Actelion
Recruiting - verified March 2011 - Condition: Alzheimer's Disease
Interventions: Behavioral: Home based occupational therapy; Behavioral: Best practices primary care
Sponsors: Regenstrief Institute, IU Center for Aging Research; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Condition: Depression
Interventions: Behavioral: Telephone-supported self-help and GP treatment as usual; Behavioral: Unsupported self-help and GP treatment as usual; Other: General practitioner treatment as usual
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR); Canadian Mental Health Association
Recruiting - verified November 2011 - Condition: Stage IIIA Non-small Cell Lung Cancer
Interventions: Procedure: positron emission tomography/computed tomography (PET/CT); Radiation: fludeoxyglucose F 18
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Parkinson`s Disease; Freezing of Gait
Intervention: Drug: PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj
Sponsor: Seoul National University Hospital
Recruiting - verified November 2011 - Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint DysfunctionConditions: Interstitial Cystitis; Sacroiliac Joint Dysfunction
Intervention: Procedure: Osteopathic Manipulation Therapy
Sponsors: Pelvic and Sexual Health Institute; Interstitial Cystitis Association
Recruiting - verified December 2011 - Condition: Severe Sepsis
Intervention: Device: S.A.F.E.BT
Sponsor: B. Braun Medical Inc.
Recruiting - verified May 2011 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified January 2012 - Condition: Type 1 Diabetes
Interventions: Device: MD Logic Pump Advisor; Other: Control Group
Sponsors: Rabin Medical Center; Medtronic
Recruiting - verified December 2011 - Conditions: Mania; Hypomania; Bipolar Affective Disorder
Interventions: Other: Cognitive Interpersonal Therapy; Other: Normal Clinical Care
Sponsors: NHS Greater Glasgow and Clyde; Chief Scientist Office of the Scottish Government; University of Glasgow
Recruiting - verified December 2011 - Conditions: Ovarian Cancer; Uterine Cancer
Interventions: Behavioral: Guided imagery and music therapy; Behavioral: White Noise; Other: No intervention
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified August 2011 - Condition: Psoriasis
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo/CP-690,550; Drug: Placebo/CP-690,550
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Neoplasms
Intervention: Behavioral: Mindfulness-based day-care clinic group program
Sponsor: Universität Duisburg-Essen
Recruiting - verified March 2011 - Condition: Stroke
Interventions: Behavioral: CO-OP; Behavioral: Standard OT
Sponsors: St. John's Rehab Hospital; University of Toronto; Washington University School of Medicine
Not yet recruiting - verified March 2011 - Condition: Benign Prostatic Hyperplasia
Interventions: Drug: combination therapy; Drug: alpha blocker monotherapy; Drug: 5 alpha reductase inhibitor monotherapy
Sponsor: Samsung Medical Center
Recruiting - verified December 2011 - Condition: Coronary Artery Disease
Interventions: Procedure: PCI with IVUS guidance; Procedure: PCI without IVUS guidance
Sponsor: Yonsei University
Recruiting - verified January 2012 - Condition: Cancer
Interventions: Behavioral: Exercise Behaviour Maintenance; Behavioral: Smoking Relapse prevention booklets; Behavioral: Contact control
Sponsors: University of Western Ontario, Canada; NCIC Clinical Trials Group
Recruiting - verified February 2011 - Condition: Infantile Colic
Interventions: Drug: Nepadutant oral solution; Drug: Placebo matching Nepadutant oral solution; Drug: Nepadutant oral solution
Sponsor: Menarini Group
Recruiting - verified October 2011 - Condition: Osteoarthritis
Interventions: Other: Exercise; Other: manual therapy
Sponsor: Agency for Healthcare Research and Quality (AHRQ)
Not yet recruiting - verified November 2010 - Condition: Depression
Interventions: Drug: Methylphenidate; Drug: Placebo
Sponsor: University of Malaya
Recruiting - verified December 2011 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified December 2011 - Condition: Cancer Recurrence
Intervention: Behavioral: Acceptance and Commitment Therapy
Sponsor: University of California, San Francisco
Recruiting - verified May 2011 - Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple SclerosisConditions: Multiple Sclerosis; Impaired Cognition
Interventions: Behavioral: Self-management cognitive rehabilitation group intervention; Behavioral: Control intervention
Sponsor: Tel Aviv University
Recruiting - verified February 2011 - Condition: Heart Failure
Interventions: Drug: Preset increase in frusemide dose; Other: No intervention
Sponsor: Barts & The London NHS Trust
Recruiting - verified March 2011 - Conditions: Post-concussive Symptoms; Traumatic Brain Injury
Interventions: Drug: hyperbaric oxygen; Drug: hyperbaric oxygen
Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting - verified June 2011 - Condition: Ventilatory Physiology
Intervention: Device: Ventilatory therapy
Sponsor: Tampere University Hospital
Recruiting - verified October 2010 - Condition: Post-Traumatic Stress Disorders
Interventions: Behavioral: CBT (Cognitive Behavior Therapy); Behavioral: EFT (Emotional Freedom Techniques); Behavioral: Wait List
Sponsor: Soul Medicine Institute
Recruiting - verified March 2011 - Condition: Postoperative Peritonitis
Intervention: Other: Duration of antibiotic therapy limited to 8 days
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010 - Condition: Diabetes
Interventions: Drug: Group 1: Metformin; Dietary Supplement: Group 2: Cinnamon Bark; Dietary Supplement: Group 3: Cinnulin PF
Sponsor: Mike O'Callaghan Federal Hospital
Not yet recruiting - verified December 2011 - Condition: Asthma
Intervention: Drug: PL-3994
Sponsor: Palatin Technologies
Not yet recruiting - verified February 2011 - Condition: Irritable Bowel Syndrome
Intervention: Behavioral: Cognitive Behavior Therapy(CBT)
Sponsor: Michigan Gastroenterology Institute
Not yet recruiting - verified February 2011 - Condition: Smoking Cessation
Interventions: Behavioral: Questionnaires; Drug: Nicotine Patch Therapy; Behavioral: Counseling Sessions
Sponsors: M.D. Anderson Cancer Center; CPRIT - Cancer Prevention Research Institute of Texas
Not yet recruiting - verified November 2011 - Conditions: Emotional Dysregulation; Dialectical Behavioral Therapy
Interventions: Behavioral: Participation in DBT Skills Group; Other: Control Group
Sponsor: Soroka University Medical Center
Recruiting - verified February 2011 - Condition: Lupus Nephritis
Interventions: Drug: cyclosporine +mycophenolic acid+prednison; Drug: Mycophenolic Acid + prednison
Sponsors: Hospital Universitario Fundación Alcorcón.; Hospital Universitario 12 de Octubre; Hospital General Universitario Gregorio Marañon; Hospital Universitario Ramon y Cajal; Hospital Infanta Sofia; Hospital Infanta Leonor. Madrid. Spain; Hospital Universitario Reina Sofia; Hospital Regional Universitario Carlos Haya. Malaga. Spain; Hospital Universitario Virgen de la Victoria; Hospital Nuestra Sra de la Candelaria. Sta Cruz Tenerife. Spain; Hospital Universitario de Guadalajara. Spain; Hospital San Pedro Alcantara. Caceres. Spain; Hospital Juan Canalejo
Recruiting - verified February 2011 - Condition: Type 1 Diabetes
Interventions: Device: Simultaneous RT-CGM and Pump Initiation; Device: Delayed Initiation of RT-CGM
Sponsors: Children's Hospital of Eastern Ontario; JDRF Canadian Clinical Trial Network
Recruiting - verified November 2011 - Condition: Neuroblastoma
Intervention: Device: FLT-PET
Sponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Ground Walking Program
Sponsors: Universidade Federal de Sao Carlos; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - verified February 2011 - Condition: Hepatocellular Carcinoma,
Interventions: Other: DC Bead; Other: 1DC BEAD+ RTC
Sponsor: Nantes University Hospital
Recruiting - verified August 2011 - Condition: Nicotine Dependence
Interventions: Behavioral: Integrated Training for Smokers; Behavioral: Mindfulness Training for Smokers
Sponsors: University of Wisconsin, Madison; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified February 2011 - Conditions: Alcohol Dependence; Alcohol Abuse
Interventions: Drug: Naltrexone; Behavioral: Brenda Therapy Sessions
Sponsors: University of North Carolina, Chapel Hill; National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer
Interventions: Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: enzyme-linked immunosorbent assay; Genetic: gene expression analysis; Drug: systemic chemotherapy; Drug: tamoxifen citrate; Drug: aromatase inhibition therapy
Sponsors: Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: TcLand Expression S.A.; Premier Research Group plc; Theradis pharma; Medpharmgene Inc.
Recruiting - verified October 2011 - Conditions: Thyroid Associated Ophthalmopathies; Graves´ Ophthalmopathy; Thyroid Associated Opthalmopathies
Interventions: Drug: Tocilizumab (RoActemra®); Drug: Sterile 0.9% Sodium Chloride
Sponsors: Hospital Clinico Universitario de Santiago; Juan Jesús Gómez-Reino Carnota, MD, PhD; UCICEC-CAIBER Hospital Clínico de Santiago
Not yet recruiting - verified February 2011 - Conditions: Liver Diseases; Healthy
Interventions: Drug: Afatinib; Drug: Afatinib; Drug: Afatinib
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified January 2012 - Condition: Hemiparesis
Interventions: Behavioral: Mental Practice Group; Behavioral: Active Control Group
Sponsor: University of Cincinnati
Recruiting - verified March 2011 - Conditions: Psoriasis; Psoriatic Arthritis
Intervention:
Sponsor: Abbott
Recruiting - verified December 2011 - Conditions: Basal Cell Carcinoma of the Skin; Pain; Recurrent Skin Cancer
Interventions: Drug: methyl-5-aminolevulinate hydrochloride cream; Drug: photodynamic therapy; Procedure: laser therapy
Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Achilles Tendon Rupture
Intervention: Other: Early Neuromuscular Exercise
Sponsors: Region Skane; Lund University
Recruiting - verified January 2012 - Conditions: Developmental Delays; Global Developmental Delay; Stroke; Cancers; Seizures Disorders; Behavior Problems; Feeding Disorder; Developmental Delay in Feeding
Intervention: Behavioral: Animal Assisted Therapy
Sponsor: Children's Hospitals and Clinics of Minnesota
Recruiting - verified September 2011 - Conditions: Fungal Infection; Leukemia; Myelodysplastic Syndromes
Interventions: Drug: caspofungin acetate; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis
Sponsor: European Organization for Research and Treatment of Cancer - EORTC
Not yet recruiting - verified September 2011 - Condition: Diabetic Foot Ulcers
Interventions: Device: Epiflo; Other: Moist Wound Therapy
Sponsor: Ogenix Corporation
Recruiting - verified December 2011 - Conditions: Oral Mucositis; Stomatitis
Interventions: Drug: Amifostine; Radiation: Amifostine
Sponsor: Sun Pharmaceutical Industries Limited
Not yet recruiting - verified February 2011 - Condition: Hyperlipidemias
Interventions: Drug: HMGCoA reductase inhibitor; Drug: HMGCoA reductase inhibitor + probucol; Drug: HMGCA reductase inhibitor + probucol + cilostazol
Sponsors: Seoul National University Hospital; Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting - verified July 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Varenicline tartrate tablets; Behavioral: Counseling and psychosocial support
Sponsor: General Hospital of Chinese Armed Police Forces
Recruiting - verified March 2011 - Condition: Neoplasms
Interventions: Drug: Regorafenib (BAY73-4506) + warfarin + omeprazole + midazolam; Drug: Regorafenib (BAY73-4506) + rosiglitazone
Sponsor: Bayer
Recruiting - verified February 2012 - Conditions: Smoking Cessation; Alcohol Abuse
Interventions: Drug: varenicline; Drug: placebo
Sponsors: Centre for Addiction and Mental Health; Ontario Lung Association
Recruiting - verified August 2011 - Condition: Multiple Myeloma
Interventions: Other: no treatment; Drug: bortezomib (Velcade)
Sponsor: Janssen-Cilag International NV
Recruiting - verified July 2011 - Condition: Major Depressive Disorder
Interventions: Drug: TC-5214; Drug: Duloxetine; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified September 2011 - Condition: Rectal Cancer
Interventions: Procedure: Early reversal of temporary ileostomy; Procedure: Standard reversal of temporary ileostomy
Sponsor: Herlev Hospital
Recruiting - verified September 2011 - Condition: Myeloma
Interventions: Other: Placebo; Drug: Minocycline
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Fish Oil Supplementation; Drug: Placebo Supplementation
Sponsors: Columbia University; GlaxoSmithKline
Not yet recruiting - verified August 2011 - Condition: Hepatitis B Virus Infection, Pregnancy
Intervention: Drug: antiviral therapy
Sponsor: National Taiwan University Hospital
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: adalimumab; Drug: Placebo; Drug: Placebo; Drug: methotrexate; Drug: folate
Sponsor: Hoffmann-La Roche
Recruiting - verified January 2012 - Condition: Stroke
Interventions: Behavioral: modified constraint induced movement therapy (mCIMT); Other: Usual and Customary Care
Sponsors: Capital District Health Authority, Canada; Dalhousie University; Sunnybrook Research Institute
Recruiting - verified December 2011 - Conditions: Depression; Anxiety; Infertility
Intervention: Behavioral: Digicoach
Sponsors: University Medical Center Nijmegen; Stichting Nuts Ohra
Recruiting - verified September 2011 - Condition: Overactive Bladder
Interventions: Drug: solifenacin; Procedure: PFMT and WBVT
Sponsors: Cantonal Hospital, Frauenfeld; Astellas Pharma AG, Switzerland
Recruiting - verified December 2011 - Condition: Prostate Cancer
Interventions: Behavioral: Sexual Medicine Rehabilitation Program + nurse practitioner information phone calls; Behavioral: Sexual Medicine Rehabilitation Program + Acceptance and Commitment Therapy for Erectile Dysfunction
Sponsors: Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH); Center for Marital and Sexual Health of South Florida
Recruiting - verified November 2011 - Condition: High Risk Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal Photocoagulation (PRP); Drug: Intravitreous injection of ranibizumab
Sponsor: Association for Innovation and Biomedical Research on Light and Image
Recruiting - verified January 2011 - Conditions: High Risk Proliferative Diabetic Retinopathy; Diabetes Mellitus Type I; Diabetes Mellitus Type II
Interventions: Procedure: Panretinal Photocoagulation (PRP); Drug: Intravitreous injection of pegaptanib
Sponsor: Association for Innovation and Biomedical Research on Light and Image
Recruiting - verified September 2011 - The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese PopulationConditions: Lactose Intolerance; Irritable Bowel Syndrome
Intervention: Dietary Supplement: dietary restriction
Sponsors: Sir Run Run Shaw Hospital; University Hospital, Zürich
Recruiting - verified January 2011 - Condition: Psoriasis
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo/CP-690,550; Drug: Placebo/CP-690,550
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Vasomotor Symptoms
Intervention: Procedure: Acupuncture
Sponsors: Wake Forest University Baptist Medical Center; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: Obsessive-compulsive Disorder
Interventions: Drug: Ondansetron; Drug: Placebo
Sponsor: Transcept Pharmaceuticals
Recruiting - verified October 2011 - Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ CancersConditions: Solid Tumors; Acute Kidney Injury
Intervention: Biological: Mesenchymal stromal cell infusion
Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Interventions: Behavioral: Comprehensive, CBT-based, multi-component treatment; Behavioral: Treatment as usual
Sponsors: University of Zurich; Psychiatric University Hospital, Zurich
Recruiting - verified October 2011 - Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine; Drug: S-1
Sponsor: Kansai Hepatobiliary Oncology Group
Recruiting - verified November 2011 - Conditions: Diabetes Mellitus Type 2; Severe Hyperglycemia - Blood Glucose Level >300mg/dl.
Interventions: Drug: Glipizide XL; Drug: Saxagliptin + Metformin XR; Drug: Metformin XR
Sponsors: John H. Stroger Hospital; Bristol-Myers Squibb
Recruiting - verified December 2010 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Reslizumab; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified December 2011 - Condition: Transient Tachypnea of the Newborn
Interventions: Other: High Flow Nasal Cannula; Other: Bubble Nasal CPAP
Sponsor: Mount Sinai School of Medicine
Recruiting - verified January 2012 - Conditions: Obesity; Child
Interventions: Behavioral: Cognitive Behavioural Therapy (CBT); Behavioral: Psycho-Education Program (PEP)
Sponsors: University of Alberta; Alberta Health Services; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Radiation: Hypofractionated Whole Breast Irradiation; Radiation: Conventionally Fractionated Whole Breast Irradiation
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: GERD
Interventions: Device: Nissen fundoplication; Drug: baclofen; Drug: Desipramine
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified January 2012 - Conditions: Glaucoma; Ocular Hypertension
Interventions: Other: No intervention other than routine medical care; Other: No intervention other than routine medical care
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa2a; Drug: Ribavirin; Drug: Peginterferon alfa2a; Drug: Ribavirin
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Recruiting - verified December 2010 - Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural EffusionConditions: Malignant Ascites; Malignant Pleural Effusion
Interventions: Drug: immediate cediranib; Drug: Start cediranib after 28 days Best Supportive Care
Sponsor: Radboud University
Recruiting - verified September 2011 - Conditions: Partial Seizures; Epilepsies, Partial
Interventions: Drug: pregabalin; Drug: pregabalin; Drug: pregabalin; Drug: pregabalin; Drug: pregabalin; Drug: pregabalin; Drug: placebo
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and placebo of fostamatinib; Drug: Placebo of fostamatinib, fostamatinib, and placebo injections
Sponsor: AstraZeneca
Recruiting - verified December 2011 - Condition: Pain
Interventions: Drug: Sativex®; Drug: Placebo (GA-0034)
Sponsors: GW Pharmaceuticals Ltd.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified May 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: PDA001
Sponsors: Celgene Corporation; Celgene Cellular Therapeutics
Recruiting - verified January 2012 - Condition: Obstructive Sleep Apnea
Interventions: Behavioral: Conservative Medical Therapy; Device: Active PAP with Respiratory Therapy Support; Behavioral: Active PAP with Behavior Modification; Device: Sham PAP
Sponsors: Brigham and Women's Hospital; Beth Israel Deaconess Medical Center
Recruiting - verified December 2011 - Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy; Drug: concomitant therapy
Sponsors: National Taiwan University Hospital; National Science Council, Taiwan
Recruiting - verified September 2011 - Condition: Shoulder Impingement Syndrome
Interventions: Other: supervised exercise; Other: homebased exercises
Sponsor: Norwegian University of Science and Technology
Recruiting - verified August 2011 - Condition: Mild to Moderate Acne
Intervention: Device: Photopneumatic therapy
Sponsor: Solta Medical
Recruiting - verified October 2011 - Condition: Epilepsy
Interventions: Drug: Placebo; Drug: Brivaracetam; Drug: Brivaracetam
Sponsor: UCB, Inc.
Recruiting - verified January 2012 - Condition: Colorectal Liver Metastases
Intervention: Other: MR imaging
Sponsors: University Health Network, Toronto; Bayer
Recruiting - verified December 2010 - Condition: Prostate
Interventions: Drug: Abiraterone Acetate; Drug: Prednisone; Drug: Sunitinib; Drug: Dasatinib
Sponsors: M.D. Anderson Cancer Center; Bristol-Myers Squibb; Ortho Biotech, Inc.; Pfizer
Recruiting - verified September 2011 - Condition: Alzheimer Disease
Interventions: Drug: Donepezil,; Drug: STA-1; Drug: placebo
Sponsor: Sinphar Pharmaceutical Co., Ltd
Not yet recruiting - verified July 2011 - Conditions: COPD Method Evaluation; Chronic Obstructive Pulmonary Disease Method Evaluation
Interventions: Drug: Formoterol Turbuhaler; Drug: Budesonide/Formoterol Turbuhaler; Drug: Formoterol Turbuhaler
Sponsor: AstraZeneca
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified January 2012 - Conditions: Vascular Accident, Brain; Traumatic Brain Injury
Interventions: Device: Armeo Spring; Other: conventional physiotherapy
Sponsors: Krankenhaus Bozen; Valduce Hospital
Recruiting - verified July 2011 - Conditions: Idiopathic Short Stature; Self Image
Interventions: Drug: GH treatment (Genotropin); Drug: 1 year treatment with placebo followed by optional 3 years of GH treatment; Other: Non treatment group; Other: Normal stature control group
Sponsors: Rabin Medical Center; Pfizer
Recruiting - verified December 2011 - Condition: Lung Cancer
Interventions: Drug: Erlotinib; Drug: AZD6244; Drug: MK-2206; Drug: Sorafenib; Drug: Erlotinib; Drug: MK-2206
Sponsors: M.D. Anderson Cancer Center; AstraZeneca; Bayer; Merck; National Cancer Institute (NCI); OSI Pharmaceuticals
Recruiting - verified January 2012 - Conditions: Stress Disorders, Post Traumatic; Trust
Intervention: Behavioral: Group CPT-C
Sponsor: Department of Veterans Affairs
Recruiting - verified November 2011 - Conditions: Pregnant Women; Severe Hypertension
Intervention:
Sponsor: University of Mississippi Medical Center
Recruiting - verified August 2011 - Condition: Sepsis
Interventions: Drug: Insulin; Drug: Insulin
Sponsor: McGill University Health Center
Recruiting - verified November 2010 - Condition: Breast Cancer
Intervention: Other: art therapy
Sponsors: McGill University Health Center; The Cedars Cancer Institute
Recruiting - verified August 2011 - Conditions: Stroke; Upper Limb Paresis
Interventions: Behavioral: verum group; Behavioral: Placebo group
Sponsor: RWTH Aachen University
Recruiting - verified September 2011 - Condition: Men With Low Risk Prostate Cancer Considering Treatment
Intervention: Behavioral: Prostate cancer treatment DESI
Sponsors: University of North Carolina, Chapel Hill; Palo Alto Medical Foundation; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Conditions: Analgesia, Epidural; Instrumental Delivery; Maternal Outcome; Neonatal Outcome
Interventions: Drug: Ropivacaine/ Sufentanil according to local hospital protocol; Other: Care-as usual pain treatment
Sponsor: Maastricht University Medical Center
Recruiting - verified July 2011 - Conditions: Diabetes; Obesity
Intervention: Drug: Detemir
Sponsors: Vanderbilt University; Novo Nordisk
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Other: Disease Management; Other: Usual site management
Sponsors: Air Liquide Santé International; ITEC Services; Lincoln
Recruiting - verified August 2011 - Condition: Cervical Cancer
Interventions: Drug: Interferon, Retinoic Acid and radiation; Drug: Cisplatin and radiation
Sponsor: James Graham Brown Cancer Center
Recruiting - verified September 2011 - Condition: Malaria
Intervention:
Sponsors: Centre Muraz; World Health Organization
Recruiting - verified November 2010 - Conditions: Colorectal Carcinoma; Liver Metastases; Efficacy; Toxicity
Intervention: Procedure: SBRT or RFA
Sponsors: University of Aarhus; Danish Center for Interventional Research in Radiation Oncology (CIRRO)
Recruiting - verified June 2011 - Condition: Treatment Resistant Depression
Interventions: Drug: CX157; Drug: Placebo
Sponsor: CeNeRx BioPharma Inc.
Recruiting - verified October 2011 - Condition: Obesity
Interventions: Behavioral: Internet Obesity Treatment; Behavioral: Internet Obesity Treatment with MI
Sponsors: University of Vermont; University of Arkansas
Recruiting - verified August 2011 - Condition: Post-Traumatic Stress Disorder
Intervention: Behavioral: music therapy with guitar lessons
Sponsor: Department of Veterans Affairs
Recruiting - verified July 2011 - Conditions: Stroke; Hemiplegia; Shoulder Pain
Interventions: Other: Standard education/exercises for hemiplegic shoulder pain; Other: Three dimensional Scapular-Humeral Mobilizations
Sponsors: Toronto Rehabilitation Institute; University of Toronto; Connect Learning Centre; Ontario Stroke Network
Recruiting - verified June 2011 - Conditions: Macular Edema; Central Retinal Vein Occlusion
Interventions: Drug: Ozurdex; Drug: Avastin
Sponsor: Long Island Vitreoretinal Consultants
Recruiting - verified April 2011 - Conditions: Stable Claudication (Fontaine IIa and IIb); Superficial Femoral Artery Disease; Best Medical Treatment; Quality of Life Scores at 12 and 24 Months
Interventions: Procedure: Stenting; Other: Best medical treatment
Sponsor: Lund University
Recruiting - verified June 2011 - Condition: Bipolar I Disorder
Intervention: Behavioral: Enhancing Emotion Regulation
Sponsor: Massachusetts General Hospital
Recruiting - verified July 2011 - Conditions: Nasal Congestion and Inflammations; Rhinitis
Interventions: Drug: Group 1; Drug: Group 2
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified July 2011 - Condition: Alcohol Abuse
Interventions: Behavioral: Standard Care; Behavioral: Multidimensional Family Therapy; Behavioral: Family Motivational Interviewing Intervention
Sponsor: University of Miami
Recruiting - verified January 2012 - Condition: Epilepsy
Interventions: Drug: Levetiracetam; Drug: Topiramate
Sponsor: UCB, Inc.
Recruiting - verified January 2012 - Conditions: Depression; Personality Disorder
Interventions: Other: MBT; Other: treatment as usual
Sponsor: North East London Foundation Trust
Recruiting - verified July 2011 - Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and Pegylated interferon α-2a Sequential Treatment Group; Drug: Pegylated interferon α-2a Monotreatment Group
Sponsors: Hanyang University; Roche Pharma AG
Recruiting - verified June 2011 - Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.
Intervention:
Sponsors: The HIV Netherlands Australia Thailand Research Collaboration; Commission of higher education (CHE), Ministry of Education, Thailand; Thai National Health Security Office (NHSO)
Recruiting - verified November 2011 - Conditions: Chronic Kidney Disease (CKD); End-stage Renal Disease (ESRD)
Interventions: Drug: Cholecalciferol; Device: calcitriol; Drug: Cholecalciferol
Sponsor: University of Kansas
Recruiting - verified May 2011 - Condition: Intermittent Claudication
Interventions: Procedure: INVASIVE (INV) treatment; Other: Best medical treatment (BMT)
Sponsors: Sahlgrenska University Hospital, Sweden; Göteborg University
Recruiting - verified January 2010 - Conditions: Glioblastoma; Gliosarcoma; Anaplastic Astrocytoma
Intervention: Drug: PD 0332991
Sponsors: University of California, San Francisco; Pfizer
Recruiting - verified January 2012 - Condition: Osteoarthritis
Interventions: Other: Complex Ayurvedic Treatment; Other: Conventional Care
Sponsors: Charite University, Berlin, Germany; Ministry of Health & Family Welfare, India
Recruiting - verified November 2011 - Conditions: Neoplasms, Breast; WT1-positive Primary Invasive Breast Cancer
Interventions: Biological: GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) GSK2302024A; Biological: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Kidney Cancer
Interventions: Drug: Pazopanib; Drug: Bevacizumab; Drug: Everolimus
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Benign Bile Duct Strictures
Interventions: Device: Fully covered Metallic Stent; Device: Plastic Stent
Sponsors: Indiana University; American Society for Gastrointestinal Endoscopy
Recruiting - verified September 2011 - Conditions: Brain Metastases; Lung Tumors; Breast Tumors
Intervention: Drug: Lapatinib
Sponsor: Hellenic Cooperative Oncology Group
Recruiting - verified December 2011 - Conditions: Gastric Cancer; Lung Cancer
Interventions: Procedure: respiration correlated CT scan; Procedure: respiration correlated CT scan
Sponsors: Memorial Sloan-Kettering Cancer Center; University of North Carolina, Chapel Hill; Varian Medical Systems
Recruiting - verified October 2011 - Conditions: Transitional Cell Carcinoma; Bladder Carcinoma; Urothelial Carcinoma
Interventions: Drug: Everolimus; Drug: Everolimus; Drug: Paclitaxel
Sponsors: Hoosier Oncology Group; Novartis Pharmaceuticals
Recruiting - verified August 2011 - Conditions: Major Depressive Disorder; Substance Use
Interventions: Behavioral: LETS ACT Behavioral Activation Treatment; Behavioral: Nondirective Therapy (NDT)
Sponsors: University of Maryland; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2011 - Condition: Neoplasm Metastasis
Intervention: Radiation: RapidArc
Sponsor: Emory University
Recruiting - verified October 2011 - Conditions: Burns; Hemofiltration; Kidney Failure, Acute; Shock, Septic
Interventions: Device: An FDA approved continuous renal replacement device; Other: Control Group
Sponsors: United States Army Institute of Surgical Research; American Burn Association; The University of Texas Health Science Center, Houston; Tampa General Hospital; Washington Hospital Center; Loyola University; University of Texas Southwestern Medical Center; Maricopa Integrated Health System; University of Tennessee Health Science Center
Recruiting - verified December 2011 - Conditions: Autism; Autism Spectrum Disorder
Interventions: Behavioral: Cognitive Behavioral Therapy (CBT); Behavioral: Play Therapy
Sponsors: Mount Sinai School of Medicine; National Institute of Mental Health (NIMH)
Recruiting - verified June 2011 - Condition: HIV Positive Patient Receive Implant Supported Restoration
Intervention:
Sponsors: University of Alabama at Birmingham; Astra Tech AB
Recruiting - verified April 2011 - Conditions: Migraine Headache; Adolescents
Interventions: Drug: Zolmitriptan; Drug: Zolmitriptan; Drug: Zolmitriptan; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified October 2011 - Condition: Chronic Renal Failure With Uremic Nephropathy
Interventions: Drug: Cyclophosphamide + Bortezomib + Dexamethasone regimen; Drug: Bortezomib +Dexamethasone regimen; Device: HCO group; Device: conventional high-flux dialyzer
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified November 2011 - Conditions: Hearing Loss; Tinnitus; Stress, Psychological; Mental Fatigue
Intervention: Behavioral: 8-session CBTcourse
Sponsors: Oslo University Hospital; South-Eastern Norway Regional Health Authority
Recruiting - verified February 2011 - Condition: Traumatic Brain Injury
Interventions: Behavioral: memory retraining exercises; Behavioral: placebo control memory exercises
Sponsors: Kessler Foundation; U.S. Department of Education
Recruiting - verified June 2011 - Conditions: Cancer; Pain; Tolerance
Intervention: Drug: oral ketamine
Sponsor: Tel-Aviv Sourasky Medical Center
Recruiting - verified September 2010 - Condition: Moderate to Severe Plaque Psoriasis
Intervention:
Sponsor: Abbott
Recruiting - verified June 2011 - Conditions: Brain Injuries; Visually Impaired Persons
Interventions: Other: Vision Restoration Therapy; Behavioral: NVT Eye Scanning Therapy; Behavioral: Eccentric Viewing Training; Behavioral: Sham
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified September 2011 - Condition: Psychotic Disorder
Interventions: Behavioral: Yoga therapy; Behavioral: Physical exercise
Sponsor: The University of Hong Kong
Recruiting - verified August 2011 - Condition: VARICOSE VEINS
Intervention: Drug: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G
Sponsor: EMS
Not yet recruiting - verified May 2011 - Condition: Persistent Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsors: Novartis Pharmaceuticals; Genentech
Recruiting - verified January 2012 - Conditions: Testosterone; Trauma; Brain Injury
Interventions: Drug: Androgel (Testosterone Gel); Drug: Androgel Placebo
Sponsors: Craig Hospital; University of Colorado, Denver
Recruiting - verified June 2011 - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Device: treatment by HLPFC coil
Sponsor: Brainsway
Recruiting - verified July 2011 - Condition: Multiple Sclerosis
Intervention: Dietary Supplement: Cholecalciferol (Vitamin D3)
Sponsors: Merck KGaA; Merck Serono S.A.S., France, an affiliate of Merck KGaA, Darmstadt, Germany
Recruiting - verified October 2011 - Condition: Venous Leg Ulcers
Interventions: Drug: Nexagon® 1.0 mg/mL; Drug: Nexagon® 3.0 mg/mL; Drug: Nexagon® Vehicle; Device: Compression dressings
Sponsor: CoDa Therapeutics Inc.
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: Sleeve Gastrectomy and Ileal transposition; Dietary Supplement: dietary and medical management
Sponsor: The University of Texas Health Science Center, Houston
Recruiting - verified February 2011 - Condition: Atrial Fibrillation
Intervention: Drug: DRONEDARONE
Sponsor: Sanofi-Aventis
Recruiting - verified December 2011 - Condition: Borderline Personality Disorder
Intervention: Behavioral: Skills Training
Sponsors: Centre for Addiction and Mental Health; Ontario Mental Health Foundation
Recruiting - verified September 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Aspirin; Drug: Clopidogrel; Drug: Cilostazol
Sponsors: Dio; Yonsei University
Recruiting - verified March 2011 - Condition: Breast Cancer
Intervention: Device: Oncotype DX breast cancer test
Sponsors: Genomic Health®, Inc.; REGISTRAT-MAPI
Recruiting - verified April 2011 - Condition: Spinal Cord Injury
Interventions: Device: FES Cycling; Device: Cycling without FES; Procedure: Lumbar puncture; Behavioral: Mood assessment
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Recruiting - verified November 2011 - Condition: Acute Myelogenous Leukemia
Interventions: Drug: Clofarabine; Drug: Cytarabine
Sponsors: PETHEMA Foundation; Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Recruiting - verified September 2011 - Condition: Alzheimer's Dementia
Intervention: Device: Resonator
Sponsor: pico-tesla Magnetic Therapies, LLC
Recruiting - verified June 2011 - Condition: Advanced Cancers
Interventions: Device: Bright Light Therapy Device; Device: Dim Red Light Therapy Device; Behavioral: Questionnaires; Behavioral: Study Diaries
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Hemorrhage
Interventions: Biological: secondary hemostatic treatment; Device: Surgicel® Original
Sponsor: Nycomed
Recruiting - verified November 2011 - Conditions: Solid Tumors; Pancreatic Cancer; Cancer; Lung Cancer, Non-Small Cell
Interventions: Drug: GSK1120212; Drug: Docetaxel; Drug: Erlotinib; Drug: Pemetrexed; Drug: Carboplatin; Drug: nab-Paclitaxel
Sponsor: GlaxoSmithKline
Recruiting - verified January 2012 - Conditions: Insomnia; Chronic Pain
Interventions: Behavioral: Sleep diary; Behavioral: Self-help manual for insomnia
Sponsors: Ottawa Hospital Research Institute; The Ottawa Hospital
Recruiting - verified July 2011 - Condition: Stroke
Interventions: Behavioral: conventional therapy; Device: conventional plus robotic gait assisted therapy
Sponsors: Prasat Neurological Institute; Mahidol University; Charite University, Berlin, Germany
Recruiting - verified September 2011 - Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine; Drug: Spiramycine
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2010 - Condition: Obesity
Interventions: Behavioral: Parent-only Group; Behavioral: Parent + Child Group
Sponsor: University of California, San Diego
Recruiting - verified August 2010 - Condition: Epilepsy
Intervention: Drug: USL255
Sponsor: Upsher-Smith Laboratories
Recruiting - verified November 2011 - Condition: Psoriasis
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified October 2011 - Conditions: Stroke; Cerebral Palsy
Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation (rTMS); Procedure: Constraint-induced movement therapy (CIMT)
Sponsors: University of Calgary; Heart and Stroke Foundation of Canada; University of Alberta
Recruiting - verified September 2011 - Conditions: Head and Neck Cancer; Surgery; Nutrition; Swallowing
Interventions: Behavioral: nutrition /swallowing counseling; Behavioral: G-tube/swallowing intervention; Behavioral: nutrition /swallowing intervention
Sponsor: University of Alberta
Not yet recruiting - verified March 2011 - Conditions: Hyperglycemia; Coronary Artery Bypass Graft; Coronary Artery Bypass
Interventions: Other: hyperinsulinemic normoglycemic clamp (HNC); Other: control group
Sponsors: Outcomes Research Consortium; National Institutes of Health (NIH)
Recruiting - verified June 2011 - Condition: LUNG DISEASES, OBSTRUCTIVE
Interventions: Device: pulse oxygen supplementation devices; Device: continuous oxygen
Sponsor: Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire
Recruiting - verified February 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Pioglitazone 15 mg; Drug: Pioglitazone 45 mg; Drug: Pioglitazone 30 mg; Drug: BI 1356 / Pioglitazone 15 mg FDC; Drug: BI 1356; Drug: BI 1356 / Pioglitazone 30 mg FDC; Drug: BI 1356 / Pioglitazone 45 mg FDC
Sponsors: Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified January 2012 - Condition: Hepatitis C
Interventions: Drug: Placebo; Drug: Nitazoxanide
Sponsor: National Liver Institute, Egypt
Recruiting - verified September 2011 - Condition: Carcinoma, Renal Cell
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
Sponsor: Bayer
Recruiting - verified February 2012 - Condition: Congenital Heart Disease
Intervention: Drug: Bosentan
Sponsor: Berto J Bouma
Recruiting - verified September 2011 - Condition: Nicotine Dependence
Interventions: Drug: GSK598809; Drug: Placebo
Sponsors: Massachusetts General Hospital; National Institute on Drug Abuse (NIDA); Mclean Hospital; GlaxoSmithKline
Recruiting - verified May 2011 - Condition: HIV-1
Interventions: Drug: Efavirenz or Nevirapine; Drug: Ritonavir-boosted lopinavir
Sponsors: University of Aarhus; Aarhus University Hospital; Bandim Health Project; Ministry of Health, Guinea-Bissau; Abbott
Recruiting - verified November 2011 - Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004; Drug: LuAA21004; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified September 2011 - Condition: Dental Caries
Interventions: Other: active treatment caries preventive measures; Other: control treatment
Sponsors: University of California, San Francisco; California Dental Association Foundation
Not yet recruiting - verified November 2011 - Condition: Heart Failure
Interventions: Device: Cardiac Resynchronization Therapy; Device: Optimization using echocardiography
Sponsor: St. Jude Medical
Recruiting - verified February 2011 - Condition: Acute Myeloid Leukemia (AML)
Interventions: Drug: Cytarabine; Drug: Idarubicin; Drug: Etoposide; Drug: Azacitidine; Drug: Lenograstim
Sponsor: University of Ulm
Recruiting - verified October 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring; Other: Continuous Glucose Monitoring; Other: SMBG; Other: SMBG With Knowledge
Sponsor: Endocrine Research Society
Recruiting - verified August 2010 - Condition: Schizophrenia
Interventions: Drug: PF-02545920; Drug: PF-02545920; Drug: Placebo; Drug: Risperidone
Sponsor: Pfizer
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: randomisation
Sponsors: P. Verschueren; Het agentschap voor Innovatie door Wetenschap en Technologie (IWT)
Recruiting - verified October 2011 - Conditions: Atrial Fibrillation; Heart Failure
Interventions: Procedure: Catheter ablation of persistent atrial fibrillation; Drug: Medical treatment alone
Sponsors: Barts & The London NHS Trust; British Heart Foundation
Recruiting - verified May 2010 - Conditions: Orthostatic Hypotension; Parkinson's Disease
Intervention: Drug: Droxidopa
Sponsor: Chelsea Therapeutics
Recruiting - verified January 2012 - Conditions: Asthma; Quality of Life; Children; Health Disparities; Telemedicine Education
Interventions: Other: Asthma Education Sessions; Other: Asthma Health Assessment via Telemonitoring; Other: Provider Treatment Prompt; Other: School Absenteeism; Other: Prescription Filling Profile
Sponsors: Arkansas Children's Hospital Research Institute; National Institutes of Health (NIH); University of Arkansas
Recruiting - verified January 2012 - Condition: Fractures
Interventions: Drug: Teriparatide; Drug: Placebo
Sponsors: Ohio Orthopedic Center of Excellence; Eli Lilly and Company
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Behavioral: Education and Peer Support; Behavioral: Asthma Education
Sponsors: Rush University Medical Center; National Institutes of Health (NIH); GlaxoSmithKline
Recruiting - verified December 2011 - Conditions: Crohns Disease; Fistula; Abscess
Intervention: Other: Surgically established drainage of perianal fistulas &/or abscesses BEFORE medical tx
Sponsors: Vanderbilt University; UCB, Inc.
Recruiting - verified July 2011 - Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM; Behavioral: Wait-list Control Group
Sponsor: University of Kansas
Recruiting - verified April 2011 - Condition: Obesity, Morbid
Interventions: Procedure: laparoscopic adjustable gastric band; Behavioral: Combined life style interventions
Sponsor: Maastricht University Medical Center
Recruiting - verified October 2011 - Condition: Substance Use Disorders
Interventions: Behavioral: Voucher Reinforcement; Behavioral: Standard Control
Sponsors: Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Conditions: Non-small Cell Lung Cancer; Small Cell Lung Cancer; Carcinoid; Thymic Cancer; Lung Cancer
Intervention: Radiation: Proton Therapy
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified October 2011 - Conditions: Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma
Interventions: Drug: bortezomib; Drug: fludarabine phosphate; Other: melphalan; Radiation: intensity-modulated radiation therapy; Radiation: total marrow irradiation; Radiation: tomotherapy; Drug: tacrolimus; Drug: sirolimus
Sponsor: City of Hope Medical Center
Recruiting - verified September 2011 - Condition: Erectile Dysfunction
Interventions: Device: Extracorporeal Shockwave Therapy Generator (Vascuspec); Device: Low intensity shock wave therapy
Sponsor: Rambam Health Care Campus
Recruiting - verified May 2010 - Conditions: Emotional Distress; Problem Behavior
Interventions: Behavioral: Cognitive Behavioral Group Therapy; Behavioral: Nondirective supportive group therapy
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified May 2010 - Condition: Pelvic Inflammatory Disease
Interventions: Drug: ceftriaxone, doxycycline, and placebo; Drug: ceftriaxone, doxycycline, metronidazole
Sponsors: University of Pittsburgh; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified July 2011 - Conditions: Myocardial Infarction; Cardiovascular Death; Atherothrombosis; Stroke
Interventions: Drug: Ticagrelor 90 mg; Drug: Ticagrelor 60 mg; Drug: Ticagrelor Placebo
Sponsor: AstraZeneca
Recruiting - verified December 2011 - Condition: Menorrhagia
Interventions: Drug: Estradiol 30 mcg / Levonorgestrel 150 mcg monophasic oral contraceptive pills; Drug: Naproxen sodium pills; Device: Nova Sure Radiofrequency Endometrial Ablation
Sponsors: Mayo Clinic; Hologic, Inc.
Recruiting - verified January 2012 - Condition: Wounds and Injuries
Intervention:
Sponsors: CW Optics, Inc.; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Obesity
Interventions: Drug: Leuprolide; Drug: Testosterone
Sponsors: Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Abbott
Recruiting - verified January 2012 - Condition: Severe Sepsis
Intervention: Dietary Supplement: Zinc sulfate
Sponsors: University of Vermont; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified September 2011 - Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Paclitaxel; Drug: Carboplatin; Drug: Cetuximab; Drug: Cetuximab; Drug: Docetaxel; Drug: Cisplatin; Drug: Fluorouracil; Radiation: Radiotherapy (RT); Other: Chemotherapy
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Helicobacter Infection
Interventions: Drug: high dose dual therapy; Drug: sequential therapy; Drug: clarithromycin-based triple therapy; Drug: levofloxacin-based triple therapy
Sponsors: National Taiwan University Hospital; National Science Council, Taiwan
Recruiting - verified September 2011 - Condition: Necrotizing Enterocolitis
Interventions: Drug: hydrocortisone; Drug: placebo
Sponsors: NorthShore University HealthSystem Research Institute; University of Chicago
Recruiting - verified March 2009 - Condition: CVD
Interventions: Drug: Argatroban; Drug: non-argatroban treated group
Sponsor: Jinling Hospital, China
Recruiting - verified June 2010 - Condition: Asthma
Interventions: Drug: Citalopram; Drug: Placebo
Sponsors: Liam Heaney; Asthma UK
Recruiting - verified February 2012 - Condition: ST-segment Elevation AMI
Intervention: Drug: Early intensive rosuvastatin therapy (40 mg for 7days, starting in ER prior to primary PCI)
Sponsors: Yonsei University; CardioVascular Research Foundation, Korea
Recruiting - verified January 2012 - Conditions: Type 1 Diabetes; Insulin Pump Therapy
Interventions: Device: MD Logic Pump Advisor; Other: No intervention
Sponsors: Rabin Medical Center; Medtronic
Recruiting - verified July 2011 - Condition: Secondary Malignant Neoplasm of Liver
Intervention: Radiation: SBRT
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified October 2010 - Conditions: Chronic Obstructive Pulmonary Disease; Telemedicine
Intervention: Other: Telemedical admission and treatment in the patients´ own homes instead of conventional admission and treatment at the hospital
Sponsors: Frederiksberg University Hospital; TRYG Foundation; The TOYOTA Foundation; Helsefonden; Lykfeldt legat; Frederiksberg Fonden; Danmarks Lungeforening
Recruiting - verified October 2011 - Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
Sponsor: University Hospital, Grenoble
Recruiting - verified January 2012 - Condition: Cervical Cancer
Intervention: Procedure: Lymphadenectomy in cervical cancer
Sponsor: Charite University, Berlin, Germany
Recruiting - verified December 2009 - Condition: Stroke, Acute
Interventions: Device: GangTrainer GT1; Device: Lokomat; Other: Conventional Physiotherapy
Sponsors: Research Department for Neurorehabilitation South Tyrol; Privatklinik Villa Melitta; Hochzirl Hospital; Krankenhaus Bozen; Krankenhaus Brixen; Krankenhaus Meran; Krankenhaus Bruneck; Claudiana Landesfachhochschule
Recruiting - verified August 2010 - Conditions: Children; Malnutrition
Interventions: Behavioral: Nutrition education; Dietary Supplement: RUTF
Sponsors: Aga Khan University; International Atomic Energy Agency
Recruiting - verified June 2010 - Condition: Depression
Interventions: Behavioral: Intensive Short-term Dynamic Psychotherapy; Behavioral: Medical treatment as Usual
Sponsor: Capital District Health Authority, Canada
Not yet recruiting - verified July 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010); Drug: placebo
Sponsor: Sanofi-Aventis
Recruiting - verified February 2012 - Conditions: Crohn's Disease; Fistula
Interventions: Procedure: Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.; Procedure: Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection.
Sponsors: Leiden University Medical Center; DigestScience
Recruiting - verified June 2011 - Condition: Nicotine Dependence
Interventions: Behavioral: Cognitive Behavioural Therapy; Behavioral: Contingency Management; Drug: Nicotine Transdermal Patch
Sponsors: Yale University; National Institutes of Health (NIH)
Recruiting - verified May 2011 - Conditions: Endodontic Treatment; Irreversible Pulpitis; Health Pulp; Infected Pulp
Interventions: Device: IABN; Device: IABN; Device: IABN
Sponsor: Hadassah Medical Organization
Not yet recruiting - verified June 2011 - Condition: Hypolactasia
Intervention: Drug: Lactase
Sponsor: Eurofarma Laboratorios S.A.
Recruiting - verified October 2011 - Conditions: Post-Stroke; Sensorimotor Gait Disorder; Neurologic Ambulation Disorder; Gait, Drop Foot
Interventions: Device: Ness L300; Device: Ness L300
Sponsors: Bioness Inc; Medidata Solutions; University of Cincinnati
Recruiting - verified November 2011 - Condition: Stroke
Interventions: Device: Hand Mentor (TM) robotic stroke therapy device; Device: Home Therapy Program
Sponsors: Kinetic Muscles; The Cleveland Clinic; Emory University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2011 - Conditions: HIV/AIDS; HIV Infections
Interventions: Drug: Efavirenz; Drug: Lopinavir/ritonavir (LPV/r); Drug: D4T; Drug: Abacavir (ABC)
Sponsors: Columbia University; University of Witwatersrand, South Africa; National Institutes of Health (NIH)
Recruiting - verified July 2011 - Conditions: Gastric Bypass; Parathyroid Hormone
Interventions: Drug: Paricalcitol; Drug: Cholecalciferol; Drug: Placebo
Sponsors: William Beaumont Hospitals; Abbott
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: GW766944; Other: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified February 2011 - Condition: Epilepsy
Interventions: Drug: USL255; Drug: Placebo
Sponsor: Upsher-Smith Laboratories
Recruiting - verified November 2011 - Conditions: Head and Neck Cancer; Long-term Effects of Cancer Treatment; Oral Complications of Radiation Therapy; Radiation Toxicity; Xerostomia
Interventions: Procedure: acupuncture therapy; Procedure: sham intervention; Procedure: standard follow-up care
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified June 2011 - Condition: Ileus
Interventions: Drug: Treatment Group; Drug: Control Group
Sponsors: Intermountain Health Care, Inc.; Cubist Pharmaceuticals
Recruiting - verified March 2011 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome; Genetic Resistance to Clopidogrel; Compliance to Thienopyridine Treatment
Intervention:
Sponsors: Biotronik France; European Cardiovascular Research Center; ACTION - Allies in Cardiovascular Trials Initiatives and Organized Network
Recruiting - verified July 2011 - Condition: Recurrent Aphthous Stomatitis
Intervention: Drug: vitamin B12 treatment
Sponsor: Meir Medical Center
Not yet recruiting - verified May 2011 - Condition: End Stage Renal Disease
Interventions: Device: WSTM TY101 FIR emitter (Far infrared therapy); Other: no intervention
Sponsor: Taipei Veterans General Hospital,Taiwan
Recruiting - verified July 2011 - Conditions: Atopic Dermatitis; Eczema
Interventions: Other: Current standard eczema treatment and standard pillow at night; Other: Chillow cooling pillow
Sponsor: Northwestern University
Recruiting - verified April 2011 - Condition: Hepatocellular Carcinoma
Interventions: Procedure: RFA; Procedure: Radioembolization (SIRT)
Sponsors: University of Magdeburg; Bayer; Sirtex Medical
Recruiting - verified May 2011 - Condition: Breast Cancer
Intervention: Radiation: Multi-Beam Intensity-Modulated Radiation Therapy
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Conditions: Ischemic Heart Disease; Stenotic Coronary Lesion; Cardiovascular Diseases; Arteriosclerosis; Coronary Artery Disease
Intervention: Device: Drug eluting stent treatment
Sponsor: Medtronic Vascular
Recruiting - verified October 2011 - Conditions: Obesity; Body Fat; Insulin Resistance
Intervention: Dietary Supplement: Double blind dietary intervention with EPA and lipoic acid
Sponsor: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra
Recruiting - verified October 2011 - Conditions: End Stage Renal Disease; Anemia
Interventions: Drug: FG-4592; Drug: Epoetin Alfa; Drug: FG-4592; Other: Placebo; Drug: Epoetin Alfa
Sponsor: FibroGen
Recruiting - verified June 2010 - Condition: Congestive Heart Failure
Intervention:
Sponsors: University of Utah; Intermountain Health Care, Inc.; VA Salt Lake City Health Care System
Recruiting - verified July 2011 - Condition: Migraine
Interventions: Drug: Amitriptyline; Drug: Melatonin; Drug: Placebo
Sponsors: Hospital Israelita Albert Einstein; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified January 2009 - Condition: Tobacco Use Cessation
Interventions: Other: proactive outreach (PRO); Other: Free telephone counseling (TC); Other: Nicotine replacement therapy (NRT); Other: Usual care (UC)
Sponsors: Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: Stroke; Shoulder Pain
Interventions: Device: Intramuscular Electrical Stimulator; Other: Outpatient Therapy
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2011 - Condition: Peptic Ulcer Hemorrhage
Interventions: Procedure: Angiographic embolization; Procedure: Therapeutic endoscopy
Sponsors: Odense University Hospital; Aarhus University Hospital
Recruiting - verified July 2011 - Condition: Humeral Diaphysis Fracture
Interventions: Procedure: Plate and screws or nailing; Device: Hanging Support System (HSS) brace
Sponsor: Hopital de l'Enfant-Jesus
Recruiting - verified November 2011 - Condition: Lateral Ankle Sprain
Interventions: Other: Sham ("laying of hands") intervention; Other: Grade IV AP joint mobilizations
Sponsors: University of Virginia; National Athletic Training Association Research & Education Foundation
Recruiting - verified May 2011 - Condition: Multiple Sclerosis
Intervention: Other: Physical exercise training
Sponsors: University of British Columbia; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Recruiting - verified February 2011 - Conditions: Atherosclerotic Cardiovascular Disease; Cardiovascular Disease
Intervention: Behavioral: IMPRESS intervention
Sponsors: National University Hospital, Singapore; National University, Singapore
Recruiting - verified April 2011 - Conditions: Heart Failure; Sleep Disordered Breathing
Intervention: Other: ventilation therapy
Sponsors: French Cardiology Society; ResMed; ResMed Foundation; ADEP Assistance
Recruiting - verified December 2011 - Condition: Acute Ischemic Stroke
Intervention: Device: NeuroThera® Laser System
Sponsor: PhotoThera, Inc
Recruiting - verified January 2012 - Condition: Hypertension
Intervention: Drug: Nifedipine (Adalat, BAY-A1040)
Sponsor: Bayer
Recruiting - verified January 2012 - Conditions: Knee Pain; Osteoarthritis
Interventions: Device: Elf care; Other: control group
Sponsor: Meir Medical Center
Recruiting - verified August 2011 - Conditions: Stroke; Plegia; Paresis; Cerebrovascular Accident
Intervention: Device: AMES Therapy (assisted movement and enhanced sensation)
Sponsors: AMES Technology; Oregon Health and Science University; Emory University; Northwestern University
Recruiting - verified October 2011 - Conditions: Blood Pressure Control; Kidney Transplant Recipient
Intervention: Other: Medication Adjustment
Sponsor: Mayo Clinic
Recruiting - verified September 2011 - Condition: Ankle Sprain
Interventions: Other: Mobilization therapy in addition to standard therapy; Other: Sham intervention
Sponsors: University of Virginia; American Physical Therapy Association
Recruiting - verified May 2011 - Condition: Stroke, Acute
Interventions: Device: hypothermia; Other: Group1: IV t-PA and normothermia
Sponsors: University of California, San Diego; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2010 - Condition: Partial Supraspinatus Tear
Interventions: Biological: PRGF; Other: NACL
Sponsor: Meir Medical Center
Recruiting - verified September 2011 - Condition: Depressive Disorder, Major
Interventions: Drug: venlafaxine XR; Drug: placebo; Drug: 26489112
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified December 2011 - Condition: Prostate Cancer
Interventions: Other: Placebo; Drug: SM; Drug: Third Group; Drug: Fourth Group
Sponsor: Penn State University
Recruiting - verified July 2011 - Condition: Drug Abuse
Interventions: Behavioral: Computer-delivered Brief Intervention (CBI); Behavioral: Intervener-delivered Brief Intervention (IBI); Behavioral: Adapted Motivational Enhancement Therapy (AMET); Behavioral: Enhanced Usual Care (EUC)
Sponsors: University of Michigan; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2011 - Conditions: ADHD; Growth
Interventions: Behavioral: behavioral therapy; Drug: 12 hour methylphenidate product; Behavioral: increased monitoring of growth; Drug: drug holiday; Dietary Supplement: caloric supplement
Sponsor: Florida International University
Recruiting - verified May 2011 - Condition: Tobacco Cessation
Interventions: Behavioral: Written self-help materials; Behavioral: Group behavioral counseling
Sponsor: Mayo Clinic
Recruiting - verified May 2011 - Conditions: Caregivers; Brain Injury
Interventions: Behavioral: Internet-based supportive coaching OSCAR; Other: Waiting-list control group (TAU)
Sponsors: University of Bern; Swiss National Science Foundation; University Hospital Inselspital, Berne
Recruiting - verified October 2011 - Conditions: Head and Neck Cancer; Smoking Cessation
Interventions: Behavioral: Acceptance and Commitment Therapy; Behavioral: Motivational and Behavioral Counseling; Drug: Varenicline
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified November 2011 - Conditions: Hypochondriasis; Somatization Disorder
Interventions: Behavioral: Acceptance and Commitment Therapy (ACT); Other: Treatment as usual & waiting list
Sponsor: University of Aarhus
Recruiting - verified June 2011 - Condition: Postcancer Fatigue
Interventions: Behavioral: immediate CBT; Behavioral: Delayed CBT
Sponsor: Radboud University
Recruiting - verified September 2011 - Condition: Glioblastomas
Interventions: Drug: Temozolomide; Drug: Bevacizumab; Radiation: Standard radiation therapy
Sponsor: Grupo Español de Investigación en Neurooncología
Recruiting - verified January 2012 - Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Lovaza (fish oil)
Sponsor: University of Tennessee
Recruiting - verified June 2011 - Condition: Kidney Transplant
Intervention: Drug: eculizumab
Sponsors: Mayo Clinic; Alexion Pharmaceuticals
Recruiting - verified September 2011 - Conditions: Major Depressive Disorder; Personality Disorder
Interventions: Behavioral: Mindfulness-based Behavioural Therapy (MIBT); Behavioral: PT (psychodynamic therapy)
Sponsor: Psychiatry Roskilde
Recruiting - verified February 2010 - Conditions: Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm; Drug: Fumaric acid esters treatment group; Other: Narrow band UVB radiation
Sponsor: Medical University of Vienna
Recruiting - verified January 2012 - Condition: Hepatitis C
Interventions: Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut ; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut
Sponsors: Okairos; University of Oxford
Recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Imatinib mesylate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Washington University School of Medicine; University of Wisconsin, Madison; Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Melanoma
Intervention: Drug: Dasatinib
Sponsors: M.D. Anderson Cancer Center; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Anemia; Inflammation; Malaria Morbidity; Cognitive Development
Intervention: Dietary Supplement: Ferrous Sulphate Syrup
Sponsors: University of Minnesota - Clinical and Translational Science Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Condition: Multiple Myeloma
Interventions: Drug: zoledronic acid; Other: No treatment control
Sponsors: PETHEMA Foundation; Dynamic Solutions S.L.; Novartis Farmacéutica S.A
Recruiting - verified September 2011 - Conditions: Head and Neck Cancer; Precancerous Condition
Interventions: Biological: cetuximab; Radiation: intensity-modulated radiation therapy
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified June 2011 - Condition: Neuroma, Acoustic
Interventions: Procedure: Microsurgery; Procedure: Stereotactic radiation therapy
Sponsors: Stanford University; University of Cincinnati; Baylor College of Medicine; Weill Medical College of Cornell University; University of Iowa
Recruiting - verified May 2011 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal CarcinomaCondition: Nasopharyngeal Carcinoma
Intervention: Drug: FOSCAN
Sponsor: Ministry of Health, Malaysia
Recruiting - verified July 2011 - Condition: Psoriasis
Interventions: Biological: anti-TNF biologics; Drug: systemic non-biological treatments; Other: general population; Biological: ustekinumab; Biological: non-anti-TNF biologics
Sponsor: Centocor Ortho Biotech Services, L.L.C.
Not yet recruiting - verified July 2011 - Conditions: Rheumatoid Arthritis; Arthritis, Psoriatic; Ankylosing Spondylitis
Interventions: Biological: anti-TNF biologics; Biological: non-anti-TNF biologics; Other: general population; Biological: golimumab; Drug: systemic non-biological treatments
Sponsor: Centocor Ortho Biotech Services, L.L.C.
Not yet recruiting - verified July 2011 - Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes
Interventions: Drug: azacitidine; Drug: gemtuzumab ozogamicin; Other: laboratory biomarker analysis
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified September 2011 - Conditions: Stress Disorders, Post-Traumatic; Borderline Personality Disorder; Suicide; Self-Injurious Behavior
Interventions: Behavioral: Dialectical Behavior Therapy; Behavioral: PTSD Protocol
Sponsors: University of Washington; National Institute of Mental Health (NIMH)
Recruiting - verified March 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.
Sponsors: Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.
Recruiting - verified November 2011 - Condition: Diverticulitis
Intervention: Other: Ambulatory versus hospitalisation
Sponsor: Hospital Universitari de Bellvitge
Recruiting - verified September 2011 - Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
Sponsors: Azienda Ospedaliero, Universitaria Meyer; Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Recruiting - verified January 2012 - Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsors: Abbott; Veeda Clinical Research, Belgium
Recruiting - verified November 2011 - Conditions: Renal Insufficiency; Secondary Hyperparathyroidism
Intervention: Drug: Zemplar (paricalcitol)
Sponsor: Abbott
Recruiting - verified December 2011 - Condition: Chronic Pain
Intervention: Device: Deep Brain Stimulation for Thalamic Pain Syndrome
Sponsors: Andre Machado; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Infertility
Intervention:
Sponsor: Merck KGaA
Recruiting - verified August 2011 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified December 2011 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified December 2011 - Conditions: Hypertension; Physical Activity; Diet; Medication Adherence
Interventions: Behavioral: Therapeutic Lifestyle Changes (MINT-TLC); Behavioral: Usual Care
Sponsors: New York University School of Medicine; Columbia University; Hebrew Home for the Aged; New York City Health and Hospitals Corporation
Recruiting - verified July 2011 - Condition: Chronic Major Depression
Interventions: Behavioral: Mindfulness-based Cognitive Therapy; Behavioral: The Cognitive Behavioral Analysis System of Psychotherapy; Biological: Standard psychiatric care
Sponsor: Ruhr University of Bochum
Recruiting - verified July 2011 - Conditions: Erectile Dysfunction; Urinary Incontinence
Interventions: Device: Transcutaneous mechanical nerve stimulation (TMNS); Other: Pelvic floor muscle training
Sponsors: Copenhagen University Hospital at Herlev; Skejby Hospital; Velux Fonden
Recruiting - verified May 2011 - Condition: Obesity
Interventions: Behavioral: Diet + Resistance Training; Behavioral: Diet + Aerobic Training; Behavioral: Diet + Resistance/Aerobic Exercise; Behavioral: Control group
Sponsors: Biomedical Research Institute of New Mexico; National Institute on Aging (NIA)
Recruiting - verified July 2011 - Conditions: Pancreatic Cancer Stage II; Pancreatic Cancer Stage III
Interventions: Drug: Neoadjuvant gemcitabine, capecitabine, and docetaxel; Drug: Gemcitabine, capecitabine, docetaxel followed by radiotherapy
Sponsor: Columbia University
Recruiting - verified October 2011 - Condition: Osteoarthritis
Interventions: Other: Group Physical Therapy for Knee OA; Other: Individual Physical Therapy for Knee OA
Sponsor: Department of Veterans Affairs
Recruiting - verified October 2011 - Conditions: Subacute Nonspecific Low Back Pain; Chronic Nonspecific Low Back Pain
Interventions: Behavioral: Education on active management; Other: Group GDS physiotherapy; Other: Individual GDS physiotherapy
Sponsor: Kovacs Foundation
Recruiting - verified June 2011 - Condition: Critical Limb Ischemia
Interventions: Genetic: VM202; Genetic: VM202; Other: Normal Saline
Sponsors: ViroMed Co., Ltd.; VM Biopharma
Recruiting - verified November 2011 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention: Drug: anti-TNF therapy (etanercept or adalimumab)
Sponsor: Imperial College London
Recruiting - verified September 2011 - Condition: Sarcoma
Interventions: Biological: cixutumumab; Biological: dactinomycin; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: irinotecan hydrochloride; Drug: temozolomide; Drug: vincristine sulfate
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Mitral Valve Regurgitation; Left Atrium Dilatation and Hypertrophy; Mitochondrial Dysfunction in the Heart; Cardiomyocyte Apoptosis; Cardiac Inflammation
Intervention: Drug: Lovaza group
Sponsors: East Carolina University; GlaxoSmithKline
Recruiting - verified June 2011 - Condition: Nicotine Dependence
Interventions: Drug: Bupropion SR; Drug: Nicotine; Drug: Placebo pill and Placebo Patch; Other: Delayed-Quit Control
Sponsors: Southern Illinois University Carbondale; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Condition: Bronchiolitis
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsor: Hamad Medical Corporation
Recruiting - verified July 2011 - Condition: Neuropathy
Interventions: Drug: pregabalin; Drug: placebo
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: H. Pylori Infection
Interventions: Drug: Sequential therapy for 14 days; Drug: Sequential therapy for 10 days; Drug: Triple therapy for 14 days
Sponsor: National Taiwan University Hospital
Recruiting - verified June 2011 - Condition: Suspected Invasive Candidiasis
Interventions: Drug: caspofungin acetate; Drug: Comparator: placebo
Sponsors: Merck; Mycoses Study Group
Recruiting - verified October 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2011 - Condition: Acute Lymphoblastic Leukemia
Intervention:
Sponsors: St. Jude Children's Research Hospital; National Institutes of Health (NIH)
Recruiting - verified July 2011 - Condition: Mature B-Cell Lymphoma
Interventions: Drug: COPAD; Drug: COP, COPD M3, CYM; Drug: COP, COPADM8, CYVE
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified July 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Atorvastatin; Drug: Atorvastatin
Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting - verified February 2011 - Condition: Insomnia
Intervention: Behavioral: Cognitive-behavioral therapy for Insomnia (CBT)
Sponsors: University of Manitoba; Health Sciences Centre Foundation, Manitoba
Recruiting - verified March 2011 - Condition: Stage IV Resectable Melanoma
Interventions: Procedure: Surgery; Procedure: Surgery plus 2 adjuvant doses of BCG; Other: best medical therapy
Sponsors: John Wayne Cancer Institute; Melanoma Research Alliance
Recruiting - verified January 2012 - Condition: Exotropia
Intervention: Device: occlusion treatment
Sponsors: Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Conditions: Asthma; Obstructive Sleep Apnea
Interventions: Other: FDA-Approved Treatment; Other: No intervention for Control Group
Sponsor: University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Type 1 Diabetes
Intervention: Behavioral: Family-based cognitive-behavioral treatment
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Conditions: Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission; B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma
Interventions: Other: laboratory biomarker analysis; Genetic: polymerase chain reaction; Genetic: reverse transcriptase-polymerase chain reaction; Biological: anti-CD19-CAR retroviral vector-transduced autologous T cells; Biological: genetically engineered lymphocyte therapy
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified January 2012 - Condition: Severe Spasticity
Intervention: Drug: intrathecal baclofen
Sponsor: Medtronic International Trading Sarl
Recruiting - verified January 2012 - Conditions: Alzheimer's Disease; Dementia
Intervention: Drug: donepezil
Sponsors: Samsung Medical Center; Eisai Korea Inc.
Recruiting - verified May 2011 - Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin
Sponsor: Cubist Pharmaceuticals
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Behavioral: Mindfulness-Based Cognitive Therapy (MBCT); Behavioral: Health-Enhancement Program (HEP)
Sponsors: University of California, San Francisco; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified September 2011 - Conditions: Heart Failure; Cardiac Resynchronization Therapy; Echocardiography
Interventions: Device: Empirical group; Device: Echocardiography-guided approach
Sponsors: Princess Margaret Hospital, Hong Kong; Medtronic
Not yet recruiting - verified November 2009 - Condition: Brain Cancer
Intervention: Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
Sponsors: Memorial Sloan-Kettering Cancer Center; Children's Healthcare of Atlanta; Dana-Farber Cancer Institute; M.D. Anderson Cancer Center; Phoenix Children's Hospital; Alberta Children's Hospital; University of Colorado, Denver; Seattle Children's Hospital; Johns Hopkins University; Children's Mercy Hospital-Kansas City, MO; MD Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children
Recruiting - verified January 2012 - Conditions: Chronic Pancreatitis; Chronic Pain; Abdominal Pain
Intervention: Procedure: Percutaneous Radiofrequent Lesioning
Sponsor: Maastricht University Medical Center
Recruiting - verified July 2011 - Condition: Peripartum Cardiomyopathy
Intervention: Drug: Bromocriptine
Sponsors: Hannover Medical School; German Federal Ministry of Education and Research
Recruiting - verified October 2009 - Condition: Depression
Intervention: Behavioral: CBT in combination with WBT and life style modification
Sponsors: University of Bologna; Compagnia San Paolo
Recruiting - verified September 2010 - Condition: Alcohol Misuse
Interventions: Behavioral: Computerized Motivational Intervention for Alcohol Misuse; Behavioral: Treatment-as-Usual
Sponsor: Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: Lumbosacral Radicular Syndrome
Interventions: Other: Pulsed Radiofrequency; Other: Conventional treatment
Sponsors: Maastricht University Medical Center; Ziekenhuis Oost-Limburg, Genk, Belgium; Sint Jozef Hospital Bornem en Willebroek Belgium
Recruiting - verified July 2011 - Conditions: Domestic Violence; Intimate Partner Violence
Intervention: Behavioral: Mind-Body Bridging
Sponsor: University of Utah
Recruiting - verified July 2011 - Conditions: HPV16+; Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: Biological: DNA vaccination; Device: Gene gun vaccine; Biological: intramuscular vaccination; Biological: intra-lesional vaccine administration; Procedure: therapeutic resection of the lesion
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Partial Epilepsy in Children and Adolescents
Interventions: Drug: Eslicarbazepine acetate (BIA 2-093); Drug: Eslicarbazepine acetate
Sponsor: Bial - Portela C S.A.
Recruiting - verified October 2009 - Condition: Partial Epilepsy
Interventions: Drug: Eslicarbazepine acetate; Drug: Eslicarbazepine acetate; Drug: Eslicarbazepine acetate
Sponsors: Bial - Portela C S.A.; Sunovion
Recruiting - verified June 2011 - Condition: COPD
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: Amphia Hospital; Erasmus Medical Center; Stichting Solong
Recruiting - verified May 2010 - Conditions: Acute Surgery; Alcohol Intervention; Postoperative Morbidity; Infection; Ankle Injuries
Interventions: Other: Postoperative alcohol cessation intervention programme; Other: Standard treatment
Sponsors: Bispebjerg Hospital; Hvidovre University Hospital; Helse Stavanger HF; Haukeland University Hospital, Norway; Lund University; Karolinska Institutet; National Board of Health, Denmark
Recruiting - verified May 2010 - Condition: Chronic Pain
Interventions: Behavioral: cognitive-behavioral treatment; Behavioral: educational supportive group
Sponsor: Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Age-related Macular Degeneration
Intervention: Dietary Supplement: Ocean Nutrition MEG3 4020EE product
Sponsors: Yves Sauve; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified November 2011 - Conditions: Heart Diseases; Diabetes Mellitus, Type 2; Behavior; Motivation
Intervention: Behavioral: Intervention Group (IG)
Sponsors: Freie Universität Berlin; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified June 2011 - Conditions: Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Thromboembolism; Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b); Drug: low molecular weight heparin/unfractionated heparin; Drug: warfarin
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified September 2011 - Condition: Liver Cancer
Interventions: Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: vincristine sulfate; Procedure: liver transplantation; Procedure: therapeutic conventional surgery
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Hepatocellular Cancer; Non-small Cell Lung Cancer; Renal Cell Cancer; Colorectal Cancer
Interventions: Drug: Avastin; Drug: Suntent; Drug: Nexavar
Sponsor: Medical University Innsbruck
Recruiting - verified January 2012 - Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL); Drug: Atazanavir (ATV); Drug: Ritonavir (RTV); Drug: Tenofovir (TDF); Drug: Etravirine (ETV); Drug: Darunavir (DRV); Drug: Maraviroc (MVC); Drug: Lopinavir/ritonavir (LPV/r)
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Conditions: Sepsis; Intensive Care
Intervention: Other: Procalcitonin measurement
Sponsors: Rijnstate Hospital; Stichting Vrienden van het Alysis Leerhuis
Not yet recruiting - verified August 2011 - Condition: Bladder Cancer
Interventions: Drug: Mitomycin C (MMC); Biological: Bacillus Calmette-Guerin (BCG)
Sponsors: Memorial Sloan-Kettering Cancer Center; New York Presbyterian Hospital; Weill Medical College of Cornell University
Recruiting - verified January 2012 - Conditions: Blood Coagulation Disorders; Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Sponsor: Bayer
Recruiting - verified December 2011 - Condition: Mantle Cell Lymphoma
Interventions: Drug: lenalidomide, bendamustine, rituximab; Drug: lenalidomide, bendamustine, rituximab
Sponsors: Lund University Hospital; Mundipharma; Celgene Corporation; Roche Pharma AG
Recruiting - verified January 2012 - Conditions: Pain; Pancreatic Cancer
Intervention: Procedure: Ultrasound guided celiac plexus neurolysis (CPN)
Sponsor: University of Alabama at Birmingham
Recruiting - verified April 2011 - Condition: Relapsed or Refractory Chronic Lymphocytic Leukemia
Intervention: Drug: lenalidomide
Sponsor: Celgene Corporation
Recruiting - verified October 2011 - Condition: Social Anxiety Disorder
Intervention: Behavioral: Group Cognitive Behavioral Therapy
Sponsor: Southern Methodist University
Recruiting - verified July 2011 - Conditions: Schizoaffective Disorder; Schizophrenia; Mood Disorders With Psychotic Features
Interventions: Behavioral: BTSCS; Behavioral: StSST
Sponsor: Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Domestic Violence
Intervention: Behavioral: PTSD-Focused CBT for Partner Violence
Sponsors: Boston VA Research Institute, Inc.; Department of Defense
Recruiting - verified September 2011 - Condition: Bipolar I Disorder
Interventions: Drug: Escitalopram; Drug: Bupropion XL
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR); Glaxo Smith Kline Biovail; H. Lundbeck A/S
Recruiting - verified September 2011 - Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Cetuximab; Drug: IMC-A12; Procedure: Surgical tumor resection
Sponsors: M.D. Anderson Cancer Center; ImClone LLC
Recruiting - verified February 2012 - Conditions: Heart Failure; Ischemic Cardiomyopathy
Interventions: Device: AV-optimization followed by AV- and VV-optimization; Device: AV- and VV-optimization followed by AV-optimization only.
Sponsors: University Hospital, Gentofte, Copenhagen; Lund University Hospital; Rigshospitalet, Denmark
Recruiting - verified October 2011 - Condition: Partial Epilepsies
Intervention: Drug: Lacosamide
Sponsor: UCB, Inc.
Recruiting - verified January 2012 - Condition: Type 1 Diabetes
Intervention: Device: monitor Paradigm 754 VEO, MINILINK Real Time, Medtronic, CE
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified July 2009 - Condition: Type 1 Diabetes Mellitus
Interventions: Device: Continuous Glucose Sensor; Other: Standard Care; Behavioral: CGS + Behavior Therapy
Sponsor: Nemours Children's Clinic
Recruiting - verified July 2011 - Condition: Constipation-predominant Irritable Bowel Syndrome
Interventions: Drug: Neomycin; Drug: Placebo; Drug: Rifaximin
Sponsors: Cedars-Sinai Medical Center; Salix Pharmaceuticals
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Radiation: intracavitary balloon brachytherapy; Radiation: intraoperative radiation therapy
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Delayed Sleep Phase Disorder; Jet-lag; Shift-work Disorder
Interventions: Dietary Supplement: Melatonin; Dietary Supplement: Placebo
Sponsor: Brigham and Women's Hospital
Recruiting - verified June 2011 - Condition: Metastatic Colorectal Cancer
Intervention: Other: Early and active nutritional support.
Sponsors: Department of Clinical Research and Innovation; Centre Hospitalier Universitaire de Nice; Federation Nationale des Centres de Lutte Contre le Cancer; Centre Leon Berard; Centre Val d'Aurelle; University Hospital, Clermont-Ferrand; University Hospital, Montpellier; Assistance Publique Hopitaux De Marseille
Recruiting - verified December 2011 - Conditions: Graves Disease; Hyperthyroidism
Intervention: Drug: Potassium Iodine
Sponsor: University of Massachusetts, Worcester
Recruiting - verified October 2011 - Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Drug: NX-1207; Drug: Placebo
Sponsor: Nymox Corporation
Recruiting - verified December 2011 - Conditions: Sciatica; Radiculopathy; Spinal Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Intervertebral Disk Displacement
Interventions: Other: Physical therapy rehabilitation; Other: Physical therapy rehabilitation
Sponsors: Intermountain Health Care, Inc.; University of Utah; Wilford Hall Medical Center; Empi, A DJO Company
Recruiting - verified October 2011 - Condition: Transtibial Amputation
Intervention: Device: NMES (EMPI 300PV stimulator) plus standard of care
Sponsors: University of North Carolina, Charlotte; Walter Reed Army Medical Center; United States Naval Medical Center, San Diego
Recruiting - verified August 2011 - Condition: TYPE 2 DIABETES
Interventions: Device: placebo; Device: IVS; Device: PDAphone
Sponsors: Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète; Novo Nordisk
Recruiting - verified March 2010 - Condition: Constipation
Interventions: Drug: MOA728; Drug: MOA728
Sponsors: Salix Pharmaceuticals; Progenics Pharmaceuticals, Inc.
Recruiting - verified August 2011 - Conditions: Advanced Non-small Cell Lung Cancer; Postmenopausal Women
Interventions: Drug: fulvestrant (Faslodex); Drug: anastrozole (Arimidex); Drug: Bevacizumab (Avastin); Drug: Best standard of care
Sponsor: University of Pittsburgh
Recruiting - verified January 2012 - Condition: Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Sponsor: Bayer
Recruiting - verified December 2011 - Conditions: Head and Neck Cancer; Oropharyngeal Cancer; Gastroesophageal Reflux Disease
Intervention: Drug: Dexlansoprazole
Sponsors: M.D. Anderson Cancer Center; TAP Pharmaceutical Products Inc.
Not yet recruiting - verified November 2011 - Condition: Non-Small-Cell Lung Carcinoma
Interventions: Radiation: Photon Therapy; Radiation: Proton Therapy
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified October 2011 - Condition: Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: ABVD regimen; Drug: carmustine; Drug: cisplatin; Drug: cytarabine; Drug: dacarbazine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: gemcitabine hydrochloride; Drug: ifosfamide; Drug: melphalan; Drug: methylprednisolone; Drug: mitoguazone; Drug: vincristine sulfate; Drug: vindesine; Drug: vinorelbine tartrate; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: autologous hematopoietic stem cell transplantation
Sponsor: Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS
Recruiting - verified April 2010 - Condition: Nonmalignant Neoplasm
Interventions: Procedure: umbilical cord blood transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: allogeneic bone marrow transplantation; Drug: fludarabine phosphate; Drug: treosulfan; Radiation: total-body irradiation; Drug: tacrolimus; Drug: methotrexate; Drug: cyclosporine; Drug: mycophenolate mofetil; Genetic: DNA analysis; Other: laboratory biomarker analysis; Genetic: cytogenetic analysis; Biological: anti-thymocyte globulin
Sponsors: Fred Hutchinson Cancer Research Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Condition: Benign Prostatic Hyperplasia
Interventions: Drug: NX-1207; Drug: Placebo
Sponsor: Nymox Corporation
Recruiting - verified December 2011 - Condition: Obesity
Interventions: Behavioral: lifestyle intervention; Behavioral: Health Education Control
Sponsor: University of Florida
Recruiting - verified May 2009 - Condition: Posttraumatic Stress Disorder
Interventions: Behavioral: Cognitive Processing Group Therapy Through Videoteleconference; Behavioral: Cognitive Processing Group Therapy In-Person
Sponsor: Department of Veterans Affairs
Recruiting - verified October 2011 - Condition: B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Interventions: Drug: Lenalidomide; Drug: Chlorambucil
Sponsor: Celgene Corporation
Recruiting - verified September 2011 - Condition: Bulimia Nervosa
Intervention: Behavioral: Cognitive Behavioral Group Therapy
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: Fulvestrant; Drug: MK-0646; Drug: Dasatinib
Sponsors: M.D. Anderson Cancer Center; Bristol-Myers Squibb; Merck; Commonwealth Foundation for Cancer Research
Recruiting - verified January 2012 - Conditions: Impotence; Prostatic Neoplasms
Interventions: Drug: Sildenafil therapy plus post-NSRRP HBO2T; Drug: Sildenafil therapy plus sham post-NSRRP HBO2T
Sponsor: Hartford Hospital
Recruiting - verified April 2011 - Condition: Acute Lymphoblastic Leukemia
Interventions: Behavioral: Physical Therapy; Behavioral: Support
Sponsors: St. Jude Children's Research Hospital; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Autistic Disorder
Interventions: Behavioral: Cognitive Enhancement Therapy; Behavioral: Enriched Supportive Therapy
Sponsors: University of Pittsburgh; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Behavioral: MEDIAS ICT; Behavioral: Current ICT program (ACC-ICT); Behavioral: MEDIAS CT; Behavioral: Current CT program (ACC-CT)
Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim
Recruiting - verified May 2009 - Condition: Brain and Central Nervous System Tumors
Interventions: Other: clinical observation; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified April 2011 - Conditions: Acute Decompensated Heart Failure; Congestive Heart Failure
Interventions: Drug: Aliskiren; Drug: Placebo
Sponsor: Novartis
Recruiting - verified May 2011 - Conditions: Acute Ischemic Stroke; Stroke; Brain Infarction
Interventions: Drug: Eptifibatide; Drug: rt-PA
Sponsors: University of Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2011 - Condition: Metastatic Breast Cancer
Interventions: Other: Action Group; Other: Standard care
Sponsor: Centre Leon Berard
Recruiting - verified June 2011 - Conditions: Graft Rejection; Kidney Transplant; Renal Allograft Recipients; Renal Transplant
Interventions: Drug: Tacrolimus; Drug: Sirolimus; Drug: Tacrolimus
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: MELAS Syndrome
Interventions: Drug: Idebenone; Drug: Idebenone; Other: Placebo
Sponsors: Columbia University; Santhera Pharmaceuticals
Recruiting - verified August 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: gemcitabine hydrochloride; Drug: vinorelbine ditartrate
Sponsor: University of Miami Sylvester Comprehensive Cancer Center
Recruiting - verified August 2011 - Conditions: Osteopenia; Prematurity
Intervention:
Sponsor: University of Utah
Recruiting - verified October 2011 - Condition: Hypertension
Interventions: Other: Enhanced pharmacist care; Other: Usual Care
Sponsors: University of Alberta; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Conditions: Atrial Fibrillation; Deep Vein Thrombosis; Pulmonary Embolism; Artificial Heart Valve
Interventions: Other: Genotype-guided dose determination; Other: Non-genotype guided warfarin dosing
Sponsors: University of North Carolina, Chapel Hill; UNC Institute for Pharmacogenomics and Individualized Therapy
Recruiting - verified February 2012 - Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Olanzapine
Sponsor: Charite University, Berlin, Germany
Recruiting - verified March 2011 - Condition: Breast Cancer
Intervention: Drug: Ixabepilone
Sponsors: M.D. Anderson Cancer Center; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Aripiprazole (Fixed dose); Drug: Aripiprazole (Titrated dose); Drug: Placebo
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified June 2011 - Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Transdermal nicotine; Other: Usual drug treatment of Parkinson's disease
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2011 - Conditions: Stroke; Brain Infarction; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders
Interventions: Behavioral: Accelerated Skill Acquisition Program (ASAP); Behavioral: Dose-Equivalent Usual & Customary Care - DEUCC; Behavioral: Usual and Customary Care - UCC
Sponsors: University of Southern California; National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Prematurity; Intraventricular Hemorrhage; Hydrocephalus
Interventions: Procedure: Removal of CSF through ventricular access device; Procedure: Removal of CSF through a ventricular access device
Sponsor: Washington University School of Medicine
Recruiting - verified August 2011 - Conditions: Cigarette Smoking; Hypertension
Interventions: Drug: Varenicline; Behavioral: behavioral therapy
Sponsors: University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Behavioral: Mindfulness Based Cognitive Therapy; Behavioral: Health Enhancement Program and medication management
Sponsors: University of California, San Francisco; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified June 2011 - Condition: Depression
Interventions: Behavioral: Behavioral Family Treatment; Other: Community-based treatment as usual
Sponsors: Oregon Research Institute; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Hematopoietic/Lymphoid Cancer
Interventions: Other: educational intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Other: survey administration; Procedure: psychosocial assessment and care; Procedure: stress management therapy; Procedure: support group therapy
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI)
Recruiting - verified January 2009 - Condition: Non Small Cell Lung Cancer
Interventions: Radiation: radiation; Other: Chemotherapy and radiotherapy; Drug: Chemotherapy; Other: Palliative radiotherapy and chemotherapy
Sponsor: International Atomic Energy Agency
Recruiting - verified October 2011 - Condition: Melanoma
Interventions: Drug: Pegylated Interferon-Alfa 2b (PEG Intron); Drug: GP-100 Peptide Vaccine
Sponsors: M.D. Anderson Cancer Center; Schering-Plough
Recruiting - verified October 2011 - Conditions: Aggression; Post Traumatic Stress Disorders
Interventions: Behavioral: Strength at Home Couples Group; Behavioral: Supportive Group Therapy
Sponsors: Boston VA Research Institute, Inc.; Centers for Disease Control and Prevention
Recruiting - verified September 2011 - Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot StudyCondition: Schizophrenia
Interventions: Behavioral: Cognitive Behavioral Social Skills Training (CBSST) plus treatment as usual; Behavioral: Treatment as usual (TAU)
Sponsor: Centre for Addiction and Mental Health
Recruiting - verified November 2011 - Conditions: Cognitive Decline; Mucopolysaccharidosis I; Hurler-Scheie Syndrome; Scheie Syndrome; Lysosomal Storage Disease
Intervention: Drug: laronidase
Sponsors: Dickson, Patricia I., M.D.; MPS I Intrathecal Research Collaborative; The Ryan Foundation for MPS Children; BioMarin Pharmaceutical; Rare Diseases Clinical Research Network; University of Minnesota - Clinical and Translational Science Institute; University of California, Los Angeles
Recruiting - verified May 2011 - Condition: Chronic Heart Failure
Interventions: Drug: Enalapril monotherapy; Drug: Aliskiren monotherapy; Drug: Aliskiren / Enalapril combination therapy
Sponsor: Novartis
Recruiting - verified May 2011 - Condition: Head and Neck Cancer
Intervention: Radiation: stereotactic radiosurgery
Sponsor: Boston Medical Center
Recruiting - verified June 2011 - Condition: Depression
Intervention: Behavioral: Telepsychiatry-based Culturally Sensitive Collaborative Treatment
Sponsor: Massachusetts General Hospital
Recruiting - verified March 2011 - Conditions: Low Back Pain; Neck Pain
Interventions: Behavioral: Exercises and work related rehabilitation; Behavioral: Brief intervention; Behavioral: multidisciplinary exercise group
Sponsors: Ullevaal University Hospital; The Research Council of Norway
Recruiting - verified May 2011 - Condition: Substance Abuse
Intervention: Behavioral: contingency management
Sponsors: University of Connecticut Health Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Conditions: Degenerative Spondylolisthesis; Isthmic Spondylolisthesis
Intervention: Other: Outcome of lumbar spinal fusion patients and significance of postoperative exercise therapy: RCT
Sponsors: Jyväskylä Central Hospital; Tampere University Hospital; University of Tampere
Recruiting - verified March 2011 - Condition: Malaria
Interventions: Device: RDT; Other: Clinical Judgement as basis for treatment of malaria with ACT
Sponsors: Kintampo Health Research Centre, Ghana; London School of Hygiene and Tropical Medicine
Recruiting - verified April 2011 - Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
Sponsor: Pfizer
Recruiting - verified January 2012 - Conditions: Pain; Chronic Pain; Hyperalgesia
Intervention: Drug: Ketamine
Sponsor: Massachusetts General Hospital
Recruiting - verified July 2011 - Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939); Drug: Standard care treatment for VTE prophylaxis
Sponsor: Bayer
Recruiting - verified January 2012 - Condition: Schizophrenia
Interventions: Behavioral: Support Group; Behavioral: Cognitive Behavior Therapy; Behavioral: Cognitive Remediation
Sponsors: Department of Veterans Affairs; Indiana University School of Medicine
Recruiting - verified November 2011 - Condition: Nocturia
Interventions: Behavioral: Behavioral; Drug: tamsulosin (alpha-adrenergic antagonist medication); Drug: placebo; Behavioral: placebo
Sponsors: Atlanta VA Medical Center; Emory University; University of Alabama at Birmingham
Recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Beclomethasone
Sponsor: Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Breast Cancer
Intervention: Other: Blood draw and questionaires
Sponsors: Memorial Sloan-Kettering Cancer Center; New York Medical College; New York Presbyterian Hospital; Weill Medical College of Cornell University
Recruiting - verified January 2012 - Conditions: Conduct Disorder; Attention Deficit Hyperactivity Disorder; Oppositional Defiant Disorder
Interventions: Dietary Supplement: Omega-3; Behavioral: Social Skills Training; Other: Standard Treatment (or TAU in Child Guidance Clinic)
Sponsors: National Healthcare Group, Singapore; Nanchang University; University of Pennsylvania; National University, Singapore; Duke-NUS Graduate Medical School; Alexandra Hospital, Singapore; Singapore Institute for Clinical Studies
Recruiting - verified June 2010 - Condition: Type 1 Diabetes
Interventions: Other: Medtronic CareLink therapy management system; Other: regular home use and Medtronic CareLink Therapy Management
Sponsor: Rabin Medical Center
Recruiting - verified October 2011 - Conditions: Smouldering Systemic Mastocytosis; Indolent Systemic Mastocytosis; Cutaneous Mastocytosis With Handicap; Mastocytosis
Interventions: Drug: masitinib (AB1010); Drug: placebo
Sponsor: AB Science
Recruiting - verified January 2012 - Condition: Urinary Tract Infection
Intervention: Drug: short treatment (ciprofloxacin)
Sponsors: Leiden University Medical Center; Bronovo Hospital; Medical Center Haaglanden; Spaarne Hospital; Rijnland Hospital; Diaconessenhuis Leiden; Groene Hart Hospital
Recruiting - verified August 2009 - Condition: Congestive Heart Failure
Intervention: Device: CRT Therapy - LV Lead Registry
Sponsor: Biotronik, Inc.
Recruiting - verified June 2011 - Conditions: Candidemia; Invasive Candidiasis
Intervention: Drug: anidulafungin treatment
Sponsor: Pfizer
Not yet recruiting - verified January 2012 - Conditions: Cervical Cancer; Endometrial Cancer; Vaginal Cancer
Intervention: Procedure: CT or MRI + Blood Test
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Condition: Stroke
Interventions: Device: Whole body vibration therapy; Other: standing on the vibration platform but no vibration will be applied
Sponsors: The Hong Kong Polytechnic University; Tung Wah Hospital
Recruiting - verified August 2011 - Conditions: Solid Tumors; Neoplasms, Breast; Cancer
Interventions: Drug: Lapatinib in combination with an anti-cancer agent; Drug: Lapatinib; Drug: Lapatinib in combination with an anti-cancer agent as specified by parent protocol
Sponsor: GlaxoSmithKline
Recruiting - verified November 2011 - Conditions: Soft Tissue Sarcoma; Non Metastatic Disease
Interventions: Drug: doxorubicin , ifosfamide; Drug: doxorubicin, ifosfamide; Drug: doxorubicin, ifosfamide; Drug: doxorubicin, ifosfamide
Sponsors: Oslo University Hospital; Scandinavian Sarcoma Group
Recruiting - verified November 2008 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol; Drug: placebo tablets
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified January 2012 - Conditions: Psychological Stress; Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2011 - Condition: Lumbar Spinal Stenosis
Interventions: Other: Epidural steroid injection plus physical therapy; Other: Epidural steroid injection
Sponsors: Franklin Pierce University; University of Colorado, Denver
Recruiting - verified August 2009 - Condition: Insomnia
Interventions: Behavioral: Individual-behavioral sleep intervention; Behavioral: Group-based behavioral sleep intervention I; Behavioral: Group-based behavioral sleep intervention II
Sponsor: Department of Veterans Affairs
Recruiting - verified November 2011 - Condition: Osteonecrosis
Interventions: Drug: Zoledronic Acid; Drug: Placebo
Sponsors: University of Sydney; Novartis
Recruiting - verified February 2011 - Condition: Sickle Cell Disease
Intervention: Drug: Hydroxycarbamide, Hydroxyurea (drug)
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified October 2008 - Condition: Prostate Cancer
Interventions: Drug: Androgen Deprivation Therapy; Drug: bicalutamide; Drug: bevacizumab
Sponsors: Dana-Farber Cancer Institute; Genentech; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Cancer Institute of New Jersey
Recruiting - verified June 2011 - Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Rapamycin
Sponsors: State University of New York - Upstate Medical University; Pfizer
Recruiting - verified July 2011 - Conditions: Brain Injury; Aggression
Interventions: Drug: Amantadine Hydrochloride; Drug: Placebo
Sponsors: Carolinas Healthcare System; Indiana University; University of Washington; The Institute for Rehabilitation and Research; Spaulding Rehabilitation Hospital; Ohio State University; Mount Sinai School of Medicine
Recruiting - verified September 2011 - Conditions: Renal Cell Carcinoma; Gastrointestinal Stromal Tumor
Interventions: Drug: usage oral angiogenesis inhibitor; Drug: stop oral angiogenesis inhibitor
Sponsor: Radboud University
Recruiting - verified September 2011 - Conditions: Generalized Anxiety Disorder; Separation Anxiety Disorder; Social Phobia
Interventions: Behavioral: Cognitive Behavioral Therapy; Behavioral: Client Centered Therapy
Sponsors: University of Pittsburgh; National Institute of Mental Health (NIMH)
Recruiting - verified May 2011 - Condition: Lymphoma
Interventions: Procedure: Biopsy; Radiation: Fluordeoxyglucose F 18; Other: [3'-deoxy-3'-[F-18] fluorothymidine; Procedure: computed tomography; Procedure: fine-needle aspiration
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2011 - Condition: B-cell Chronic Lymphocytic Leukemia
Interventions: Drug: Lenalidomide; Drug: Placebo
Sponsor: Celgene Corporation
Recruiting - verified October 2011 - Condition: Systemic Lupus Erythematosus
Interventions: Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: Placebo
Sponsor: State University of New York - Upstate Medical University
Recruiting - verified January 2012 - Condition: Head and Neck Cancer
Interventions: Radiation: conventional radiotherapy with 'high' dose cisplatin; Radiation: accelerated radiotherapy with 'low' dose cisplatin
Sponsors: Radboud University; Sanofi-Aventis
Recruiting - verified September 2011 - Condition: Advanced Bulky Malignancies
Interventions: Radiation: Spatially Fractioned Radiation Therapy; Radiation: Treatment Group 1; Radiation: Standard radiation; Radiation: Standard radiation
Sponsor: Summa Health System
Recruiting - verified July 2011 - Condition: Gastric Cancer
Intervention: Drug: EOF5
Sponsor: Fudan University
Recruiting - verified September 2010 - Condition: Acute Myeloid Leukemia
Interventions: Procedure: hematopoietic cell transplantation; Drug: Non-Transplant treatment approach for consolidation
Sponsors: European Group for Blood and Marrow Transplantation; Acute Leukemia French Association; Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias; European Organization for Research and Treatment of Cancer - EORTC; Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS; HOVON - Dutch Haemato-Oncology Association; East German Study Group of Hematology and Oncology (OSHO); Swiss Group for Clinical Cancer Research
Recruiting - verified December 2011 - Condition: Osteomyelitis of Vertebra
Intervention: Drug: antibiotic
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2011 - Conditions: Barrett's Esophagus; Esophageal Cancer
Intervention: Device: CryoSpray Ablation(TM)
Sponsor: CSA Medical, Inc.
Recruiting - verified January 2012 - Conditions: Cardiovascular Disease; Atherosclerosis; Coronary Artery Disease; Coronary Stenosis
Intervention: Other: Comprehensive therapy program for risk factor modification
Sponsor: Stefano Sdringola
Recruiting - verified October 2011 - Conditions: Depression; Traumatic Brain Injury
Intervention: Behavioral: Mindfulness-Based Cognitive Therapy
Sponsors: Lakehead University; Ontario Neurotrauma Foundation
Recruiting - verified June 2011 - Conditions: HIV; AIDS; Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB; Drug: Deferred RV and antiMTB treatment
Sponsors: Instituto Nacional de Enfermedades Respiratorias; Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).
Recruiting - verified August 2008 - Conditions: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Long-term Effects Secondary to Cancer Therapy in Children; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: survey administration; Procedure: assessment of therapy complications; Procedure: long-term screening; Procedure: study of high risk factors
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified April 2011 - Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular EdemaCondition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab intravitreal; Drug: Triamcinolone; Drug: Triamcinolone + Bevacizumab
Sponsor: Federal University of São Paulo
Recruiting - verified August 2008 - Condition: Cancer of Liver
Interventions: Procedure: radiofrequency ablation associated with TACE; Procedure: radiofrequency ablation only
Sponsors: Southwest Hospital, China; Agency for Science, Technology and Research
Recruiting - verified July 2011 - Condition: Ulcerative Colitis
Interventions: Biological: infliximab; Drug: Standard Therapy; Biological: infliximab
Sponsors: Schering-Plough; Centocor, Inc.
Recruiting - verified December 2011 - Condition: Renal Transplantation
Interventions: Drug: Basiliximab, Tacrolimus, MMF, Prednisolon; Drug: Basiliximab, Tacrolimus, MMF; Drug: Tacrolimus, MMF, rATG
Sponsors: ClinTrio Ltd.; Roche Pharma AG; Astellas Pharma GmbH; Genzyme
Recruiting - verified February 2011 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: exemestane; Drug: letrozole; Procedure: assessment of therapy complications
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified May 2011 - Condition: Acne Vulgaris
Interventions: Drug: drospirenone and ethinyl estradiol; Drug: Placebo tablets
Sponsors: Massachusetts General Hospital; Bayer
Recruiting - verified March 2011 - Condition: Stress Disorders, Post-Traumatic
Interventions: Behavioral: Trauma-focused Cognitive Behavior Therapy; Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)
Sponsor: VU University of Amsterdam
Recruiting - verified September 2011 - Condition: Head and Neck Cancer
Interventions: Other: TPF, radiotherapy and cisplatin.; Other: TPF, radiotherapy and cetuximab.
Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Recruiting - verified February 2011 - Conditions: Intensive Care Unit; Muscle Weakness
Interventions: Device: Neuromuscular Electrostimulation (NMES) CareStim Muscle Stimulation Device (Care Rehab; McLean, VA); Device: Sham
Sponsor: Johns Hopkins University
Recruiting - verified May 2010 - Conditions: Alcohol Dependence; Dual Diagnosis; Drug Dependence
Intervention: Behavioral: In-Home-Messaging-Device (IHMDs)
Sponsor: Department of Veterans Affairs
Recruiting - verified October 2011 - Condition: Substance Abuse
Interventions: Behavioral: CBT, Cognitive Behavioral Therapy; Behavioral: FFT, Family Functional Therapy
Sponsor: Oregon Research Institute
Recruiting - verified October 2011 - Conditions: Severe Sepsis; Septic Shock
Interventions: Other: Albumin and Crystalloids; Other: Crystalloids
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Recruiting - verified July 2011 - Condition: Breast Cancer
Intervention:
Sponsors: University Health Network, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified November 2008 - Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach; Other: multifactorial approach - for enhanced care group; Other: reflects current patterns of care
Sponsors: University of Alberta; Alberta Heritage Foundation for Medical Research
Recruiting - verified November 2011 - Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin; Drug: heparin + clopidogrel + aspirin; Drug: enoxaparin + clopidogrel + aspirin; Drug: bivalirudin + clopidogrel + aspirin
Sponsor: Centre Hospitalier de PAU
Recruiting - verified July 2011 - Condition: Leprosy
Interventions: Drug: Rifampicin and Dapsone; Drug: Rifampicin, Clofazimine and Dapsone; Drug: Rifampicin, Clofazimine and Dapsone; Drug: Rifampicin, Clofazimine and Dapsone
Sponsors: University of Brasilia; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministério de Ciência e Tecnologia; Ministério da Saúde
Recruiting - verified August 2011 - Condition: HIV Infections
Interventions: Drug: Treatment initiation for HIV-1 group O infected patients; Drug: Treatment initiation for HIV-1 group M infected patients
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified August 2011 - Condition: IgA Nephropathy
Interventions: Drug: irbesartan; Drug: methylprednisolone (MP) or prednisone (pred); Drug: mycophenolate mofetil (MMF)
Sponsor: Sun Yat-sen University
Recruiting - verified September 2011 - Conditions: Localized Breast Cancer; Localized Prostate Cancer; Patients Receiving External Beam Radiotherapy
Interventions: Dietary Supplement: Organic Germanium; Dietary Supplement: Placebo
Sponsor: Arizona Oncology Services
Recruiting - verified June 2011 - Condition: Perioperative Inflammatory Response
Interventions: Drug: simvastatin; Drug: placebo
Sponsor: Mayo Clinic
Recruiting - verified April 2011 - Conditions: Cardiomyopathy, Dilated; Arrhythmia; Anger; Stress
Interventions: Behavioral: Cognitive Behavioral Stress Management (CBSM); Other: Control "Patient Education" program
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Abrupt Clopidogrel Interruption; Drug: Clopidogrel Tapering
Sponsor: Deutsches Herzzentrum Muenchen
Recruiting - verified January 2012 - Condition: Prostate Cancer
Intervention: Biological: Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine
Sponsor: Biotech Equity Partners Pty Ltd
Recruiting - verified July 2011 - Condition: Burns
Intervention: Drug: Sulfamylon® (mafenide acetate) For 5 % Topical Solution
Sponsors: Mylan Bertek Pharmaceuticals; Mylan Pharmaceuticals
Recruiting - verified December 2008 - Conditions: Heart Failure; Sleep Disordered Breathing
Intervention: Device: Europe: AutoSet CS 2 (USA: VPAP Adapt SV)
Sponsor: ResMed
Recruiting - verified December 2011 - Condition: Traumatic Brain Injury
Interventions: Drug: Carbamazepine; Drug: Placebo
Sponsors: Carolinas Healthcare System; U.S. Department of Education
Recruiting - verified June 2011 - Condition: Cancer
Interventions: Behavioral: Family Focused Group Therapy; Behavioral: Family Focused Group Therapy; Behavioral: Standard of Care
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI); Beth Israel Medical Center; Calvary Hospital, Bronx, NY
Recruiting - verified September 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: panitumumab; Drug: everolimus; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Condition: Schizophrenia
Interventions: Behavioral: Social Cognition Interaction Training; Behavioral: WLC
Sponsor: VA Connecticut Healthcare System
Recruiting - verified July 2011 - Condition: Sleep-Related Eating Disorder
Intervention: Drug: Topiramate or Placebo
Sponsor: Brigham and Women's Hospital
Recruiting - verified July 2011 - Condition: Acute Myeloid Leukemia (AML)
Intervention: Biological: Hematopoietic stem cells from bone marrow or peripheral blood
Sponsor: Hannover Clinical Trial Center GmbH
Recruiting - verified September 2011 - Condition: Major Depression
Intervention: Behavioral: Treatment Initiation Program (TIP) intervention
Sponsor: Weill Medical College of Cornell University
Recruiting - verified January 2011 - Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: neoadjuvant erlotinib therapy; Drug: neoadjuvant gemcitabine/carboplatin therapy
Sponsor: Guangdong Provincial People's Hospital
Recruiting - verified January 2010 - Condition: Smoking Cessation
Interventions: Behavioral: Vignette, questionnaires and Saliva Samples; Behavioral: Urine Collection, Smoking cessation treatment
Sponsors: Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; Vanderbilt University School of Medicine
Recruiting - verified December 2011 - Condition: Chronic Schizophrenia
Interventions: Behavioral: Cognitive remediation therapy; Genetic: COMT Genotyping
Sponsors: Manhattan Psychiatric Center; National Institute of Mental Health (NIMH); Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified April 2008 - Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension; PAH WHO Group I
Interventions: Drug: Sitaxsentan; Drug: Bosentan, Ambrisentan
Sponsors: West Penn Allegheny Health System; National Institutes of Health (NIH); Baylor College of Medicine; Emory University; University of Chicago; Johns Hopkins University; Tufts Medical Center; Sir Mortimer B. Davis - Jewish General Hospital; London Health Sciences Centre; University of Maryland; University of California, San Francisco; University of Calgary; Chest Medical Associates; Columbia University; Lung Diagnostics, Ltd.; Duke University; University of California, Los Angeles; Latter Day Saints Hospital; Louisiana State University Health Sciences Center in New Orleans; Massachusetts General Hospital; Mayo Clinic; Medical College of Wisconsin; Southeastern Lung Care; Suncoast Lung Center; Children's Hospital Colorad; University Hospitals of Cleveland; University of Colorado, Denver; University of Michigan; University of Pittsburgh; University of Southern California; The University of Texas, Galveston; Vanderbilt University; Wayne State University; Ohio State University; University of Alabama at Birmingham; Washington University School of Medicine; Sentara Norfolk General Hospital; University of Texas Southwestern Medical Center; Bay Area Chest Physicians
Recruiting - verified January 2012 - Condition: Cocaine Addiction
Interventions: Behavioral: I/GDC + VR/CER; Behavioral: I/GDC
Sponsors: Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Condition: Prostate Cancer
Interventions: Behavioral: Questionaires; Behavioral: Questionaires
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI); City of Hope National Medical Center; Fordham University; Columbia University; New York University Medical Center
Recruiting - verified January 2012 - Condition: Atrial Fibrillation
Intervention: Procedure: Endoscopy in group I (all patients)
Sponsor: University of Oklahoma
Recruiting - verified March 2011 - Conditions: Atrial Fibrillation; Atrial Flutter; Stroke; Embolism, Systemic Arterial; Major Bleeding
Interventions: Drug: Oral Anticoagulation; Drug: Oral Anticoagulation
Sponsor: Biotronik, Inc.
Recruiting - verified January 2012 - Conditions: Breast Cancer; Cognitive Side Effects of Cancer Treatments; Stage I, II and III A Breast Cancer
Interventions: Behavioral: Questionnaires, MRI, Comet assay and Cell senescence; Behavioral: Questionnaires, MRI, Comet assay and Cell senescence; Behavioral: Questionnaires, MRI, Comet assay and Cell senescence
Sponsors: Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; The City College of New York; Brigham and Women's Hospital
Recruiting - verified August 2011 - Conditions: Epilepsy; Partial Seizure Disorder; Epilepsies, Partial; Complex Partial Seizure Disorder
Interventions: Drug: Pregabalin; Drug: Gabapentin
Sponsor: Pfizer
Recruiting - verified January 2012 - Condition: Spinal Cord Injury
Interventions: Behavioral: Cardiovascular training; Behavioral: Balance training
Sponsor: University of British Columbia
Recruiting - verified September 2011 - Condition: Joint Range of Motion
Interventions: Behavioral: Emotional Freedom Techniques (EFT); Behavioral: Diaphragmatic Breathing (DB); Behavioral: No Treatment
Sponsor: Soul Medicine Institute
Recruiting - verified June 2011 - Condition: Neuropathic Pain
Interventions: Procedure: Acupuncture + electrical stimulation; Procedure: Sham acupuncture
Sponsors: Toronto Rehabilitation Institute; Canadian Institutes of Health Research (CIHR); University of British Columbia
Recruiting - verified November 2011 - Condition: Palliative Care
Interventions: Behavioral: Meaning Centered Group Psychotherapy; Behavioral: Supportive Group Psychotherapy
Sponsors: Memorial Sloan-Kettering Cancer Center; Fordham University
Recruiting - verified January 2012 - Condition: Oppositional-Defiant Disorder
Interventions: Behavioral: Parent management training (PMT); Behavioral: Collaborative problem solving (CPS); Behavioral: Waitlist control
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Birdshot Chorioretinopathy; Cystoid Macular Edema; Transient Partial Visual Loss
Interventions: Drug: interferon alpha 2a; Drug: prednisone
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified October 2008 - Condition: Constipation
Interventions: Procedure: Individually acupuncture; Drug: Lactulose; Procedure: shallow acupuncture
Sponsors: Guang'anmen Hospital of China Academy of Chinese Medical Sciences; Ministry of Science and Technology of the People´s Republic of China
Recruiting - verified September 2011 - Condition: IgA Nephropathy
Interventions: Drug: Intravenous Rituximab; Drug: Group 2 ACE/ARB
Sponsors: Mayo Clinic; Georgia Health Sciences University; Ohio State University; Stanford University; University of North Carolina, Chapel Hill; Vanderbilt University; Columbia University
Recruiting - verified May 2011 - Conditions: Pulmonary Hypertension; Connective Tissue Disease
Intervention: Behavioral: exercise training
Sponsor: University of Heidelberg
Recruiting - verified May 2007 - Conditions: Colorectal Cancer; Neoplasm Metastasis
Interventions: Drug: dexamethasone; Drug: floxuridine; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Recruiting - verified July 2009 - Condition: Bipolar II Depression
Interventions: Drug: Lamotrigine plus plus antidepressant medication subjects were prescribed prior to study entry; Drug: Lamotrigine
Sponsor: University of British Columbia
Recruiting - verified August 2011 - Condition: Endometriosis
Interventions: Drug: Conjugated equine estrogens; Drug: Placebo; Drug: Norethindrone acetate
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: Graft Versus Host Disease; Infection; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Genetic: polymerase chain reaction; Other: bronchoalveolar lavage; Other: immunoenzyme technique; Other: laboratory biomarker analysis; Procedure: bronchoscopy; Procedure: management of therapy complications
Sponsor: St. Bartholomew's Hospital
Recruiting - verified September 2007 - Conditions: Ototoxicity; Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Procedure: management of therapy complications
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified April 2011 - Conditions: Depression; Sleep Apnea, Obstructive
Intervention: Device: continuous positive airway pressure (CPAP)
Sponsor: Queen's University
Recruiting - verified June 2011 - Conditions: Obesity; Oligospermia
Interventions: Drug: Anastrozole; Drug: Placebo
Sponsor: University of Utah
Recruiting - verified November 2011 - Condition: Dyspepsia
Interventions: Procedure: Individualized and comprehensive information; Drug: Lanzo Melt; Drug: Lanzo Melt
Sponsor: Helse Fonna
Recruiting - verified June 2011 - Condition: Small Intestine Cancer
Interventions: Drug: capecitabine; Drug: irinotecan hydrochloride; Drug: oxaliplatin
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified April 2011 - Condition: Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: carmustine; Drug: cyclophosphamide; Drug: cytarabine; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: etoposide phosphate; Drug: ifosfamide; Drug: melphalan; Drug: prednisolone; Drug: prednisone; Drug: procarbazine hydrochloride; Drug: vinblastine sulfate; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy
Sponsor: Martin-Luther-Universität Halle-Wittenberg
Recruiting - verified June 2007 - Conditions: Sleep Apnea, Obstructive; Respiration Disorders
Interventions: Procedure: supraglottoplasty with laser; Procedure: laser supraglottoplasty
Sponsor: Indiana University School of Medicine
Recruiting - verified June 2011 - Condition: Sickle Cell Disease
Intervention: Behavioral: Brief Cognitive-Behavioral Pain Management Training
Sponsors: University of South Carolina; Pfizer
Recruiting - verified August 2011 - Conditions: Chronic Kidney Disease; Chronic Heart Failure; Anemia
Intervention: Drug: intravenous administration of iron-sucrose
Sponsor: Anemia Working Group Romania
Recruiting - verified January 2012 - Condition: Breast Cancer
Intervention: Drug: chemotherapy
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI); Cancer and Leukemia Group B
Recruiting - verified September 2011 - Condition: Cocaine Abuse
Interventions: Other: Treatment as usual (TAU); Behavioral: CBT for CBT
Sponsors: Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2011 - Condition: Graft Versus Host Disease
Interventions: Drug: Alefacept (AMEVIVE®); Drug: control group
Sponsor: Hadassah Medical Organization
Recruiting - verified December 2010 - Conditions: Heart Failure; Anemia; Cardiovascular Disease; Ventricular Dysfunction; Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa; Drug: Placebo
Sponsor: Amgen
Recruiting - verified January 2012 - Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
Interventions: Drug: doxorubicin hydrochloride; Drug: ifosfamide; Other: clinical observation; Procedure: therapeutic conventional surgery; Radiation: radiation therapy
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Schizophrenia
Interventions: Behavioral: Group Skills Training and Psychoeducation; Behavioral: Individual Case Management; Drug: Oral Risperidone; Drug: Risperidone in Long-Acting Injectable Form (Consta)
Sponsors: National Institute of Mental Health (NIMH); Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified October 2011 - Conditions: Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders
Interventions: Biological: therapeutic allogeneic lymphocytes; Drug: Sirolimus
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Smoking; Tobacco Use Cessation
Interventions: Behavioral: MBAT Group Therapy; Drug: Nicotine; Behavioral: Group Therapy; Behavioral: Individual Therapy
Sponsors: M.D. Anderson Cancer Center; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: chemotherapy; Drug: exemestane; Drug: letrozole; Drug: tamoxifen citrate
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B; American College of Surgeons; North Central Cancer Treatment Group; NCIC Clinical Trials Group; National Surgical Adjuvant Breast and Bowel Project (NSABP)
Recruiting - verified July 2011 - Condition: Cerebral Palsy
Interventions: Procedure: Upper Extremity Tendon transfer; Procedure: Botulinum Toxin injections in Upper Extremity; Procedure: Regularly ongoing therapy
Sponsor: Shriners Hospitals for Children
Recruiting - verified January 2012 - Condition: Bladder Cancer
Interventions: Biological: trastuzumab; Drug: paclitaxel; Radiation: radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With OsteosarcomaCondition: Sarcoma
Interventions: Biological: PEG-interferon alfa-2b; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: methotrexate
Sponsors: Children's Oncology Group; National Cancer Institute (NCI); University College London Hospitals
Recruiting - verified June 2011 - Condition: Neoplasms
Interventions: Behavioral: Mind-Body Psychotherapy Group; Behavioral: Mind-Body Psychotherapy Group
Sponsors: Albert Einstein College of Medicine of Yeshiva University; American Cancer Society
Recruiting - verified February 2012 - Conditions: Parkinson's Disease; Dysphagia; Dysarthria
Interventions: Behavioral: Voice/Respiration Treatment; Behavioral: Speech/Articulation Treatment; Behavioral: No intervention (PD); Behavioral: HC control
Sponsors: University of Colorado, Boulder; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified May 2011 - Condition: Retinoblastoma
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: cyclosporine; Drug: etoposide; Drug: vincristine sulfate; Procedure: cryosurgery; Procedure: laser surgery; Procedure: neoadjuvant therapy
Sponsor: The Hospital for Sick Children
Recruiting - verified April 2009 - Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: cyclophosphamide; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: radiation therapy
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Conditions: Hodgkin Disease; Non Hodgkin Lymphoma
Interventions: Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 1); Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 2); Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 3)
Sponsors: Baylor College of Medicine; Texas Children's Hospital; The Methodist Hospital System; Center for Cell and Gene Therapy, Baylor College of Medicine
Recruiting - verified August 2011 - Condition: Sarcoma
Interventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: University Hospitals, Leicester; National Cancer Institute (NCI); Children's Cancer and Leukaemia Group; Societe Francaise Oncologie Pediatrique; European Organization for Research and Treatment of Cancer - EORTC; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria; Swiss Group for Clinical Cancer Research; EBMT Solid Tumors Working Party; Children's Oncology Group
Recruiting - verified December 2011 - Condition: Lymphoma
Interventions: Biological: filgrastim; Biological: rituximab; Biological: sargramostim; Drug: CHOP regimen; Drug: carmustine; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: prednisone; Drug: vincristine sulfate; Procedure: bone marrow ablation with stem cell support; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI); Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; NCIC Clinical Trials Group
Recruiting - verified February 2009
 |
Join Clinical Trials for Group therapy |
